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Seeking to make the EU “the most competitive knowledge-based economy 
by 2010,” the 2002 Barcelona European Council set a target for EU Research 
and Development (R&D) investment of 3 % of EU GDP, of which two thirds 
should be ﬁnanced by the private sector. This has triggered an ambitious 
policy  process.  Its  implementation  is  set  out  in  the  Commission’s  3  % 
Action Plan.1 Among other things, the plan calls for “an industrial research 
monitoring activity, including a score-board, to analyse trends and facilitate 
benchmarking of research investment and research management practices 
between ﬁrms, building on experience in Member States”. This document is 
the ﬁrst attempt to create such a scoreboard on industrial R&D investment.
The 2004 EU Industrial R&D Investment Scoreboard has been produced as 
a pilot exercise to develop a closer understanding of company-level R&D 
in Europe by comparing European companies with those elsewhere. The 
Scoreboard lists the research investments of the top 500 corporate investors 
in R&D whose ultimate parent is located in the EU and of the top 500 
companies whose ultimate parent is outside the EU. It provides corporate 
economic and ﬁnancial data, R&D investment patterns by sectors, company 
rankings, and comparisons between EU, US and Japanese companies.
The Scoreboard presents a perspective on company R&D which is different 
to that offered by the ofﬁcial R&D statistics prepared by national statistical 
agencies and Eurostat. Ofﬁcial data look at R&D within particular territorial 
units. Here the focus is on the major R&D-investing companies, regardless 
of where their R&D is performed. This provides a complementary vantage 
point for the analysis, formulation, and promotion of new policy measures 
in support of the 3 % Action Plan. The Scoreboard enables users, such as 
companies, investors, and ﬁnancial analysts, to compare research investment 
among EU companies and sectors, not only among themselves, but also 
with US and Japanese companies. For policymakers, it is a new tool for 
understanding  the  economic  dimensions  of  corporate  R&D,  and  makes 
an important contribution to the policy debate. The wealth of new data 
provided by the Scoreboard helps to enrich our understanding of this vital 
component of the Lisbon strategy.
Achilleas Mitsos
Director General for Research
European Commission
Roland Schenkel
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Executive Summary
The 2004 EU Industrial R&D Investment Scoreboard aims to provide a tool 
for companies and organisations to benchmark their industrial research, and 
to provide relevant information for policy-makers concerning research at the 
corporate level, particularly in the context of the Barcelona 3 % objective.
The Scoreboard provides a snapshot of the top 500 companies with registered 
ofﬁces in the EU, as well as the top 500 companies with registered ofﬁces 
outside the EU, ranked by the size of their R&D investments. These companies 
are responsible for a high proportion of global business-ﬁnanced R&D.
NOTE:  The  term  “R&D  Investment”  used  in  this  report  refers  to 
corporate investment in R&D funded by companies themselves and 
their subsidiaries. It therefore excludes R&D ﬁnanced by third parties 
such  as  governments  or  other  companies.  It  also  excludes  a  given 
company’s share of any associated company or minority joint venture 
R&D  investment.  The  deﬁnitions  of  “R&D”  used  by  companies, 
following accepted international accounting standards, accord with 
deﬁnitions used in ofﬁcial statistics (as set out in the OECD’s ‘Frascati 
Manual’).
To compile this ﬁrst edition of the Scoreboard, data has been collected from 
the latest audited company reports and accounts that have been published 
up to 31 July 2004. It also encompasses data for the previous three reporting 
years.
Companies  listed  on  ofﬁcial  stock  exchanges,  private  and  state-owned 
companies  are  included,  but  companies  that  are  subsidiaries  of  any 
other  company  are  excluded  to  avoid  double  counting.  Majority-owned 
subsidiaries are consolidated in the accounts of the parent, whereas joint 
ventures that are 50 % owned by each of two partners are included as stand 
alone companies.
The  information  used  here  is  taken  directly  from  company  reports  and 
accounts, and differs from ofﬁcial R&D statistics in signiﬁcant ways. This is 
described in more detail in the ﬁrst main section of the report. The principal 
strength of the data used here is that it provides a measure of global business-
ﬁnanced investments in R&D at the corporate level. The main limitations are 
the reliance on companies’ disclosure of their R&D investments, and the 
absence of a territorial dimension to R&D performance.
In the 2004 Scoreboard, the R&D investment of the top 500 EU companies 
totalled  €  100.8  billion.  The  R&D  investment  of  the  top  500  non-EU 
companies listed in the Scoreboard is equivalent to € 195.6 billion. Over 
a. Introduction
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the past four years R&D investment in EU Scoreboard companies has grown 
signiﬁcantly slower than in non-EU companies – by 1.2 % per year, compared 
to 3.7 %.
NOTE: The terms “EU company” and “non-EU company” are used 
throughout this report refer to a company whose registered head ofﬁce 
is located in the EU or elsewhere in the world, respectively.
Comparing trends in the EU and non-EU over time is complicated by changing 
price levels and exchange rates, by business-cycle differences, and by different 
patterns of global sales across companies. However the data suggests that, 
although the proﬁtability of both EU and non-EU ﬁrms has been recovering 
from  the  recession  years  of  2001-2002,  non-EU  companies  have  been 
increasing their R&D investment at a faster rate than EU companies.
Scoreboard R&D investment is highly concentrated along three dimensions:
1.  R&D  is  concentrated  in  large  companies.  For  both  EU  and  non-EU 
companies in the Scoreboard, a small group of ﬁrms is responsible for a 
high proportion of aggregate R&D investment. The top 20 EU companies 
account for more than 55 % of total R&D investment by the EU-500 
companies. For the non-EU, the top 20 companies account for 37 %.
2.  Just as R&D investment tends to be concentrated among the largest 
companies,  the  Scoreboard  shows  that  it  is  also  concentrated  in  a 
few of the 31 FTSE sectors. For the EU-500 as well as for the non-
EU 500 companies, the four largest sectors in terms of aggregate R&D 
investment are automobiles & parts, pharmaceuticals & biotechnology, 
IT hardware, and electronics & electrical equipment. Together, these four 
sectors constitute 67 % of the global R&D investment by the Scoreboard 
companies (although they constitute only 37 % of total sales).
NOTE: The term “sector” within the text of the report refers to the 
sector of economic activities according to the FTSE (Financial Times 
Stock Exchange index) classiﬁcation, and corresponds to the sector 
in which a company declares its main activity.
  Looking at R&D investment by the two groups of EU and non-EU companies, 
the aggregate share of these four sectors is roughly the same (64 % compared 
to 68 %). However, there is a sharp difference between the two groups in the 
relative size of these sectors. The EU’s largest R&D investment is in automobiles 
& parts, while the non-EU’s largest share is in IT hardware.
3.  R&D  in  Europe  is  also  concentrated  geographically.  Companies  with 
registered head ofﬁces located in three EU countries – Germany, France, 
and the UK – together account for 74 % of EU-500 R&D investment 
(whereas these countries account for only 54 % of EU25 GDP).
The table below summarises the EU and non-EU shares of R&D investment 
within the European top 10 R&D performing sectors, together with the 
respective R&D/Sales ratios for each sector.  6  The 2004 EU Industrial R&D Investment Scoreboard
NOTE: The term “R&D/Sales ratio” used here means the ratio of a 
company’s R&D investment to its net sales.
The key point emerging from the table above is that in seven of the top ten 
R&D-performing sectors the EU companies have equivalent or higher R&D/
Sales ratios than the non-EU companies. In particular, EU ﬁrms have higher 
R&D/Sales ratios in each of the EU’s top ﬁve R&D performing sectors.
Even so, overall industrial R&D intensity (the average R&D/Sales ratio for 
the entire group of companies) is lower in the EU-500 than in the non-EU 
500. The value for the EU is 3.2 %, signiﬁcantly less than that for Japan at 
4.2 % and for the US at 4.5%.
Why is the overall ratio lower, when the sectoral comparison is so favourable? 
The main reason is that the mix of industrial sectors in the EU differs from 
that of the non-EU world. The EU has a smaller proportion of output ﬂowing 
from high R&D/Sales sectors. This is particularly noticeable in IT Hardware 
and Software & Computer Services. Together, IT Hardware and Software & 
Computer Services represent only 3.2 % of the sales of the EU ﬁrms in this 
Scoreboard, compared to 15.5 % for the non-EU ﬁrms.
Much of the difference in overall R&D/Sales ratios can be explained by the 
size difference in IT Hardware and Software & Computer Services between 
the EU and non-EU worlds. Because these two sectors together have a high 
R&D/Sales ratio relative to other sectors, their larger size in the non-EU raises 
the average R&D/Sales ratio for the whole group of non-EU companies. 
These structural differences raise important but complex issues that deserve 
attention in the future.
Table ES-1.
EU and non-EU R&D investments by sector 
EU Top 500 Non-EU Top 500
FTSE Sector Sector R&D 
Investment 
as % of  all 
sectors
R&D/









Automobiles & Parts 23.8 4.6 15.7 4.1
Pharmaceuticals & Biotechnology 17.0 15.2 18.5 15.1
IT Hardware 12.4 15.6 22.9 8.6
Electronic & Electrical Equipment 10.3 6.5 10.9 5.7
Chemicals 7.2 4.2 4.2 3.8
Aerospace & Defence 6.8 8.0 2.1 2.7
Engineering & Machinery 4.6 2.5 2.5 2.8
Telecommunication Services 2.8 1.0 2.0 2.5
Software & Computer Services 2.6 12.8 7.8 10.0
Oil & Gas 1.9 0.3 1.2 0.5
Others (21 sectors) 10.6 1.5 12.2 2.1
Total  (31 sectors) 100 3.2 100 4.5  The 2004 EU Industrial R&D Investment Scoreboard  7 
The 2004 EU Industrial 
R&D Investment 
Scoreboard presents data 
on the 500 companies in 
the European Union, with 
the greatest ﬁnancial 
commitments to R&D. 
For comparison, the 
Scoreboard also shows 
R&D investment data 
for the top 500 R&D-
active companies whose 
ultimate parent is 
registered outside the EU.
The 2004 EU Industrial R&D Investment Scoreboard presents data on the 
top 500 R&D-investing companies in the European Union, ranked according 
to their total ﬁnancial commitments to R&D. The ranking rests on worldwide 
R&D  investments  derived  from  the  consolidated  accounts  of  companies 
whose ultimate parent company is registered in one of the 25 Member States 
of the EU. The Scoreboard also includes separate R&D rankings of such 
companies located in each EU Member State. In addition, the Scoreboard 
collects R&D investment data for the top 500 R&D-investing companies 
whose ultimate parent is registered outside the EU25. All data are extracted 
from the audited annual reports & accounts of EU and non-EU companies, 
using rigorous ﬁnancial reporting practice veriﬁcation processes.
NOTE:
 - The  term  “R&D  Investment”  is  used  in  this  report  to  refer  to 
companies’  cash  investment  in  R&D  conducted  on  their  own 
behalf and funded by the companies themselves. It excludes R&D 
undertaken  under  contract  for  customers  such  as  governments 
or other companies. It also excludes the companies’ share of any 
associated company or joint-venture R&D investment. Where part 
or all of a company’s R&D costs have been capitalised, the additions 
to the appropriate intangible assets are included to calculate the 
cash investment net of amortisation.
-  The  deﬁnition  of  “R&D”  is  that  used  by  companies,  following 
accepted international accounting standards (IAS 38), in accordance 
with  the  deﬁnitions  used  in  ofﬁcial  statistics  (as  deﬁned  in  the 
OECD’s ‘Frascati Manual’).
-  The  terms  “EU-company,  non-EU  company  or  German- 
company, Finnish-company, US- company, Japanese- company, 
etc. ” are used throughout this report to refer to a company 
whose ultimate parent has chosen to locate its registered office 
in that country or region.
-  The term “R&D/Sales ratio” is used in this report to mean the ratio 
of company’s R&D investment to its net sales.
-  The “sectors” in which groups of companies are classiﬁed in this 
report are those sectors of economic activity as deﬁned by the FTSE 
(Financial Times Stock Exchange index) sectorial classiﬁcations, and 
corresponds to the sector in which individual companies declare 
their main activity to be.
-  When a year is mentioned in the analysis of company data, it refers 
to the company’s published accounts for the given ﬁnancial year. 
Companies from most countries have discretion in the choice of 
accounting  period  end  and  as  a  result  the  current  year  set  can 
include accounts ending on a range of dates from the middle of one 
year to early next year.
The company data (in Annex 2 and in Volume II) presented in the 2004 EU 
Industrial R&D Investment Scoreboard for the last four available ﬁnancial 
years (i.e. 2000/2001 to 2003/2004) are:
1.  Company name.
2.  Sector  of  main  activity  declared  by  the  company,  according  to  FTSE 
classiﬁcation.
Content of the 2004 EU Industrial
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3.  Country of registration (country in which the ultimate parent company 
has chosen to locate its registered ofﬁce).
4.  Total R&D investment (in euro equivalent terms).
5.  Net sales.
6.  Operating proﬁt (or loss).
7.  Number of employees (the consolidated number of employees in the 
given year).
8.  Market capitalisation.
9.  Market breadth: net sales-percentage by destination broken down by 
location Europe, North America, Rest of the World.
10. Capital expenditure (CAPEX).
In addition, the 2004 Scoreboard includes the following information: 
a) R&D investment/net sales [as a percentage]); 
b) Net sales per employee; 
c) (R&D investment + capital expenditure) / net sales [as a percentage]; 
The 2004 Scoreboard presents rankings of the companies according to the 
following criteria:
n  Current R&D investments for EU companies.
n  Current value of R&D investments for non-EU companies.
n  Value of R&D investments for EU companies by Member State and for 
non-EU companies by country of head ofﬁce registration.
n  Value of R&D investments for all companies by industry sector (according 
to FTSE-classiﬁcation).
The analysis section (Volume I) of the 2004 EU Industrial R&D Investment 
Scoreboard  aims  to  identify  and  discuss  some  of  the  main  points  and 
trends emerging from the data collected for the 500 EU and 500 non-EU 
companies making the largest investments in R&D. There are three main 
levels of analysis described in the sections that follow:
n  An overview of the whole set of largest R&D-investing companies both 
by world region (Europe, N America, Asia Paciﬁc) and by major economy 
(EU, Japan, US). This overview rests on top-level measures such as total 
R&D investment, R&D investment as a percentage of sales (R&D/Sales 
ratio), and business performance (measured by sales growth, proﬁtability 
etc.).
n  The second level of analysis is concerned with sectors (within the limits 
of the sample size), and the way in which differences in sector size, 
sector mix and sector R&D/Sales ratio affect overall totals of R&D and 
the overall R&D/Sales ratio.
n  Third, it is important to explore the apparent or possible strengths and 
weaknesses of the companies within the main R&D investing sectors. This is 
done by comparing major EU companies with those headquartered in other 
The analysis section of the 
Scoreboard aims to identify 
and discuss some of the 
main points and trends 
emerging from the data 
collected for the 500 EU and 
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economies, identifying the concentration of R&D by sector, and comparing 
company  distributions  of  R&D/Sales  ratios.  The  sectoral  distributions 
highlight the importance of the overall investment intensity of a large sample 
of companies rather than just the small number of very large R&D-investing 
companies. This in-depth comparison of distributions can only be made for 
the EU vs. the US (for which a similar R&D Scoreboard is available) and is 
useful for comparing the large and medium-sized companies. Finally, there 
is a discussion of the links that exist between company input investments 
like R&D and capital expenditure, and company performance as output.
Key Features of the 2004 EU Industrial R&D
Investment Scoreboard:
It  relies  exclusively  on  R&D  investment  disclosed  by  companies  in 
published annual reports and accounts (it does not, therefore, include 
undeclared R&D investments). It refers to and lists only the top R&D-
investing companies.
The Scoreboard does not provide ﬁgures for all R&D investment by all 
companies.
It refers to the worldwide R&D investment of ultimate parent companies 
ranked by R&D investment in two “top 500” lists, subdivided by the 
region (EU vs. non-EU) in which these companies have chosen to locate 
their registered ofﬁce, and offers additional disaggregation by country.
The  Scoreboard  does  not  say  where  (i.e.  the  actual  geographical 
location) companies perform their R&D.
It shows the sectors of activities (following the FTSE classiﬁcation) which 
the companies themselves state as being their main activity in their 
published annual reports or when listed on an ofﬁcial stock exchange
The Scoreboard says nothing about the ﬁelds of research in which 
companies are doing R&D.
The Scoreboard does not say anything about how companies invest 
in R&D. In particular, it does not distinguish between intramural and 
extramural R&D. However, it does exclude R&D investment undertaken 
under contract for customers such as governments or other companies. 
It also excludes the companies’ share of any associated company or 
joint venture R&D investment.
The  Scoreboard’s  data  therefore  complement  information  collected 
from other sources, such as national statistical ofﬁces, Eurostat or other 
organisations (e.g. business enterprise expenditure on R&D). It can also 
complement any other information companies may choose to disclose or 
to gather and that may be relevant to R&D activity at a micro-economic 
level.
The Scoreboard does not aim to replace other sources of information 
with which to monitor private R&D.
It is a direct input measure of industrial investment in R&D.
Industrial R&D investment is not intended to be the only measure 
of innovation and business attractiveness. The Scoreboard does not 
report or analyse any types of investment in non-tangible assets or 
knowledge-related activities other than companies’ R&D investments.  10  The 2004 EU Industrial R&D Investment Scoreboard  The 2004 EU Industrial R&D Investment Scoreboard  11 
Introduction
This ﬁrst European Union R&D Scoreboard presents information on the R&D 
investments of each of the 500 largest EU companies in terms of their R&D 
investments.2 It also lists the 500 largest non-EU R&D investing companies. 
The aim is to provide an in-depth assessment of future-oriented investments 
being  made  by  European  companies,  in  the  form  of  R&D  and  capital 
expenditure (Capex), and to compare these with those of the larger R&D-
active companies outside Europe. As well as R&D and capital expenditure, 
a range of ﬁnancial performance data is included, such as sales, operating 
proﬁts and market capitalisation. The EU R&D Scoreboard thus provides a 
detailed perspective on EU company-level R&D compared to the rest of the 
world in the same way that the existing UK and US Scoreboards do for these 
countries.3 
The  “Lisbon  Strategy”,  agreed  by  EU  leaders  at  the  Lisbon  European 
Council in 2000, aims at making the EU “the most competitive knowledge-
based economy in the world”. It recognises that this will require an increase 
in productivity, and that productivity is increased through activities such 
as R&D and skills development. In March 2002, the European Council in 
Barcelona set an overall goal of 3 % for R&D as a proportion of GDP, with 
two-thirds of this ﬁnanced by the private sector. The most recent data 
(2002) show that R&D in the EU is about 2 % of GDP of which about 55 
% is ﬁnanced by industry. Overall R&D investment by industry in the EU 
will need to rise by about 10 % per annum between now and 2010 to meet 
the Barcelona target.
The EU Scoreboard is a particularly valuable tool with which to assess the 
progress being made by EU companies at the high end of the R&D investment 
spectrum and to compare their progress with that of their competitors based 
in other leading economies, particularly the US and Japan. However, while 
the Scoreboard enables changes in the worldwide R&D investments of larger 
companies to be monitored, it does not permit a direct assessment of progress 
of the contribution being made by EU companies to the Barcelona goal of 
increasing business R&D investment intensity in the EU. This is because it 
measures total EU company R&D investments worldwide rather the amount 
of industrial R&D investment within the EU. The Scoreboard is nonetheless 
very instructive and relevant to the broader remit of the 3 % Action Plan 
as it provides a means of monitoring global R&D trends of companies on a 
sectoral, country-by-country, or world-region basis. This is complementary 
to, and does not replace, the “territorially speciﬁc” data collected by ofﬁcial 
statistical agencies.
The approach used for collecting the data for this Scoreboard is explained 
in detail in the next section. It uses the published and audited accounts of 
2  Companies are allocated to the country where their ultimate parent company has chosen 
to locate its registered ofﬁce. The accounts used are the consolidated group accounts of 
the ultimate parent company. Companies which are subsidiaries of any other company 
are not ranked. This is the meaning given to the expressions “company headquarters” or 
“headquartered …. [in a given country]” which are used in the text of this report.
3  DTI 2003 R&D Scoreboard, UK Department of Trade & Industry, October 2004. Copies 
can be obtained by email from publications@dti.gsi.gov.uk. See also the website: www.
innovation.gov.uk/ﬁnance.  U.S.  Industrial  R&D  Scoreboard  2003,  Industrial  Research 
Institute, December 2003.
Section 1
Overall R&D investment by 
industry in the EU will need 
to rise by about 10% per 
annum between now and 
2010 to meet the Barcelona 
target of 3% of GDP being 
devoted to R&D.
The EU Scoreboard is a 
means of assessing the 
progress being made by 
EU companies at the high 
end of the R&D investment 
spectrum and to compare 
their progress with that of 
their competitors based in 
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each company’s consolidated operations so that ﬁgures for R&D investment, 
sales, proﬁts etc. used are those published for the company’s worldwide 
activities. This approach enables inputs such as R&D and Capex to be related 
to outputs such as sales growth, market capitalisation, and value added 
for each company and its competitors. Of course, there are cases where 
companies concentrate R&D investment in one speciﬁc sector of their multi-
sector portfolio of commercial operations. However, even in this case, such 
a sector-oriented type of R&D investment can beneﬁt the overall economic 
performance of the company in question.
While the location of a company’s R&D is important for the countries in which 
it chooses to locate (or not to locate) its R&D facilities, this factor does not 
affect the Scoreboard data, either overall or in terms of the R&D/Sales ratio 
(taken as a measure of company-level R&D intensity), except when changes 
in exchange rates affect the annual ranking, as exchange rate ﬂuctuations 
can inﬂuence the R&D/ sales ratio if R&D investment is highly concentrated 
in the euro or dollar area while sales are more evenly distributed worldwide. 
The Scoreboard focuses instead on companies’ consolidated operations so 
that all sales, manufacturing and R&D are included, wherever they occur 
in the world. This approach has its limitations, of course, particularly in the 
case of those few companies that have two or more divisions operating in 
different sectors, since the consolidated results represent averages of R&D, 
sales etc. across the sectors.
Although  complementary,  this  approach  is  fundamentally  different  to 
that followed by EUROSTAT, the OECD and national statistics ofﬁces for 
Business Enterprise Expenditure on R&D (BERD) data published by country. 
More information about differences and complementarities between the 
Scoreboard and BERD data is offered in Box 1.
BOX 1
Scoreboard and BERD: differences and complementarities
There is an important difference between the data presented in the EU 
R&D Scoreboard and data on business enterprise expenditure on R&D 
(BERD) collected by national statistical agencies, and published by the 
OECD and Eurostat.
The R&D measure used in the Scoreboard refers to all R&D performed 
and ﬁnanced by a particular company, regardless of where that R&D 
is performed. Where possible (that is, where the relevant information 
is  available)  the  Scoreboard  ﬁgure  excludes  R&D  ﬁnanced  by 
governments or other companies, and also excludes the companies’ 
share of any associated company or joint venture R&D investment.4 
The  Scoreboard  therefore  presents  companies’  global  ﬁnancial 
commitment to R&D.
The ofﬁcial concept, BERD, refers to all R&D performed by businesses 
within a particular sector and territory, regardless of the home location 
of the business, and regardless of the sources of ﬁnance (so BERD 
includes R&D performed by a company but ﬁnanced by government, 
4  Where some or all of a company’s R&D costs have been capitalised, the additions to 
the appropriate intangible assets are included to calculate the cash investment net of 
amortisation.
The Scoreboard provides 
a means of monitoring 
global R&D trends on 
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research councils, non-proﬁt foundations, or from overseas, by other 
companies and by itself). BERD includes R&D located in a given country 
and carried out by those parts of companies (including foreign-owned 
subsidiaries) that are located in the country.
From an analytical perspective, the Scoreboard is primarily relevant 
for those concerned with benchmarking company commitments and 
performance (such as companies, investors, business organisations, and 
policymakers). BERD data is primarily used by economists, governments 
and international organisations interested in the R&D performance of 
territorial units that are deﬁned by political boundaries. However, both 
types of measure are useful to policy-makers seeking a complete picture 
of private R&D investment trends and patterns. The Scoreboard gives 
policymakers and others a vantage point on the relevant companies’ 
global R&D investments and the economic outcomes which ultimately 
derive  from  business  strategy  decisions.  In  particular  it  shows  how 
much companies are investing in R&D and in which industries the most 
R&D-active companies operate.
Further relevant differences are:
n  The  sampling  processes  are  different.  The  Scoreboard  collects 
all  the  relevant  data  published  in  its  sample  of  the  500  largest 
companies, provided the company’s R&D investment is above the 
Scoreboard’s minimum level. BERD typically takes on a stratiﬁed 
sample, covering all large companies and a representative sample of 
smaller companies.
n  R&D  intensities  are  deﬁned  differently.  BERD  measures  R&D 
intensity  for  a  sector,  region  or  country  in  terms  of  R&D  as  a 
percentage of value added. The Scoreboard measures company-
level R&D intensity in terms of the R&D/Sales ratio. The reason 
for this is that value added data are not available by company for 
US or Japanese companies because of the limitations of accounting 
practices, so European companies can only be compared with US or 
Japanese ones by using the R&D/Sales ratio.
n  In  terms  of  the  sectoral  classiﬁcations  used,  BERD  information 
follows NACE (the European statistical classiﬁcation of economic 
sectors),  while  the  Scoreboard  classiﬁes  companies’  economic 
activities according to FTSE (Financial Times Stock Exchange index) 
classiﬁcation.5
It is difﬁcult to compare the Scoreboard ﬁgures and BERD data. Even 
if it were the case that both were fully comprehensive and accurately 
measured, the global measurements would still differ (a) because BERD 
includes non-company sources of R&D ﬁnance, and (b) because the 
measurements refer to different samples of ﬁrms. For example, the 
latest available ﬁgure of BERD for EU25 is € 122 billon (in current 
euros) in 20026, while the total volume of global R&D investment by 
5  NACE  stands  for  “Nomenclature  générale  des  Activités  économiques  dans  les 
Communautés Européennes”. In fact, companies themselves decide which FTSE sector is 
the most appropriate for their particular mix of business and consequently declare a main 
activity when listing on a stock market.  14  The 2004 EU Industrial R&D Investment Scoreboard
the top 500 EU companies in the ﬁnancial year 2003/04 is of € 101 
billion (in current euros).
Bearing  in  mind  that  the  sector  classiﬁcations  in  BERD  and  the 
Scoreboard  are  different,  the  Scoreboard  can  nevertheless  provide 
useful complementary information because it refers to overall industrial 
R&D performed by companies whose registered ofﬁces are located 
in the EU. This gives rather a different perspective on the scale of 
European R&D investment compared to ofﬁcial statistics. For example, 
Scoreboard R&D expenditure by the three largest Swiss pharmaceutical 
companies Novartis, Roche, and Serono is signiﬁcantly higher than total 
Swiss BERD. In 2000 these three ﬁrms alone invested € 5.7 billion in 
R&D world-wide, while overall Swiss Business Enterprise Expenditure on 
R&D reported by Eurostat for 2000, was approximately € 5.0 billion.
How can this Scoreboard be of use to ﬁrms and policymakers? A company’s 
R&D investment is a central contributor to innovation. R&D helps ﬁrms 
develop new products, processes and services and so maintain and enhance 
value added. In a world where more and more countries are industrialising, 
Europe needs to lead in R&D in those sectors where it is a key generator 
of added value. Successful European companies will compete by staying 
ahead with new products, processes and services which, when combined 
with marketing skills, operational excellence and sound strategic choices, will 
enable them to grow value added consistently and continue to provide skilled 
jobs. The EU R&D Scoreboard allows inputs to this process to be monitored 
by  sector  and  by  company  for  comparison  with  equivalent  companies 
headquartered in the US and Japan. The Scoreboard offers policy-makers 
a picture of the relevant companies’ global R&D investments and economic 
outcomes which ultimately derive from business strategy decisions, including 
how much, and in which industries, ﬁrms are performing R&D.
The Scoreboard is intended for four main audiences:
n  Companies: To help them benchmark their own R&D investments and 
performance  against  international  and  European  competitors  in  their 
sectors.  Benchmarking,  coupled  with  more  effective  investment  and 
performance improvement programmes, is a way for companies to close 
performance gaps between them and their best international competitors. 
The data and analysis included in this Scoreboard provide opportunities 
for all interested EU companies to compare themselves with relevant 
benchmarks from the top 500 EU companies (registered in 16 countries 
and stating their main business to be in 31 different FTSE sectors) and top 
500 non-EU R&D-investing companies.
n  Investors: To help investors assess the prospects of companies which are 
in or might be added to, their portfolios. In particular, investors will want 
to ask about the size of each company’s R&D investment relative to that 
of its competitors and the adequacy of its new product pipeline. Large 
investors can use the Scoreboard to provide a ﬁrm foundation for their 
discussions with companies on this issue.
6  OECD MSTI, May 2004; and Eurostat, European Commission, New Chronos, October 
2004.
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n  Business  Organisations:  These  include  organisations  representing 
businesses (or employees) in each country, and sectoral organisations. 
Some of these organise best practice programmes which help companies 
to learn from each other.
n  Government Organisations: Governments – notably investment agencies 
- at regional and national levels, and policy-makers at the European level, 
need  information  on  businesses  as  well  as  information  on  particular 
territories. Sectoral mixes, R&D/Sales ratios and the business environment 
for key sectors are examples of important policy concerns that arise from 
Scoreboard-based comparisons of one economy with another. The R&D 
Scoreboard provides the basis for evidence-based policy development 
in the areas of R&D investment and the business environment for R&D-
active companies in the EU.  16  The 2004 EU Industrial R&D Investment Scoreboard  The 2004 EU Industrial R&D Investment Scoreboard  17 
The Company Data
The data section of the Scoreboard contains three sets of company data 
ordered by FTSE sector, by country and by size of R&D investment. All data 
are taken directly from copies of the audited annual reports and accounts 
(consolidated group accounts) of the companies concerned. Since companies 
have different ﬁnancial year ends, the Scoreboard is complied by taking data 
from the latest audited company reports and accounts published on or before 
31 July 2004. Time varying data such as market capitalisation is also taken 
at close of business on the same day. An end of July date is convenient since 
the many companies with a ﬁnancial year-end at the end of December 2003 
are included as are most companies with an end March 2004 year-end. 
Since the Scoreboard includes companies reporting in different currencies, 
all currencies have been converted to euros at the exchange rates prevailing 
on 31st December 2003. Company data are presented for the two principal 
groups of companies. These are:
n  The top 500 EU companies, all of which have R&D investment of over € 
8.5 million.
n  The top 500 non-EU companies, all of which have an R&D investment 
of over € 51.4 million. There are 185 EU companies with an R&D 
investment of over € 51.6 million giving a world top 685 companies 
within which valid comparisons can be made between countries since 
the 685 companies are all in the same R&D investment size range (i.e. 
they have an R&D investment of over € 51m). A difference between 
the global 685 and the EU 315 (i.e. the 500 less the 185) is that the 
EU 315 contains companies with smaller sales that are either in an 
earlier stage of building their businesses, are competing in national 
rather than global markets, or also operate in international markets but 
simply invest less in R&D.
To ensure that the top 500 companies have been correctly identiﬁed in 
each case, data for many additional companies have been collected and 
analysed.
The scope and limitations of the data are discussed in more detail in the 
Annex. Brieﬂy, however, the aim has been to achieve a  list  as  complete 
as  possible  without  double  counting.  There  are  two  distinct  categories 
of companies included in the EU list of this Industrial R&D Scoreboard – 
stock-exchange listed companies and private companies which have their 
headquarters (i.e. the registered ofﬁce of the ultimate parent company) in 
one of the EU Member States. A third group of companies excluded from the 
EU list are the subsidiaries of non-EU companies that are located in the EU. 
These three types of companies are described below:
n  Listed companies. These are the most visible and usually have the most 
extensive disclosure of ﬁnancial data and R&D investment in their annual 
reports and published accounts. Knowledge of the R&D/Sales ratio of 
different sectors enables the search effort to be targeted by sector if 
required. For example, companies with small sales need to be examined 
in the biotechnology sector, since they may have large enough R&D 
investments to qualify them for inclusion in the top 500.
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n  Private  companies  (including  government  controlled  companies).  The 
larger EU and international private companies such as Robert Bosch, ZF, 
JCB, Arla Foods and the BBC are almost as visible as listed companies, and 
the level of disclosure is usually similar. A similar search strategy is used to 
identify them. Smaller EU private companies, on the other hand, tend to be 
less visible, are less likely to be included in databases, and some may either 
not quote R&D in their annual reports and published accounts or, in a few 
cases, may not even be prepared to provide copies of their accounts. There 
are big variations between countries. For example, in the UK, the accounts 
of all private companies must be ﬁled with Companies House and copies 
can be obtained for a small charge. In other countries, accounts may only 
need to be deposited with a local registrar and there may be no national 
(or even regional) service to provide copies at a reasonable charge.
n  EU companies owned by companies whose ultimate parent registered 
outside the EU are excluded. These companies are not included in the 
Scoreboard for two reasons. The ﬁrst is that, if they were included in the 
EU-500, there would be double counting when the larger companies from 
the EU-500 are compared with the non-EU 500. This is because many of 
the latter would already incorporate data for large EU subsidiaries in their 
consolidated accounts. Secondly, data on foreign-owned subsidiaries are 
difﬁcult to obtain in some EU countries. Moreover, they may not contain 
R&D information and may be published long after the end of the ﬁnancial 
year in question. There are, of course, no subsidiaries included in the list 
of companies in the non-EU 500. This is because it would be necessary to 
access sources of information on unlisted companies in all the countries 
concerned - this information is not even available in many EU countries.
Despite the concerns about the double counting of R&D investments, it 
would be valuable to have a separate list of R&D-active foreign subsidiaries 
in the EU given that information on the R&D investments of foreign-owned 
companies is of great interest to the countries concerned. This would permit 
monitoring of the propensity of foreign companies to set up R&D facilities 
in the EU and identifying which EU countries have been most successful 
in attracting inward investment of this type, remembering of course that 
the R&D strategy of a foreign-owned EU company is usually decided in the 
country where the head ofﬁce of the parent company is located.
Given that, amongst the larger EU nations, the UK has a very successful 
track record of attracting inward investment, the UK R&D Scoreboard ﬁgure 
of over 20 % of total R&D carried out by foreign-owned companies is likely 
to be an upper limit for the larger EU countries7. Note that, in the UK, over 
50 % of the R&D of foreign-owned companies is accounted for by just ﬁve 
companies. This is discussed in more detail in Section 5.
The more limited disclosure for smaller private companies has a relatively 
small effect on sector totals. This is because large companies dominate the 
totals and private companies in total contribute, in most countries (but not 
in all Member States), only a small fraction of the R&D investment of listed 
companies (around 4.5 % in the UK, for example) and because the data is 
difﬁcult to obtain in some countries.
Figure 2.1 shows the top 25 companies located in the EU ranked by their worldwide 
R&D investment. Together these companies invested, € 61.2 billion in R&D in 
2003 out of a total amount of € 101 billion for the EU’s top 500 companies.
7  DTI 2003 R&D Scoreboard, UK Department of Trade & Industry, October 2003.
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1. Ford Motor, USA
2. Pfizer, USA
3. Toyota Motor, Japan
4. General Motors, USA
5. Matsushita Electric, Japan
6. IBM, USA













20. Cisco Systems, USA
21.   Samsung Electronic, South Korea
22. Nissan Motor, Japan
23. Fujitsu, Japan
24. General Electric, USA
25. Canon, Japan
Figure 2.1.
Ranking of top EU and non-EU 25 companies and their location, by worldwide R&D 









9. Robert Bosch, Germany
10.Philips Electronics, The Netherlands
11. BMW, Germany
12. Bayer, Germany
13. EADS, The Netherlands
14. Peugeot (PSA), France
15. Istituto Finanziario Industriale, Italy
16. Renault, France
17. Alcatel, France
18. BAE Systems, UK
19. Sanofi-Synthelabo, France
20. Finmeccanica, Italy
21. Boehringer Ingelheim, Germany
22. BASF, Germany
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To illustrate the effects of the largest companies, sectors and countries, 
Table 2.1 shows the percentage of total R&D for the EU-500 and non-EU 
500 contributed by the top 25 companies and the top three countries and 
sectors in each case. Some 61 % of EU-500 R&D is accounted for by the top 
25 companies. In the case of the non-EU 500, this ﬁgure is 42 %.
All the top 25 EU companies, except one, have R&D investments of over 
€ 1bn, while the top 25 non-EU companies, except one, have investments 
of over € 2bn. The difference can be understood in terms of the larger US 
plus Japanese economy having a shallower drop off in R&D with number 
of companies. The top 3 sectors - automobiles & parts, IT hardware and 
pharmaceuticals  &  biotechnology  -  account  for  about  55  %  of  R&D 
investment in both cases. Companies with registered ofﬁces in just three 
EU countries - Germany, France, UK - together account for 74 % of EU-
500 R&D. The Netherlands, with just fewer than 7 %, is the fourth largest 
country in terms of the R&D invested by companies whose ultimate parents 
have their registered ofﬁces in the country.
Table 2.1.
Incidence of top companies, sectors and countries on the total R&D investment for 
the EU-500 and non-EU 500
Share of R&D investment to total contributed by EU-500 Non-EU 500
Top 25 Companies 61% 42%
Top 3 Countries8 74% 95%
Top 3 Sectors9 53% 57%
Table 2.2 lists the numbers of companies in the EU-500 for the top 10 countries 
(all those with 10 or more companies in the Scoreboard). The other six countries 
represented in the Scoreboard have 20 companies between them, nine of these 
being from Spain. The average size of company by R&D investment is also 
shown in Table 2.2 and it is clear from this that Germany has the largest average 
size due to its six very large companies with R&D over € 2.4bn.
Table 2.2.
Number of Companies and Average R&D investment per Company for companies 
with registered ofﬁce in Top 10 EU Member States














8  Largest countries by R&D investment from ﬁrms with headquarters in these countries
9  Largest sectors by R&D investment from ﬁrms operating in these sectors
10  Largest countries by R&D investment from ﬁrms with headquarters in these countries
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The large proportion of total R&D contributed by the top 25 companies 
in  each  case  does  not  mean  that  smaller  companies  are  not  important. 
The long-term success of any country or group of countries depends on 
the vigour of small companies and the proportion of them that grow their 
businesses to become medium-sized and eventually large companies. This 
is particularly important in the newer, more R&D-intensive sectors where 
growth rates are higher and a decade can see major changes in company 
size relative to established companies in more mature sectors. This vigour 
and ability to grow differ signiﬁcantly between countries and a regularly 
published Scoreboard enables quantitative estimates to be made of such 
growth. The best results are obtained when the Scoreboard is large enough 
to capture companies with relatively small R&D and when a series of at 
least ﬁve annual Scoreboards are available. Examples of companies that have 
grown fast to reach the top 20 in the world by R&D include GlaxoSmithKline, 
Intel, Microsoft and Nokia. In the 1993 global R&D Scoreboard published in 
the UK, not one of these four companies was in the top 50 and two of the 
four (Microsoft and Nokia) were not even in the top 100. In a similar way, 
there will be companies today that are too small to reach the € 51 million 
minimum R&D investment for entry to the world top of R&D-investing 
companies which will be well up this ranking in ten years’ time.
Whilst the overall total of R&D is only slightly affected by the differing levels 
of  disclosure  in  different  countries,  the  number  of  companies  that  each 
country has in the top 500 will be affected signiﬁcantly. For example, some 
75 companies have been identiﬁed (including 16 from Germany), which are 
thought to be R&D-active but which do not quote a ﬁgure for R&D in their 
accounts. Around 50 % of these may well have R&D over € 8m. There 
are also 9 companies that appear to have R&D over € 8m but their annual 
reports only quote R&D as percentage of sales rather than as a speciﬁc 
ﬁgure for R&D investment; they have not been included in the Scoreboard 
since no audited ﬁgure for R&D is given. In addition, there are companies 
that could well have signiﬁcant R&D but which have not responded to a 
request for them to provide a copy of their accounts. In six cases (5 from 
Germany),  companies  declined  to  supply  copies  of  accounts  saying  that 
they were private companies. It is hoped that publication of this Scoreboard 
will encourage more companies to disclose R&D in their accounts and be 
prepared to provide copies of those accounts. The incentive to do this is the 
increased visibility of R&D investment as a result of the publication of an EU 
Scoreboard. In fact, a company can enhance its attractiveness to investors or 
other providers of ﬁnance if is both growing, and is seen to be investing in 
R&D to renew its range of products and services so that it has a good chance 
of being able to continue its proﬁtable growth.
Since companies rarely report how much of their R&D is performed in each 
country, it is not possible to estimate the percentage being performed inside 
the EU or to see whether this is increasing or decreasing. Reasons why a 
company might change the EU/non-EU balance of its R&D include:
n  The need to rebalance its overall R&D activity to take account of growth 
and market opportunities in particular regions. For example, a European 
company expanding its US sales will, at the very least, need more nearer-
to-market R&D operations close to its US customers.
n  The desire to reduce R&D costs by off-shoring certain types of R&D to 
lower cost countries such as India or China (e.g. software development 
to India).
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n  The desire to place particular types of R&D in favourable environments. 
Examples might be the wider availability of certain scarce skills in one 
country or protection from disruption in another (e.g. the case of animal 
testing for pharmaceuticals).
These  are  important  issues  but  are  better  explored  by  interviews  with 
companies’  CEOs  (Chief  Executive  Ofﬁcers)  since  there  is  likely  to  be 
inadequate  information  about  them  in  company  annual  reports  and 
accounts.  The 2004 EU Industrial R&D Investment Scoreboard  23 
The Business Climate
  for R&D-Active companies
The purpose of this section is to use the overall ﬁnancial and R&D totals 
for the EU-500 and non-EU 500 Scoreboards to understand the average 
recent business performance of R&D-active companies in the major world 
economies of the EU, Japan and the US. This average business performance 
reﬂects the business climate experienced by R&D-active companies and the 
mix of companies operating in that climate. The business climate differs for 
these three major economies and also differs for different sectors although 
all are affected to some extent by the business cycle. The business cycles for 
sales in the EU and US may well have their peaks and troughs at different 
times, thus we will provide some additional information on the performance 
of these companies over the last three years.
The  2003  ﬁnancial  year  saw  the  proﬁtability  of  both  EU  and  non-EU 
companies recovering from the recession of 2001-2002, although during 
the past four years non-EU companies have been increasing their net sales 
and R&D investment at faster rates than EU companies. The other important 
macroeconomic factor has been the shift in exchange rates, with the dollar 
depreciating against the euro (from $0.94 by the end of December 2000 
and $0.89 in December 2001 to $1.05 in December 2002 and $1.26 in 
December 2003). This latter change has signiﬁcantly reduced (by some 10 
%) the number of US companies over the total number of companies, in 
any world-wide top ranking by R&D investment, for the previous years. The 
big effect that exchange rate changes can have on current values means 
that  key  dimensionless  ratios  such  as  R&D/Sales  ratio  (R&D  investment 
as a percentage of net sales) or proﬁtability (gross proﬁt as a percentage 
of net sales) may become particularly valuable comparators of companies’ 
performances. However, Scoreboard comparisons of the current year against 
a previous year use the current year exchange rates in the assessment of 
equivalent values for the previous year or years. To do otherwise would 
mean annual growth rates would be heavily affected by wide ﬂuctuations in 
exchange rates against the euro, in the case of those companies with a large 
share of their ﬁnancial operations in other currencies than the euro.
A series of headline ﬁgures for the EU-500, the non-EU 500 and the 185 top EU 
companies (which have a reported R&D investment in the same size range as 
the non-EU 500 companies) are given in Table 3.1. The differences between the 
EU-500 and EU-185 are small except in terms of size of company, in R&D/Sales 
ratio (where the EU-185 is higher) and in proﬁtability (where it is lower).
When comparing EU to non-EU companies the big effects that exchange rates (and 
also some big acquisitions) can have over short periods need to be borne in mind. 
This implies less conﬁdence can be placed in the interpretation of small changes in 
quantities such as changes in sector totals between different countries11.
3.a. Overall macroeconomic conditions and business 
performance of EU versus non-EU companies
11  Experience with Scoreboards that have been running over the latest decade (such as the 
UK-DTI R&D or Value Added Scoreboards) suggests that longer term, persistent trends 
are the most meaningful (see DTI 2003 R&D Scoreboard, UK Department of Trade & 
Industry, October 2003. Copies can be obtained by email from publications@dti.gsi.gov.
uk. See also the website: www.innovation.gov.uk/ﬁnance)
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Note: The values are for the ﬁnancial year 2003 (2003/2004 in certain cases); the growth 
rates are computed for the 2003 ﬁnancial year compared with the 2002 ﬁnancial year. For 
comparability reasons, the annual growth rates are adjusted according to the available 
sample of companies in each year (i.e. if there are no data for one company in one year, 
impeding the computation of growth rate, that particular company is excluded from the 
aggregate growth rate calculation)
The key features of Table 3.1 concern the comparison of the EU-185 and 
non-EU 500 groups of companies spanning the same size range. These are:
n  The  average  EU-185  R&D  investment  per  company  is  €  0.51bn, 
signiﬁcantly larger than the € 0.39bn for the non-EU companies. This is 
due to the group of very large companies at the top of the EU-185.
n  R&D investment by the EU-185 companies decreased by 1.9 % in 2003 
with respect to the previous year whereas R&D investment by the non-
EU 500 companies increased by 3.9 %. The change in sales was also 
very different in 2003, in the two cases, with the EU decreasing by 0.7 
% but the non-EU increasing by 6.8 %. As already mentioned, this latter 
could partly be a result of the appreciation of the euro. The fact that net 
sales and R&D investment have moved in the same direction supports 
the view that R&D investment is positively correlated with company size, 
something which has already been found in many other studies.
n  The average R&D/Sales ratio of the EU-185 companies is 3.6 % - only 80 
% of the 4.5 % for the non-EU 500 companies. The R&D/Sales ratio for 
the total number of EU-500 companies is lower still at 3.2 %.
n  Employee numbers have decreased by 2.9 % for the EU-185 and 3.4 % for 
the EU-500 companies, while remaining almost constant (-0.3 % over the 
previous year) for the non-EU 500 companies. Sales per employee show 
similar ﬁgures for companies from all the regions. As a consequence, the 
ﬁgures for R&D investment per employee are approximately 20 % smaller 
in the case of EU companies than in that of the non-EU companies.
Table 3.1.
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R&D Investment per Employee (€) 8394 9706 12094
R&D / Sales Ratio (%) 3.2 3.6 4.5
Operating Proﬁt/Net Sales (%) 7.0 6.8 9.1
R&D investment by the 
top EU-185 companies 
decreased by 1.9% in 
2003 with respect to the 
previous year whereas R&D 
investment by the non-EU 
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n  Proﬁtability was lower for the EU-185 companies at 6.8 % or 73 % of 
the non-EU 500 ﬁgure of 9.1 %, and only slightly improved in the case of 
EU-500 companies (at 7.0 %).
The caveats associated with changes in Scoreboard parameters from year to 
year are that they can be affected by exchange rates, non-synchronisation of 
the business cycle between different economies and large acquisitions, which 
have in the past had a signiﬁcant impact. Conﬁdence in the importance of 
any particular trend grows if it persists in Scoreboards over several years and 
is seen in many different companies in a sector or economy.
Given  the  differences  in  business  conditions  in  the  major  economies  of 
the world, the companies in the Scoreboard are grouped – according to 
the location of their registered ofﬁces – into ﬁve major regions, which are 
used for comparative purposes within this section: European Union, United 
States, Japan, the non-EU part of Europe (mostly Swiss companies) and the 
rest of the world (companies from Korea, Canada, China, Brazil, Australia, 
etc.). The breakdown of the R&D investment by the Top 685 companies, 
by location of the registered ofﬁce of ultimate parent, is provided in Figure 
3.1, together with the breakdown of the R&D investment of the EU-500 
by EU Member State. Section 4c will address the regional breakdown in 
more detail. A comparison of the EU-185 companies with similar groups of 
companies whose registered ofﬁces are located in the US and Japan is shown 
in Table 3.2.
3.b. Business performance of R&D investing companies
in each of the major regions
Figure 3.1.
The breakdown of R&D investment of major companies, by location of registered 
ofﬁce, in 2003 (% of total)



























A comparison of the US company data in Table 3.2 with the non-EU company 
data in Table 3.1 reveals that the US companies tend to lead the non-EU 500 
companies on most measures. For example, the US companies had an average 
The average R&D/Sales 
ratio of the EU-185 
companies is 3.6% - only 
80% of the 4.5% for the 
non-EU 500 companies. 
The R&D/Sales ratio for the 
total number of
EU-500 companies is lower 
still at 3.2%.
US companies tend to lead the 
non-EU 500 companies on most 
measures. 
For example, in 2003 the top 
R&D investing companies in the 
US increased R&D investment 
by 4.7% whereas R&D spending 
by their counterparts in the EU 
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R&D/Sales ratio of 4.9 % in 2003 vs. the non-EU 500 average at 4.5 % and US 
companies’ proﬁtability (ratio of operating proﬁts to net sales) was also higher 
than that of the non-EU 500 company average during the same period.
By comparing the ﬁnancial results of companies from the US-288 and Japan-
153 samples12 with the EU-185 companies’ ﬁgures, one can see that the 
top R&D-spending companies in the US increased R&D investment by 4.7 
% whereas their counterparts in the EU decreased R&D spending by 1.9 
%. The US companies also show a substantially higher average aggregate 
proﬁtability (ratio of gross proﬁts to net sales) than those in the EU while 
registering a smaller drop in the number of employees. These comparisons 
point to a potential gap that needs to be closed between the R&D investment 
and  the  performance  of  the  two  economies.  There  is  evidence  that  EU 
economies have experienced higher growth in the ﬁrst half of 2004 and 
it will be interesting to see if the EU/US gap shows signs of closing in the 
2005 Scoreboard. Smaller EU and US companies are compared in Section 8, 
revealing a similar gap in R&D investment. The origin of the big difference in 
the R&D/Sales ratio between US companies at 4.9 % and EU companies at 
3.6 % is explained in Section 7.
Table 3.2.
Overall Comparison of Similar-Sized Companies from the R&D Scoreboards, by 
location of registered ofﬁces, in 2003
The key points from this table for the groups of large companies investing 
in R&D in each major economy (or at least for the companies with R&D 
investment over € 51.38m) are:
n  US companies had, in 2003, the largest total R&D investment, the highest 
R&D/Sales ratio (4.9 %), the highest R&D investment growth rate and 
proﬁtability of over 10 %.
n  In 2003 Japanese companies had the smallest total R&D investment, the 
second highest R&D/Sales ratio of 4.2 %, an R&D investment growth 
rate the same as the US companies over the latest 3 years, but the lowest 
proﬁtability (5.7 %).
Factor EU-185 US-288 Japan-153
R&D Investment (€ bn) 93.9 110.8 64.9
R&D Investment / Company (€ m) 508 385 424
Change of R&D Investment over previous year (%)
Change of Net Sales over previous year (%)










R&D Investment CAGR for Last 3 years (%) 1.1 3.5 3.6
Net Sales CAGR for Last 3 years (%) 0.8 2.9 2.4
Capital expenditure / Sales (%) 4.7 6.4 6.3
R&D Investment / Employee (€) 9706 13814 12724
R&D / Sales ratio (%)







12  The number of companies with registered ofﬁces located in US and Japan, which are 
present in the non-EU 500 R&D groups on the Scoreboard is 288 and 153, respectively.
There were no substantial 
differences between EU 
and non-EU companies 
in the pattern of change 
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years.  The 2004 EU Industrial R&D Investment Scoreboard  27 
n  Investment in R&D by EU companies in 2003 fell part way between that 
of Japanese and US companies. EU-based companies had the lowest 
R&D/Sales ratio (3.6 %) and the lowest R&D investment growth rate, 
but their proﬁtability was above that of Japanese companies (6.8 %).
The trends in the R&D/Sales ratio can also be discerned from the separate 
trends in R&D investment and in net sales shown in Tables 3.1 and 3.2 and 
will be further detailed in Section 4.c. The R&D/Sales ratio for the EU-
185 companies decreased in 2003 by some 1.2 % over the previous year, 
whereas for the Japanese companies it increased by almost 1 % and for the 
US companies it decreased by more than 6 %. However, the EU companies’ 
ﬁgure is made up of an R&D investment which decreased last year by almost 
2 % and a slightly smaller net sales decrease of less than 1 %. The US 
companies, on the other hand, increased R&D investment by 4.7 %, but this 
was overshadowed by a larger sales increase of 11.2 %. However, there is no 
clear trend in the evolution of R&D/Sales ratio of top companies investing in 
R&D during the latest 4 years, as will be illustrated in the following section.
There were no substantial differences between the EU and non-EU companies 
in  terms  of  the  changes  in  their  R&D  investment  during  the  period  of 
reference (Table 3.3). In both the EU and the non-EU, approximately 70 % 
of companies were steadily increasing their R&D investments during 2000-
2003.
Table 3.3.
Distribution  of  Scoreboard  companies  by  changes  in  their  R&D  investment  in 
2000-2003
However,  more  of  the  EU  companies  reduced  R&D  investment  in  2003 
than did non-EU ones. A detailed analysis needs to be based on data from 
more years so that growth rates can be compared over a longer period 
encompassing more than one business cycle.
Given the important contribution to total R&D investment made by the 
larger companies, it is interesting to compare the changes in R&D over one 
year for the top 25 EU and the top 25 US companies. Twelve of the top 25 
EU companies reduced their R&D investment over the last year, four of them 
by double ﬁgure percentages. Only four of the top 25 US companies reduced 
R&D investment, and just one of these by a double ﬁgure percentage.
The changes over three years can be estimated from the CAGR (Compound 
Annual Growth Rate, which is the average growth per year extrapolated 
Changes in R&D Investment by Companies,
2003 over the previous year (% of total companies)
R&D Increase ≥ 5 %  R&D Increase 0-5 %  R&D Decrease
EU TOP 500 38 16 46
NON-EU TOP 500 47 16 37
Changes in R&D Investment by Companies,
2000-2003 (% of total companies)
R&D Increase ≥ 5 % p.a. R&D Increase 0-5 % p.a.
R&D Decrease 
p.a.
EU Top 500 51 18 31
Non-EU Top 500 52 19 29
In both the EU and the 
non-EU, approximately 
70 % of companies were 
steadily increasing their 
R&D investments during 
2000-2003.
The EU top-185 companies have a 
3-year CAGR for R&D investment 
and net sales of 1.1% and 0.8% 
respectively in 2000-2003. The 
Japanese companies have a 
3-year CAGR of 3.6% for R&D 
investment compared to 2.4% for 
net sales: an average increase in 
their R&D/Sales ratio of over 1% a 
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from the growth over the three year period) ﬁgures reported in Table 3.2. In 
this case, all three large regional groupings of companies show increments in 
the R&D/Sales ratio, due to the fact that, on average, R&D investments grew 
faster than net sales over the three–year period. The companies in the EU 
Top-185 have a 3-year CAGR for R&D investment and net sales of 1.1 % and 
0.8 % respectively, so there has been slight positive change in their average 
R&D/Sales ratio over the period 2000-2003. The Japanese companies, on 
the other hand, have a 3-year CAGR of 3.6 % for R&D investment compared 
to 2.4 % for net sales so their R&D/Sales ratio has increased by more than 
1 % per year on average for the last three years. The performance of the 
US companies was somewhere in between, but they started out with a 
much higher R&D/Sales ratio. These changes have to be monitored in the 
medium to long term13 and need to be related to what has happened in the 
main sectors in the three large economies, given the different structures. 
However, the overall picture is one of a gap in R&D investment/Net sales 
ratio that could begin to close in 2004 if the EU’s economic and investment 
growth are maintained.
13  For example, the DTI 2000 R&D Scoreboard showed US companies’ R&D/Sales ratio over 
a period of more than 20 years and there was a very signiﬁcant change between 1981 and 
1990 when the US companies’ R&D/Sales ratio doubled and remained at the higher value 
until 1996 when further increases occurred.  The 2004 EU Industrial R&D Investment Scoreboard  29 
R&D by Major Region and Economy
The purpose of this section is to extend the analysis of Section 3 with further 
details of the R&D performance of the EU-500 vs. non-EU 500 groups of 
companies active in the major economies of the EU and the rest of the world. 
There are three main features of R&D investment for an economy:
n  The total amount of R&D investment compared to other economies and 
the way it is distributed across the different sectors.
n  The R&D/Sales ratio of companies operating in the key sectors compared 
to the similar ratio found for companies in competitor economies.
n  The distribution of the R&D investment between companies of different 
sizes. For example, two economies may both have two large companies 
in a major sector but one may also have many more smaller, fast growing 
companies in that sector which give it more ‘strength in depth’ and 
increased dynamism
The ﬁrst two aspects are discussed in this section but the third is addressed 
in Section 8 where a large sample of EU companies (from the EU-500) 
is  compared  with  a  large  sample  of  US  companies  from  the  US  1000 
Scoreboard. The United States is the only other large economy for which a 
comprehensive Scoreboard is currently available for comparison (covering 
1000 US companies).
As in the previous Section, most of the comparisons between EU companies 
non-EU companies on the Scoreboard are made by contrasting the EU-185 
with the Japan 153, US-288 and with other groupings of companies in the 
non-EU 500. This ensures that companies of similar R&D size are being 
compared. It should be noted, however, that all these comparisons consider 
only companies with R&D spending of over € 51.38m. There may be big 
differences between the three economies in the case of smaller companies.
The  total  R&D  investment  by  the  companies  in  the  ﬁve  world  regions 
considered  in  the  analysis  is  shown  in  Table  4.1.  Companies  with  their 
registered ofﬁces in Europe (the EU-185 plus the European section of the 
non-EU 500) spent a total of € 103.8bn on R&D. This was equal to 93.6 % 
of the US companies’ R&D investment (which stood at € 110.8bn). On the 
other hand, European R&D spending was much larger than that of Japan, 
which was € 64.9bn. At almost € 94bn the EU-185 accounts for over 93 
% of the EU-500, meaning that the last 315 companies contribute slightly 
more than 7 % of the R&D investment of the largest 185 (and below 7 % 
of overall R&D investment of the EU-500); this reﬂects the steep fall in the 
distribution of company R&D size against company rank. The fall in the 
value of the US dollar relative to the euro means that a table for the year 
before at the old exchange rates would show the US companies with a much 
larger R&D investment total than that reported in Table 4.114.
4.a. Total R&D for Regions and Economies
14  This is particularly true for R&D activities, which are still performed largely within the country 
where the company’s ofﬁce is registered. BERD data for the year 2000 (STI Key Figures 2004) 
show that the ﬂows of R&D investment by companies outside their region of registration do 
not exceed 10% of the total R&D expenditure (in PPS terms). In the case of the largest three 
economies of the world, the highest net outﬂow of business sector R&D funding (€ 5 billion) 
was reported for EU-15 .
Section 4
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contrasting the top EU-185 
with the Japan-153, US-288 
and with other groupings 
of companies in the non-
EU 500. This ensures that 
companies of similar R&D 
size are being compared.  30  The 2004 EU Industrial R&D Investment Scoreboard
The  R&D/Sales  ratios  are  also  shown  in  Table  4.1.  The  Top  185  EU 
companies have an R&D/Sales ratio of 3.6 %, which is lower than that of 
the comparable Japanese companies, at 4.2 %, or US companies, at 4.9 %. 
The EU companies are also below the non-EU ones (at 4.8 %) because Swiss 
companies (which are the main contributors to research investment within 
this region) are characterised by a high R&D effort of 6.4 % (due to a large 
pharmaceuticals sector).
Table 4.1.












Total R&D investment 
(€ bn) 100.8 93.9 9.9 110.8 64.9 9.9 195.6
R&D / Sales ratio (%) 3.2 3.6 4.8 4.9 4.2 2.9 4.5
These differences are partly associated with differences in sector mix and 
partly with differences in performance between similar sectors. Figure 4.1 
shows  the  big  differences  in  the  proportions  of  the  four  largest  sectors 
between the R&D performance of major companies investing in research 
belonging to the EU-185 and non-EU 500 groups on the Scoreboard.
Figure 4.1.
R&D Investment by major sector of activity for companies in the EU-500, EU-185 













































































The structure for the EU companies shows a proportionately much larger 
automobiles  &  parts  sector  but  smaller  IT  hardware  and  slightly  smaller 
pharmaceutical sectors (the latter two being sectors with a high intrinsic 
The top EU-185 companies 
have an R&D/Sales ratio of 
3.6%, which is lower than 
that of the comparable 
Japanese companies, at 
4.2%, or US companies, at 
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R&D/Sales ratio). The very large EU companies (EU-185) also have a similar 
proportion of their R&D investment falling outside the four largest sectors – 
34 % compared to 32 % for the non-EU 500 companies, but the aggregate 
share of sectors other than these four main sectors comes to 36.5 % in the 
case of the EU-500 companies.
It is these differences in the sector mix, particularly in sectors with high R&D/
Sales ratios such as IT hardware, that account for much of the difference in 
the overall R&D/Sales ratio between the EU-185 and non-EU 500 shown in 
Table 4.1. It is important to bear in mind that two companies can dominate 
the  Scoreboard  sector  ﬁgure  by  accounting  for  well  over  50  %  of  the 
sector R&D investment represented in the overall sample. This is illustrated 
by Table 4.2 which shows sector concentrations for the EU-185, US and 
Japanese companies that are present in the Scoreboard. The concentration 
is deﬁned here as the percentage of total sector R&D investment of all the 
companies listed in the Scoreboard accounted for by the top two companies. 
The two extreme examples are EU electronics & electrical equipment where 
Siemens and Philips account for 83 % of EU sector R&D investment and 
US automobiles & parts where Ford and General Motors account for 73 % 
of the sector’s total R&D investment. It is only for IT hardware where the 
concentration falls below 30 % in the case of US companies. This is because 
the US companies are very strong in IT hardware and although the largest 
two companies by R&D (Intel and Motorola) account for over € 6bn, this is 
still only 22 % of the R&D investment by the top US-288 companies in the 
sector concerned.
Table 4.2.
R&D Investment Concentration by Sector and by Major Economies for Companies 
in 2004 Industrial R&D Investment Scoreboard, in 2003
Sector
Concentration of R&D Investment: Share of Sector 
R&D Investment contributed by top 2 Companies 
(%)
EU-185 US-288 Japan-153
IT Hardware 60 22 43
Pharmaceuticals & Biotechnology 43 38 30
Automobiles & Parts 41 73 52
Electronics & Electrical Equipment 83 55 49
The analysis from the previous Section has begun to suggest the way in 
which different economies (or in any case the companies that have their 
registered ofﬁces located in the respective countries) have developed different 
specialisations. In Figure 4.2, the proportions of total R&D investment in the 
four major sectors are shown for the EU-185, Japan-153 and the US-288 
sets of similar-sized companies. Around two-thirds of total R&D investment 
is accounted for by these four sectors for the EU and US companies but this 
rises to three-quarters for Japanese companies.
4.b. Sector Specialisation
Differences in the sector 
mix, particularly in sectors 
with high R&D/Sales ratios, 
account for much of the 
difference in the overall 
R&D/Sales ratio between the 
EU-185 and non-EU 500.
In some cases just two 
companies can dominate the 
sector ﬁgure by accounting 
for well over 50% of the 
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Japanese companies appear to be more specialised in automobiles & parts 
and electronics & electrical equipment but weaker in pharmaceuticals & 
biotechnology; US companies are strong in IT hardware and pharmaceuticals 
& biotechnology but weak in electronics & electrical equipment, while, at the 
aggregate sector level, the EU companies are clearly specialised in automobiles 
& parts and pharmaceuticals & biotechnology, but comparatively weak in IT 
hardware.
In policy terms, it is important to understand the differences outlined above, 
given the need to ensure the economy keeps its edge in those areas where it 
is strong, without overlooking weaker areas which may be important for the 
future and hence need to be encouraged, and of course bearing in mind the 
need for a degree of balance in the economy as whole. Issues of the quality 
of the local business environment and barriers to growth are very important 
when one economy wishes to close a perceived gap with another. There is a 
fuller discussion of the economies’ sectoral specialisation and the effects this 
may have on the R&D/ Sales ratio in Section 7.
The evolution over the period 2000-2003 of the R&D investment worldwide by 
the top 685 (as of 2003) R&D-investing companies is presented in Table 4.3.
As the table shows, the proportion of the major R&D-investing EU companies 
that are included in the EU-185 group as of 2003 in the aggregate R&D 
Figure 4.2.
The  proportions  of  4  major  sector’s  R&D  investment  in  total  of  similar-size 














































































4.c. R&D indicators by location of companies’ ofﬁces 
in major regions of the world
The Scoreboard’s ﬁgures 
show Japanese companies 
to be strong in automobiles 
& parts and electronics 
& electrical equipment; 
US companies to be 
strong in IT hardware and 
in pharmaceuticals & 
biotechnology; and EU 
companies to be strong 
in automobiles & parts 
and pharmaceuticals & 
biotechnology.
The aggregate R&D 
investment of world’s 
top 685 R&D-investing 
companies has decreased 
slightly over the last four 
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investment  of  world’s  top  685  R&D-investing  companies  has  decreased 
slightly over the last four years, while US companies and the companies sited 
in the Rest of the World region (mainly Korea) increased their share in total 
Scoreboard companies’ R&D investment.
Table 4.3.
The 2000-2003 evolution of the proportions of R&D investment of regional groups 
of R&D-investing top companies in aggregate R&D investment of the world’s top 
685 companies ranked as of 2003 (%)
REGIONAL GROUPS 2000 2001 2002 2003
EU (185) 33.7 34.2 33.7 32.5
US (288) 37.7 37.6 37.4 38.3
Japan (153) 22.3 21.5 22.2 22.4
Europe non-EU  (23) 3.5 3.2 3.3 3.4
Rest of the World (36) 2.8 3.4 3.5 3.4
World  Top 685 R&D investment
(€ bn equivalent, at current prices) 256.8 278.8 283.0 289.7
Note: The proportions each year are computed for the same group of top companies as 
reported in the 2004 Scoreboard, based on the 2003 ranking. In first column, following the 
name of the region where the top companies are registered, the number of companies in 
each regional group is provided in brackets.
In each of the last four years, US companies were the biggest investors in 
industrial research among the top 685 companies (reaching a proportion 
over 38 % in total, in 2003), followed by EU companies (around one third of 
total) and Japanese companies (between 21.5 % and 22.4 %).
The overall deceleration in the world economy during 2001-2003 (which hit 
the major economies particularly hard) was probably the main contributor 
to the very low growth rate in R&D investment of the top 685 companies 
worldwide,  registered  in  2002  (0.5  %,  not  adjusted  for  inﬂation).  As 
Figure 4.3A highlights, the outlook for the top 685 companies in the 2004 
Scoreboard shows the signs of an incipient recovery in 2003.
The close correlation between the growth in net sales and that in R&D 
investment suggests there is a direct relationship between these two variables 
during the period studied.
Consequently, the ratio between the aggregate R&D investment and net 
sales for the top 685 companies listed in the Scoreboard15 did not change 
signiﬁcantly during the period 2000-2003, as Figure 4.3B shows. The R&D/
Sales ratio varied between 4.1 and 4.316.
15  This indicator is a good equivalent for the company R&D intensity (the ratio between R&D 
spending and the value added of the given company in one period), often used to replace 
it due to the lack of data concerning value added in publicly available company reports.
16  It means that the R&D intensity of the group of top R&D-investing companies – which 
usually is signiﬁcantly higher than the R&D/Sales ratio, due to the fact that value added 
is smaller than the net sales - is quite high in comparison to the average R&D intensity in 
the overall economy (reported at 1.9% on average for the EU economy, for example). This 
implies that achieving the overall Barcelona target involves a far higher target for these 
companies than the average 3%.
In each of the last four 
years, the US companies 
among the world’s top 
685 were the biggest 
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investment suggests there 
is a direct relationship 
between these two 
variables during the period 






































2000 2001 2002 2003
Note: For comparability reason, the annual growth rates have been adjusted depending on 
the sample of companies available in each year (if there are data missing for one company in 
one year, preventing the computation of growth rate, that particular company is excluded 
from the aggregate growth rate calculation).
Figure 4.3A.
The change in annual growth rates of R&D investment and net sales from 2001-
2003 for the world top 685 R&D-investing companies (percentage change on the 
previous year)
R&D investment change over previous year (%)




















































The change in the R&D/ Sales ratio (%) during 2000-2003 for the world top 685 
R&D-investing companies (grouped according to the 2003 Scoreboard ranking)
Another factor that drives companies’ appetite to invest in research seems 
to be how their proﬁtability changes over time (based on operating proﬁt 
deﬁned as a percentage of net sales). This is shown in Table 4.4:  The 2004 EU Industrial R&D Investment Scoreboard  35 
We may compare these data with the actual growth rates of R&D investment 
and net sales (reported for the main regions in which ultimate parent companies 
listed in the Scoreboard have chosen to site their registered ofﬁce) in order to 
understand the motivations of multinationals and large companies for their 
research investment decisions, during recent years (Tables 4.5 and 4.6):
Table 4.4.
Gross proﬁts as a percentage of net sales for the Top 685 companies worldwide 
listed in the 2004 R&D Scoreboard
REGIONS  2000 2001 2002 2003
EU-185 8.2 3.1 1.9 6.8
US-288 14.0 4.4 2.6 10.3
Japan-153 4.5 4.1 3.6 5.7
Europe non-EU 16.4 12.1 7.8 12.4
Rest of the World 20.2 12.8 7.5 14.4
EU-500 8.4 3.0 1.8 7.0
non-EU 500 11.0 5.3 3.7 9.1
Table 4.5.
R&D investment growth rates (% over the previous year) for Top 685 companies 
investing in R&D worldwide, by location of registered ofﬁces in major regions
Table 4.6.
Net sales growth rates (% over the previous year) for Top 685 companies investing 
in R&D worldwide, by location of registered ofﬁces in major regions
REGIONS 2001 2002 2003
EU-185 6.94 -1.47 -1.88
US-288 5.86 0.13 4.70
Japan-153 4.15 3.78 2.77
Europe non-EU -0.59 2.74 7.84
Rest of the World 30.12 -4.95 -0.27
EU-500 7.15 -1.36 -2.03
non-EU 500 5.96 1.21 3.95
REGIONS 2001 2002 2003
EU-185 4.39 % -1.32 % -0.66 %
US-288 0.03 % -2.00 % 11.20 %
Japan-153 4.15 % 1.02 % 2.01 %
Europe non-EU 1.17 % 1.36 % 0.74 %
Rest of the World 14.54 % 3.40 % 5.38 %
EU-500 4.39 % -1.03 % -0.58 %
non-EU 500 2.47 % -0.33 % 6.81 %
The following conclusions can be drawn from the tables presented above:
-  Companies  in  all  the  regions  suffered  a  decline  in  proﬁts  in  2001 
compared to 2000, which worsened in 2002. They began to see a 
proﬁts recover in 2003.
Companies in all the 
regions analysed 
suffered a decline 
in proﬁts in 2001. 
Companies outside 
the EU began to see a 
recovery in proﬁts in 
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R&D/Sales ratio, by company registration in major regions,
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-  The data for the top R&D investing companies may indicate the presence 
of a phase gap of one year between the economic cycles of EU vs. US 
economy; the companies registered in Unites States were crossing a bad 
period earlier than EU companies, thus sales were performing worse 
in 2001 for US ﬁrms. The economic cycles affecting Japanese and EU 
companies seem to be more synchronised.
-  Unlike the top 500 companies in the rest of the world, the EU-500 
companies did not see a recovery in 2003. Rather, their decline in net 
sales and R&D investment accelerated. One of the reasons may lie in 
the negative impact on overseas net sales for the EU companies of the 
appreciation of the euro.
-  R&D  investment  decisions  seem  to  follow  the  economic  results  of 
companies – changes in net sales and proﬁt rates - with a one year lag, 
on the average. This is the possible explanation of weak performances 
in R&D investment for EU and Japanese top R&D-investing companies 
in 2003, following the economic downturn registered in 2002.
The global picture of R&D/Sales ratio is presented in Table 4.7 and Figure 4.4:
Table 4.7.
The  R&D/Sales  ratio  for  EU  and  non-EU  500  companies  investing  in  R&D 
worldwide, by major regions, during 2000-2003
Figure 4.4.
The R&D/Sales ratio for Scoreboard Top 685 R&D-investing companies worldwide, 
by major regions, during 2000-2003
REGIONS  2000 2001 2002 2003
EU-500 3.21 % 3.37 % 3.31 % 3.21 %
non-EU 500 4.44 % 4.61 % 4.66 % 4.51 %  The 2004 EU Industrial R&D Investment Scoreboard  37 
The ﬁndings from the above table are as follows:
-  There was an overall drop in the R&D/Sales ratio in 2003, compared 
to 2002, for all the major R&D-active companies worldwide (except 
for companies in Switzerland, the main contributor in the region of 
Europe  non-EU).  This  is  due  to  the  different  patterns  of  growth  in 
R&D investment and in net sales last year, with sales showing a strong 
recovery.
-  The aggregate R&D/Sales ratio of the group of large US companies 
(4.9 %) and non-EU European companies (4.8 % overall and 6.5 % 
for Switzerland) was higher than that of the EU companies (3.6 %). 
Japanese companies had an aggregate R&D/Sales ratio somewhere in 
between. There are larger variations of this ratio for companies in US and 
the rest of the world and non-EU Europe, than for companies registered 
in EU or Japan. This fact may be inﬂuenced by changes in exchange 
rates, as the euro is taken as a base currency for this Scoreboard.
There was an overall drop in 
the R&D/Sales ratio between 
2002 and 2003 for all the 
major R&D-active companies 
worldwide.
The aggregate R&D/Sales 
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Comparative Analysis
of EU Top R&D Companies
by Member State and by Sector
As discussed in the previous section, in 2003 the largest EU companies 
accounted for 32.5 % of the total R&D investment of the top 685 companies 
worldwide shown in our combined 2004 top 500 R&D companies on the 
Scoreboard. The time course of the total R&D investment over the period 
2000-2003 is shown in table 5.1 (ﬁgures represent current prices in millions 
of euros17). The same table presents the proportions each Member State 
contributes to the overall R&D investment by the EU-500 companies, when 
ordered by the country chosen by the ultimate parent as the location of its 
registered ofﬁce, during the same reference period.
5.a. The R&D investment by location of companies’
registered ofﬁce in EU Member States, 2000-2003
17  Where currency conversion was needed, the end-year 2003 exchange rates against the 
euro were used for all years referred to in the Scoreboard.
Table 5.1.
Shares of groups of companies registered in selected EU Member States in total R&D 
expenditure of the top 500 EU-based companies investing in research, 2000-2003
EU COMPANIES REGISTERED BY 
MEMBER STATES IN Top 500
2000 2001 2002 2003
DE – Germany 35.7 % 35.4 % 37.5 % 37.2 %
FR – France 21.6 % 21.0 % 20.5 % 19.4 %
UK – United Kingdom 17.7 % 16.5 % 16.6 % 16.9 %
NL – The Netherlands 6.1 % 7.3 % 7.1 % 6.9 %
SE – Sweden 7.5 % 7.8 % 6.0 % 6.4 %
FI – Finland 4.2 % 4.3 % 4.4 % 4.9 %
IT – Italy 3.6 % 3.5 % 3.5 % 3.9 %
DK – Denmark 1.3 % 1.5 % 1.6 % 1.8 %
BE – Belgium 1.0 % 1.1 % 1.2 % 1.2 %
All other companies 1.2 % 1.7 % 1.7 % 1.5 %
R&D investment of Top 500 € m 100,790 102,207 101,883 91,900
The following conclusions may be drawn from the table above:
-  The EU’s top 500 R&D-investing companies are based in three of the 
four largest economies of the EU: Germany, France and United Kingdom. 
The proportion of German companies (37.2 % in 2003) in total EU 
R&D investment is approximately equal to the sum represented by both 
French companies (19.4 % in 2003) and UK companies (16.9 % in 
2003) together. From 2000-2003, the proportion of French companies 
declined continuously, offset by an increase in the share of German 
companies.  The  big  R&D  investors  from  these  three  countries  (315 
companies out of the total 500 in the EU Scoreboard, or 63 %) account 
The EU’s top 500 R&D-
investing companies are 
based in three of the four 
largest economies of the EU: 
Germany, France and United 
Kingdom.
The big R&D investors 
from these three countries 
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total R&D investment by 
the top 500 EU companies. 
This implies that R&D 
investment is highly 
concentrated among 
companies from these three 
countries.
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for 74 % of the total R&D investment of top 500 EU companies, which 
implies that R&D investment is highly concentrated in companies from 
these three countries.
-  A second group comprises countries whose companies account for a 
signiﬁcant share of the total EU R&D investment by companies in the 
Scoreboard’s EU-500: the Netherlands, Sweden, Finland and Italy. The 
proportions accounted for by the countries range between 6.9 % and 
3.9 %. Their overall performance during 2000-2003 shows a mixed 
picture, with Italian and Finnish companies increasing their share.
-  Only 16 of today’s 25 EU Member States are represented in the EU-500 
group on the Scoreboard18.
R&D investment in the European Union is highly concentrated. The top 20 
companies account for more than 55 % of the total by EU-500 companies. 
However, this share can be seen to have declined over the period 2000-
2003, dropping from 57.5 % in 2000 to 55.3 % in 2003. This suggests 
that an increasing number of EU companies at the bottom end of the EU-
500 were increasing their R&D investment more rapidly than the very large 
EU R&D investors. It could also mean that the top 20 EU companies have 
started to outsource more of their R&D activities.
As mentioned in the previous section, four sectors account for most of R&D 
investment worldwide by the top R&D investing companies. Further details 
will be given in section 7, which discusses the ten sectors with highest shares 
among the top 685 companies investing in R&D worldwide. The contribution 
of each of those sectors to the total R&D investment by EU-500 companies 
investing in R&D and by the location of the ofﬁces of these companies is 
shown in Figure 5.1.
The following comments can be made:
-  As mentioned in section 4, three main sectors (automobiles & parts, 
pharmaceuticals & biotechnology and IT hardware, bearing in mind that 
companies are grouped according to their stated main business) in terms 
of their share in total R&D investment of EU-500 companies listed in the 
Scoreboard accounted for 53.2 % of the total R&D investment ﬁgure in 
2003. Not all these sectors are characterised – worldwide or within the 
EU – by an intrinsically high R&D investment to net sales ratio.
-  The share of the ten main sectors19 in the total R&D investment by the 
top 500 EU R&D-investing companies, again in 2003, was 89.3 %, with 
the remainder of the 21 FTSE sectors represented in the Scoreboard 
accounting for only 10.7 % of the total R&D investment ﬁgure.
-  With one important exception (namely France), EU companies show at 
least one pronounced area specialisation in terms of R&D investment 
when  compared  to  the  average  for  EU  companies  in  the  R&D  Top 
18  This means that companies with registered ofﬁces in the rest of the EU Member States 
either do not disclose the information on their R&D investment, had R&D investments of 
less than €8.54million in 2003, or are afﬁliates or subsidiaries of ultimate parent companies 
located elsewhere.
19  Ranked by the weight of the R&D investment of companies who declared their main 
activity  in  the  respective  sector  in  total  R&D  investment  of  the  top  685  Scoreboard 
companies.
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500 (a share more than twice the EU average). Germany shows a high 
degree of specialisation in automobiles & parts, which is one of Europe’s 
most important sectors in terms of its R&D investment. Over 80 % 
of Finland’s R&D investment is concentrated in IT hardware. Sweden 
shows R&D strength and specialisation in IT hardware and its traditional 
engineering  &  machinery  sector.  The  Netherlands  is  an  interesting 
case with three clear areas of specialisation: aerospace, chemicals and 
electronics & electrical equipment. The United Kingdom has specialised 
in the pharmaceuticals & biotechnology sector, but is also well above 
the EU average in aerospace & defence.
-  No particular sectoral specialisation emerges in the case of France: The 
breakdown by sectors of R&D investments by French companies in the 
top EU-500 R&D investors in 2003 is close to the average pattern for the 
EU as a whole. However, in most of the ten sectors taken into account 
for the analysis, French companies are the second most important group 
of players in R&D investment among the EU-500 companies.
Figure 5.2 shows how the R&D/Sales ratio of the top EU R&D-investing 
companies  (from  the  Scoreboard)  whose  ultimate  parent  company  was 
located in the six Member States analysed progressed from 2000-2003. A 
number of points can be deduced from this ﬁgure, which also shows the 
average R&D/Sales ratio for all the EU companies as a whole:
Figure 5.1.
The shares (%) of major FTSE sectors in total R&D investment of the EU top 500 
R&D-investing Scoreboard companies, by Member States (in which the companies’ 
ultimate parents have located their registered ofﬁces), in 2003.
5.b. Analysis of R&D-related ratios20
of EU companies by location of registered
ofﬁce in selected EU Member States
20  More information on R&D indicators is provided in Annex 1 of this document.  42  The 2004 EU Industrial R&D Investment Scoreboard
Share of R&D investment in net sales for R&D Scoreboard















-  Companies with ofﬁces registered in two of the EU Member States that 
are major players on the world markets, as well as on the EU research 
stage (France and United Kingdom), show overall R&D/Sales ratio below 
the  EU-registered  companies’  average,  with  UK  companies  showing 
a marked declining trend, which began in 2000 from an already low 
position21. As with all the conclusions of this analysis, this ﬁnding is valid 
only for the available sample of companies included in the EU 2004 
R&D Industrial Scoreboard, although it may characterise larger groups 
of EU companies as well.
-  Only in the case of two countries from this group of six major EU 
players have the companies shown R&D investment to net sales ratios 
that are comparable or higher than those characterising the top US-288 
companies reported in the 2004 non-EU R&D group on the Scoreboard: 
Sweden (4.8 % in 2003 and higher than 6 % until 2001 for Swedish 
companies on the Scoreboard) and the Netherlands (above 6 %).22
-  There has been little change in the aggregate R&D/Sales ratios of the 
groups of top EU R&D-investing companies by Member State in the last 
year analysed (2003 shows values close to those in 2002, except for UK 
and Finland).
Figure 5.2.
Time course of R&D/Sales ratio for Scoreboard EU companies over the period 
2000-2003, by country of registration
21  The UK case will be referred to in more detail in Section 7.
22  The overall picture may improve slightly for the UK and worsen for the Netherlands if we 
change the assignment of location of headquarter for joint companies such as Shell, a case 
in which the location of the main headquarters is ambiguous. Companies with high net sales 
ﬁgures operating in low R&D intensive sectors (such as oil & gas, for example) may change 
the average share of net sales their R&D investment represents quite signiﬁcantly.
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Figure 5.3 shows the evolution, during 2000-2003, of the average proﬁtability 
(the ratio of gross proﬁts to net sales) of all companies from a given Member 
States that are among the top 500 investors in R&D in the European Union 
(reported in the 2004 Scoreboard). The conclusions are presented below:
Figure 5.3.
Proﬁtability of Scoreboard EU companies, by country in which head quarters are 
located, 2000-2003
-  The change in proﬁtability of the EU-500 companies and in their investment 
in research (according to the 2004 Scoreboard) shows a similar pattern 
and similar amplitudes for groups of companies registered in one country 
or another, with the exception of the Dutch-registered companies, whose 
amplitudes of annual variations are much larger. There has been a decrease 
in the rate during 2000-2002 and something of a recovery in 2003.
-  The overall performance of the EU companies on the Scoreboard is 
dictated by the time course of proﬁt rates among German and French 
companies, with French companies’ proﬁts appearing to be slightly more 
volatile than average. Finnish companies also show a similar pattern.
-  The companies from the other three Member States already began to 
see a recovery in proﬁts in 2002. This leads us to the conclusion that 
there is a cyclical phase-gap between EU countries, where the companies 
registered in more open economies, such as the Netherlands, Sweden 
or the UK, are inﬂuenced by the international economic outlook outside 
the EU more than companies registered in “core” EU Member States.
-  Consequently,  a  correlation  may  be  observed  between  changes  in 
proﬁtability and changes in R&D investment among the 2004 R&D 
Scoreboard companies in almost every major EU Member State. From 
the information available for 2000-2003, R&D investment of Scoreboard 
companies appears to have followed the pattern of growth in proﬁts 
(Finnish and Dutch companies deviated from this assumption in 2003) 
with a one-year lag.
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There is no clear relationship between R&D investment and employment 
among the top EU companies investing in R&D during the period of analysis. 
In any event, after adjusting the data for the sample of companies and the 
available employment and R&D investment data, there has been a certain 
amount of synchronisation – in real, inﬂation-adjusted terms – of the value 
of  R&D  expenditure  per  employee  spent  by  the  main  companies  with 
the evolution of their R&D/Sales ratio. However, the annual variations in 
employment ﬁgures for EU companies as a whole are also highly dependent 
on the local (national) labour environment.
As explained in section 4, foreign-owned companies active in R&D in the 
EU are not included on the Scoreboard. There are two reasons for this: the 
data is much more difﬁcult to obtain, and it is necessary to avoid double 
counting23 when comparing EU with Non-EU economies. Nevertheless, it is 
of considerable interest to know which foreign-owned or foreign-registered 
companies carry out R&D (as well as sales and manufacturing) in EU Member 
States, and to what extent. The key issue for a country wishing to attract 
foreign-owned companies with signiﬁcant R&D operations is the quality 
of the business environment. This includes a wide range of issues such as 
infrastructure, costs, regulations, skills, taxation, the health of various sectors 
in the country concerned including supplier networks and any barriers to the 
growth and operation of businesses.
For  this  reason,  this  section  includes  a  summary  of  the  situation  in  the 
UK since for many years it has been a major destination for foreign direct 
investment in Europe. The data that follow are taken from the 2003 UK R&D 
Scoreboard of 700 companies. The 2004 data are just becoming available 
and are referred to where relevant.
In 2003, foreign-owned companies accounted for 21 % of UK 700 R&D 
investment, an increase on the 18 % recorded in the previous year. The 
largest foreign-owned companies made a major contribution to this total. 
For example, the top 5 foreign-owned companies in the UK account for 
55 % of the foreign-owned total of R&D investment!
Three  of  the  top  ﬁve  are  pharmaceutical  companies,  a  sector  where 
the UK (and indeed Europe as a whole) is strong. However, despite this 
strong representation of foreign-owned companies in pharmaceuticals & 
biotechnology, the sectors where foreign-owned companies contribute the 
largest proportion of R&D tend to be those where the UK is relatively weak 
in that it has a lower proportion of sector R&D than is found internationally. 
This proportion would therefore be even lower were it not for the foreign-
owned companies.
Preliminary 2004 data suggest that the foreign-owned company percentage 
of UK 700 R&D has risen a little above the 2003 level.
5.c. R&D by Foreign-Owned Companies in the UK
23  This double counting would arise because, for example, if the R&D of a US subsidiary 
performing R&D in the EU were included in the EU ﬁgure, it would appear in both in the 
US total and in the EU total. In addition, it would not be valid to include foreign-owned EU 
companies in an EU listing which was then compared with US and Japanese companies’ 
totals which do not include foreign-owned companies.
In 2003, foreign-owned 
companies accounted 
for 21% of UK 700 R&D 
investment, and the 
largest foreign-owned 
companies made a major 
contribution to this total.   The 2004 EU Industrial R&D Investment Scoreboard  45 
The Top R&D
Scoreboard Companies
As highlighted in Section 2, the top R&D-active companies account for a 
major proportion of the R&D investments registered on the Scoreboard. For 
example, the top 25 companies on the 2004 EU R&D Industrial Scoreboard 
account for 61 % of total R&D investment and the top 25 companies in 
the non-EU 500 group on the same Scoreboard contribute 42 % of the 
total. The purpose of this section is to identify the top companies by R&D 
investment in the sample of EU-500 companies, as well as in the sample of 
non-EU 500 companies both of which are included on the 2004 Industrial 
R&D  Scoreboard.  We  will  also  address  some  issues  concerning  the  top 
companies located in the three largest world economies, the top companies 
from the Scoreboard that are active in the four major sectors (from the R&D 
investment point of view) and also the top companies by R&D/Sales ratio. 
These lists not only show which companies have the greatest inﬂuence on 
R&D investment totals for different parts of the Scoreboard but also indicate 
the  relative  sectoral  strengths  of  the  different  economies.  Finally,  some 
comments on the level of R&D investment concentration among R&D-active 
companies are offered, based on the Scoreboard data.
Table 6.1 shows the top 12 companies by R&D investment in both the EU-500 
and non-EU 500 Scoreboards, together with their own declared FTSE sector 
of main activity. The range of R&D investment from the ﬁrst to the twelfth 
company in each list is similar (€ 5.6 to 2.4bn for the EU and € 5.9 to 3.1bn 
for the non-EU). Given that the non-EU 500 group of companies investing in 
R&D (reported in the Scoreboard) has almost twice the total R&D investment 
of the similar EU-500 group of companies, this similarity in the size of the top 
12 companies reﬂects the very large size of the top European companies (5 
of the global top 12 by R&D investment have their registered ofﬁce in the 
European Union). Of the top 12 EU R&D-active companies, six have ofﬁces 
registered in Germany, two in the UK and one each in Finland, Sweden, France 
and The Netherlands. For the top 12 R&D-active companies registered in 
non-EU countries, the US provides seven, Japan four and Switzerland one.
For the purposes of comparison, Table 6.2 lists the top 10 US and top 10 
Japanese companies ranked by their 2003 R&D investment. The table also 
shows, as in the case of Table 6.1 for the EU companies, the declared FTSE 
sector as being the company’s main activity and the ranking the respective 
companies had in the similar 1994 UK R&D Scoreboard. The R&D range 
is similar in each economy but with the smaller Japanese economy having 
somewhat smaller companies in terms of R&D expenditure. The companies in 
these three lists all come from three groups of sectors, as shown in Table 6.3. The 
big difference between the three economies is the absence of pharmaceuticals 
& health companies from the Japanese top 10. The top Japanese companies 
are much stronger in electronics and IT Hardware but do not include any 
very large pharmaceutical companies among them. US companies’ strength 
in software & computer services is apparent in the inclusion of IBM and 
Microsoft in the top 10 - there are no software companies in the EU or 
Japan top 10s. A European top 10 (including companies registered in non-EU 
countries of Europe) as opposed to an EU top 10 would include two Swiss 
pharmaceutical companies at positions 7 & 8; this would raise the number of 
6.a. The Top Companies by R&D investment,
by region and sector
Section 6
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pharmaceutical companies to ﬁve out of a European top 10, emphasising a 
European specialisation and strength in this sector.
Table 6.1.
The Top EU and Non-EU Companies by R&D Investment
























































1 Daimler Chrysler Germany Automobiles & parts 5.6 1
2 Siemens Germany
Electronics & Electrical 
equipment 5.5 2
3 Volkswagen Germany Automobiles & parts 4.1 7
4 Nokia Finland IT Hardware 4.0 46
5 Glaxo Smith Kline United Kingdom Pharmaceuticals & 
Biotechnology
4.0 11




8 Astra Zeneca United Kingdom
Pharmaceuticals & 
Biotechnology 2.7 19
9 Robert Bosch Germany Automobiles & parts 2.7 -*
10 Philips Electronics Netherlands
Electronics & Electrical 
equipment 2.6 6
11 BMW Germany Automobiles & parts 2.6 -*
12 Bayer Germany Chemicals 2.4 -*
Total R&D investment (€ bn) 42.3  
Top 12 non-EU Companies
1 Ford Motor United States Automobiles & parts 5.9 3
2 Pﬁzer United States Pharmaceuticals & 
Biotechnology
5.7 47
3 Toyota Motor Japan Automobiles & parts 4.9 -*
4 General Motors United States Automobiles & parts 4.5 1
5 Matsushita Electric Japan Pharmaceuticals & 
Biotechnology 4.3 7
6 IBM United States IT Hardware 4.0 6
7 Johnson & Johnson United States
Pharmaceuticals & 
Biotechnology 3.7 34
8 Microsoft United States IT Hardware 3.7 86
9 Intel United States IT Hardware 3.5 48
10 Sony Japan
Electronics & Electrical 
equipment 3.3 15
11 Honda Motor Japan Automobiles & parts 3.2 17
12 Roche Switzerland Pharmaceuticals & 
Biotechnology
3.1 -*
Total R&D investment (€ bn) 49.8
-*  means  no  available  ﬁgure  (no  disclosure  or  no  ﬁnancial  accounts/reports)  for  the 
company (or its predecessor) in the ﬁnancial year 1993 (1994 UK R&D Scoreboard).  The 2004 EU Industrial R&D Investment Scoreboard  47 
Table 6.2.
The Top 10 Companies by R&D investment with registered ofﬁces in Japan and 
The US, in 2003
Top 10 US Companies



















































1 Ford Motor Automobiles & parts 5.9 2
2 Pﬁzer Pharmaceuticals & Biotechnology 5.7 19
3 General Motors Automobiles & parts 4.5 1
4 IBM Software & Computer Services 4.0 3
5 Johnson & Johnson  Pharmaceuticals & Biotechnology 3.7 13
6 Microsoft Software & Computer Services 3.7 86
7 Intel IT Hardware 3.5 20
8 Motorola IT Hardware 3.0 8
9 Hewlett-Packard IT Hardware 2.9 5
10 Merck Pharmaceuticals & Biotechnology 2.5 14
Total R&D investment (€ bn) 39.4
Top 10 Japanese Companies
1 Toyota Motor Automobiles & parts 4.9 -*
2 Matsushita Electric Electronics & Electrical equip. 4.3 2
3 Sony Electronics & Electrical equip. 3.3 7
4 Honda Motor Automobiles & parts 3.2 8
5 NTT Telecommunica-tion services 2.9 5
6 Hitachi IT Hardware 2.8 1
7 Toshiba IT Hardware 2.5 4
8 Nissan Motor Automobiles & parts 2.2 -*
9 Fujitsu IT Hardware 2.1 3
10 Canon Electronics & Electrical equip. 1.9 13
Total R&D investment(€ bn) 30.1
Note: The top 10 for North American companies would look the same as the US top 10; the 
top 10 for Asian companies would have Samsung (Korea) at rank 8, replacing Canon. Note 
that “-*” here means no data are available for 1994.
Table 6.3.
The Sector Mix of Top 10 Companies by Economy
US EU Japan
Automobile & parts 2 3 3
Electronics & IT* 5 4 6**
Pharmaceuticals & Health 3 3 0
*  Electronics & Electrical equipment, IT Hardware, Software & Computer services.
** Among top 10 Japanese companies there is one active in Telecommunication services. 
If the Electronic & Electrical equipment and IT Hardware sectors were added together, 
Japan would have 7 companies in the respective row.  48  The 2004 EU Industrial R&D Investment Scoreboard
The four largest sectors with companies in both the EU-500 and non-EU 
500 groups on the Scoreboard are automobiles & parts, pharmaceuticals & 
biotechnology, IT hardware and electronics & electrical equipment. The top 5 
companies in each sector are shown in Table 6.4, for the EU-500 companies 
and the non-EU 500 companies, respectively. These ﬁgures also show the 
proportion of total R&D investment accounted for by the top 5 companies 
in each sector. In all four sectors the top 5 companies account for more than 
50 % of sector R&D.
Table 6.4.
Top 5 EU and non-EU Companies in the Four Largest R&D Sectors
Note: The company R&D investment in 2003 is given in brackets.
A. Automobiles & Parts
EU Non-EU
1 Daimler Chrysler (€ 5.6bn) 1 Ford Motor (€ 5.9bn)
2 Volkswagen (€ 4.1bn) 2 Toyota Motor (€ 4.9bn)
3 Robert Bosch (€ 2.7bn) 3 General Motors (€ 4.5bn)
4 BMW (€ 2.6bn) 4 Honda Motor (€ 3.2bn)
5 Peugeot (PSA) (€ 2.1bn) 5 Nissan Motor (€ 2.2bn)
Top 5 as a percentage of total sector R&D = 71 % Top 5 as a percentage of total sector R&D = 68 %
B. Pharmaceuticals & Biotechnology
EU Non-EU
1 GlaxoSmithKline (€ 4.0bn) 1 Pﬁzer (€ 5.7bn)
2 Aventis (€ 2.9bn) 2 Johnson & Johnson (€ 3.7bn)
3 AstraZeneca (€ 2.7bn) 3 Roche (€ 3.1bn)
4 Sanoﬁ-Synthelabo (€ 1.3bn) 4 Novartis (€ 3.0bn)
5 Boehringer Ingelheim (€ 1.2bn) 5 Merck (€ 2.5bn)
Top 5 as a percentage of total sector R&D = 71 % Top 5 as a percentage of total sector R&D = 49 %
C. IT Hardware
EU Non-EU
1 Nokia (€ 4.0bn) 1 Intel (€ 3.5bn)
2 Ericsson (€ 3.2bn) 2 Motorola (€ 3.0bn)
3 Alcatel (€ 1.6bn) 3 Hewlett-Packard (€ 2.9bn)
4 Inﬁneon Technologies (€ 1.1bn) 4 Hitachi (€ 2.8bn)
5 ST Microelectronics (€ 0.9bn) 5 Toshiba (€ 2.5bn)
Top 5 as a percentage of total sector R&D = 55 % Top 5 as a percentage of total sector R&D = 33 %
D. Electronics & Electrical Equipment
EU Non-EU
1 Siemens (€ 5.5bn) 1 Matsushita Electric (€ 4.3bn)
2 Philips Electronics (€ 2.6bn) 2 Sony (€ 3.3bn)
3 Schneider (€ 0.5bn) 3 Samsung (€ 2.4bn)
4 Alsthom (€ 0.5bn) 4 Canon (€ 1.9bn)
5 Thomson (€ 0.3bn) 5 Sharp (€ 1.1bn)
Top 5 as a percentage of total sector R&D = 89 % Top 5 as a percentage of total sector R&D = 60 %
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The key points from Table 6.4 are:
n  The automobile & parts sector is similar in both EU and non-EU lists 
as far as both the size of the top 5 companies is concerned and the 
proportion of sector R&D investment accounted for by the top 5 (~70 
% in each case).
n  The pharmaceutical & biotechnology and IT hardware sectors both 
show the ﬁfth EU company having less than 50 % of the R&D of 
the ﬁfth non-EU company. The percentage of sector R&D accounted 
for by the top 5 companies is smaller for both sectors in the non-EU 
case because of the larger size of the non-EU sector (more than twice 
the R&D investment for pharmaceuticals & biotechnology and more 
than three times for IT hardware).
n  The largest difference is in electronics & electrical equipment, where 
Japanese companies (more generally Asian companies) dominate the 
non-EU list and the EU has only two large companies (Siemens and 
Philips), while the third EU company is less than half the size of the 
ﬁfth non-EU company. This size difference is also emphasised by the 
difference in the share of each sector’s R&D investment accounted for 
by the top 5 companies.
The  differing  relative  strengths/specialisations  of  the  EU  and  non-EU 
economies suggested by Tables 6.3 and 6.4 are discussed in more detail in 
the following sections.
Since large companies contribute a sizeable fraction of the R&D investment 
included on the Scoreboard, it is worth analysing how many of them have 
increased  their  R&D  investment  between  one  year  and  the  next.  The 
ﬁgures for the top 40 R&D-active companies in each regional section of 
the Scoreboard are given in Table 6.5. This shows that almost twice as 
many non-EU as EU companies showed large increases (of over 5 %) in 
R&D investment during the 2003 ﬁnancial year. There were more decreases 
amongst the EU companies. However, these results should be viewed in 
the context of the 3-year CAGRs (compound annual growth rate over the 
2000-2003 period), which are also shown in Table 6.5 and are more similar 
between EU and non-EU companies.
6.b. R&D Investment Indicators for the Top 2004 
R&D Scoreboard Companies
Table 6.5.
Changes in R&D investment for Top 40 Companies from 2000-2003
R&D Investment Change Over Previous Year (%)
Increase > 5 % Increase 0-5 % Decrease
EU Top 40 11 13 16
Non-EU Top 40 20 10 10
R&D Compound Annual Change Over Previous Years 2000-2003 (%)
Increase > 5 % Increase 0-5 % Decrease
EU Top 40 17 11 10
Non-EU Top 40 20 10 10
Note: For 2 of the top 40 EU companies on the Scoreboard, CAGR was not available
Almost twice as many 
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showed large increases 
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Turning to the top 10 companies in each of the larger R&D intensive sectors 
as they appear on the 2004 Scoreboard (electronic & electrical equipment, 
IT hardware, pharmaceuticals & biotechnology and software & computer 
services) there were increases in R&D investment for 14 out of 40 companies 
(see Table 6.4) for the EU-500 sectors but 29 out of 40 companies for the 
non-EU 500 sectors.
The only sector where increases outnumbered decreases among the EU-
registered companies was pharmaceuticals & biotechnology, a sector where 
these companies have a strong relative position. Once again, the situation 
looks different if one looks at companies’ performance over the last three or 
four years: 25 EU-registered companies out of the 39 (top 10 active in each 
of the four mentioned sectors, one company has no data available for CAGR 
computation) show a positive CAGR during 2000-2003, as compared to 29 
out of 3924 in the case of non-EU-registered companies.
The top companies ranked by R&D/Sales ratio need to be chosen using both 
this company R&D effort indicator and another criterion. If R&D effort alone 
were used, the rankings would all be dominated by very small biotechnology 
or software companies in the early stages of their existence which have 
signiﬁcant R&D investment but very small net sales. In this section, the 
company R&D/Sales ratio is used as the criterion together with membership 
of the FTSE global 500 set of companies which comprises the largest 500 
companies in the world by market capitalisation.
Table 6.6 shows the top 10 EU and non-EU companies by R&D/Sales ratio 
from the FTSE global 500.
Table 6.6.
Top Companies in FTSE Global 500 by R&D/Sales Ratio




































































































































1 Ericsson  24.9 Sweden 6 1 Allergan  43.4 US 65
2 AstraZeneca  18.3 UK 8 2 Broadcom 40.6 US 79
3 Aventis  16.4 France 7 3 Biogen Idec 34.4 US 195
4
Sanoﬁ-
Synthelabo  16.4 France 19 4 Maxim Integrated 
Products 
23.6 US 162
5 ST Microelectronics  16.1 France 27 5 Analog Devices  22.0 US 111
6 Novo Nordisk  15.8 Denmark 36 6 Computer Associates 21.6 US 72
7 SAP  14.2 Germany 25 7 Nortel Networks 21.1 Canada 29
8 Nokia  13.5 Finland 4 8
Applied 
Materials  20.6 US 53
9 BAE Systems  13.1 UK 18 9 Amgen  19.8 US 37
10
GlaxoSmith 
Kline  13.0 UK 5 10 Gilead Sciences 19.0 US 262
Total R&D investment  € 22.2bn Total R&D investment  € 6.4bn
24  One company has no data available for CAGR computations.
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The EU list is drawn from six EU countries whereas the non-EU list has nine 
companies from the US and one from Canada.
Both lists are mainly drawn from the companies active in sectors such as 
pharmaceuticals & biotechnology (5 EU and 4 non-EU companies) and 
the IT hardware sector (3 EU and 6 non-EU companies) with software & 
computer services and aerospace & defence also represented in the EU 
top 10. The other noteworthy feature is that all ten companies in the non-
EU list have a higher R&D/Sales ratio than all but one in the EU list. This 
reﬂects the higher R&D efforts generally found in growing US companies 
and will be discussed in more detail in section 8. The US is of course strong 
in the R&D intensive sectors, such as IT hardware, pharmaceuticals and 
software & computer services, which have grown fast over the last two 
decades. The total R&D investment for the ten companies is very different 
with the EU total being more than three times larger than the non-EU 
total. This reﬂects the Financial Times Global 500’s role in representing the 
largest companies by market capitalisation. A number of the US companies 
have only medium-sized R&D investment and sales but are R&D intensive 
and fast growing allowing them to command large market capitalisations. 
It also reﬂects the fact that while the EU has large companies (i.e. whose 
head ofﬁces are located in EU countries) that are outstanding performers 
in the R&D arena, it lacks a critical mass of medium-sized fast-growing 
companies that are strong on research and innovation, at least compared 
to the situation in the US.
As mentioned in section 4.a, there is a high degree of concentration among 
the top companies (as they appear listed in the 2004 Scoreboard) investing 
in  research  in  many  of  the  heavyweight  sectors  in  total  world  R&D 
investment, as is highlighted by the share of R&D investment accounted 
for by the ﬁrst two companies in four of the ten sectors we selected for 
analysis.  This  section  describes  the  analysis  of  the  concentration  issue, 
which compares the situation of EU companies with that of companies 
based (in terms of the location of the registered ofﬁces of their parent 
company) outside the EU.
The methodology used starts by looking at the shares of selected samples 
of top companies in the available overall R&D investment ﬁgures for the 
EU and non-EU 500 companies on the Scoreboard, and analysing the share 
of cumulative R&D investment by the top 20, top 50 and top 100 up to 
top 400 companies in the total R&D investment during the same period by 
all the companies from the 2004 Industrial R&D Investment Scoreboard 
in any of the main regions, we have obtained a picture (in the form of a 
statistical distribution) of the overall concentration of investment in research 
and development activities for the sample of companies as a whole. High 
proportions (close to one) for the ratio between the total aggregate R&D 
investment of the top 20 companies, for example, and the investment of 
all companies, will mean that most of the R&D is accounted for by the 20 
biggest R&D investors with the remaining 480 companies being responsible 
for  the  rest.  Table  6.7  shows  these  shares  for  the  various  samples  of 
companies (the top 20, 50, 100, 200, 300 and 400 companies) comparing 
companies registered in EU vs. non-EU registered companies. It also shows 
the changes undergone by these shares during the period of analysis (i.e. 
2000 to 2003).
6.c. Analysis of concentration of top companies by 
major regions and by sector
A number of the US 
companies have only 
medium-sized R&D 
investment and sales but 
are R&D intensive and fast 
growing, allowing them 
to command large market 
capitalisations.
While the EU has large 
companies that are 
outstanding performers in 
the R&D arena, it lacks a 
critical mass of medium-sized 
fast-growing companies that 
are strong on research and 
innovation.
R&D activity is more 
concentrated in the EU: the 20 
biggest companies in terms 
of investment account for 
more than half of the R&D 
investment by the top 500 EU 
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There are several ﬁndings generated by this analysis:
-  The R&D activity is more concentrated in the European Union, as all 
the equivalent shares are higher in all the years within the time horizon 
analysed. The concentration is particularly high at the top spectrum, 
where the 20 biggest EU companies by R&D investment account for 
more than half of the R&D investment by the 500 EU R&D-active 
companies (EU-500).
-  The rest of the world shows a high degree of concentration as well. The 
top 50 companies with registered ofﬁces outside the EU are responsible 
for almost 60 % of the total R&D investment by the 500 companies 
on the 2004 Scoreboard in the same geographical area. Given the size-
difference factor of almost 1 to 2 between EU and non-EU overall R&D 
investment,  the  differences  in  shares  are  explained  by  the  different 
number of companies of the same size (in terms of investment in R&D) 
that are reported in the two samples of companies.
-  A declining trend in the concentration levels of EU companies has been 
documented since the year 2000. This trend is signiﬁcant particularly 
among the top companies (top 20 and top 100), despite the ongoing 
process of mergers and acquisitions, which would act to counter this. 
This means that more and more companies in the lower part of the 
EU-500  list  were  increasing  their  R&D  investment  faster  than  the 
companies in the upper part of the EU-500 companies. This indicates 
that the EU economy may enter a phase of development in which 
growing and emerging companies may add to the in-depth strength 
of its R&D and innovation activity25.
-  There  is  no  similar  trend  in  concentrations  observed  for  non-EU 
companies in the Scoreboard during the same period.
Continuing along the same lines, Figure 6.1 points out the relative “R&D 
strength” of EU top companies compared to the US and Japanese companies 
in 2003.
Table 6.7.
The share of R&D investment of Top “n” companies in overall Top 500 R&D 
investment in EU vs. non-EU regions, 2000-2003 (%)
EU companies non-EU companies
2000 2001 2002 2003 2000 2001 2002 2003
Top 20 57.5 57.1 55.5 55.3 37.4 57.1 55.5 55.3
Top 50 76.1 75.3 75.2 75.2 61.2 75.3 75.2 75.2
Top 100 87.3 86.4 85.7 86.2 73.4 86.4 85.7 86.2
Top 200 94.7 94.2 93.9 93.9 85.6 94.2 93.9 93.9
Top 300 97.4 97.1 97.0 97.1 92.2 97.1 97.0 97.1
Top 400 99.0 98.9 98.9 98.9 97.0 98.9 98.9 98.9
25  It may also mean that top R&D-investing companies started to outsource more of their 
R&D activities.
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Note: The ratio for top “n” EU companies as compared to top “n” US companies was 
calculated  by  dividing  the  cumulative  R&D  investment  of  “n”  EU  companies  by  the 
cumulative R&D investment of the same number of top US companies. The same applies 
to Japanese companies when compared to US companies. As there are only 153 Japanese 
companies in the Scoreboard, the graph for Japanese companies stops at position 153 on 
the horizontal axis, while it goes up to 288 for the set of US companies.
The graph above was built by computing the cumulative R&D investment of 
the top 1 company, then top 2 companies, continuing up to the maximum 
number  of  companies  available  for  a  given  region  or  country  and  then 
calculating the share of each of these sums for all countries in the equivalent 
(similar) sum for US companies (the sum that proved to have the highest 
value  for  all  “n”).  Therefore,  Figure  6.1  has  a  horizontal  axis  showing 
number of companies (maximum 288 available for the US sample, with 
R&D investment of US companies taken as denominator) and a vertical axis 
showing the relative ratio between the cumulative R&D investment of the 
similar number of companies in the three major regions.
The conclusions are as follows:
-  For the top 90 companies investing in research, EU companies have almost 
the same R&D volume of R&D investment as their US counterparts, as 
the ratio deﬁned above varies between 95 % and 100 %. Japanese 
companies clearly lag from the outset, and only a small share of top 24 
group of companies manage to stay at more than 70 % of the cumulative 
R&D investment of a similar number of top US companies.
-  EU companies are gradually losing ground to their US counterparts. 
The ratio for US companies reaching 88 % in the case of the top 288 
companies (the maximum available for the US companies). A signiﬁcant 
number of “smaller” US companies invest strongly in R&D, and more 
consistently than companies in the EU, thus further bolstering the overall 
R&D performance of United States. These companies are concentrated 
in sectors which are intrinsically R&D intensive, which explains the gap 
in this indicator between the two regions.
Figure 6.1.
Ratio of cumulative R&D investment for similar samples of top companies registered 
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The sector analysis in Section 4 is now extended to all ten sectors covered 
within the Scoreboard analysis, in relation to the concentration issue. Figures 
6.2, 6.3 and 6.4 show – for 2003 - the shares of the Top 1, Top 2 and, 
respectively, Top 5 companies in total R&D investment of all the companies 
stating their main business to be in the respective sector and which are listed 
in the top 500 available in the 2004 Industrial R&D Investment Scoreboard, 
separately for companies registered in EU and non-EU regions.
Figure 6.2.
Shares of top 1 company in total sector R&D investment of companies listed in 
The EU 2004 Industrial R&D Investment Scoreboard registered in EU vs. non-EU 
regions – data for 2003 (%)
Figure 6.3.
Shares of top 2 companies in total sector R&D investment of companies listed in 
The EU 2004 Industrial R&D Investment Scoreboard registered in EU vs. non-EU 
regions – data for 2003 (%)
R&D Share of Top 2 Companies in Scoreboard Sector Aggregate
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R&D Share of Top 5 Companies in Scoreboard Sector Aggregate
EU vs. non EU: Concentration of R&D within Sectors
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The comments on the above ﬁgures apply strictly to the set of companies 
that are included in the 2004 Industrial R&D Investment Scoreboard and 
may be summarised as follows:
-  The shares calculated for both EU-based and non-EU-based companies 
in sectors such as aerospace & defence, automobiles & parts, chemicals 
and engineering & machinery are similar. These so-called “traditional” 
sectors are ones in which EU companies account for a large share of 
worldwide sectoral R&D investment and a higher R&D/Sales ratio (as 
will be discussed in section 7) than their direct major competitors from 
outside the EU. This implies the relative strength of EU companies in 
these traditional sectors in terms of R&D investment.
-  The degree of concentration among EU companies is much higher than 
average among in sectors such as IT hardware, electronics & electrical 
equipment or pharmaceuticals & biotechnology. These are sectors with 
high to very high R&D/Sales ratios and which have higher shares in 
overall  R&D  investment  among  non-EU  companies  than  among  EU 
ones. This ﬁnding is in line with the fact that regions with a lower degree 
of  concentration  in  a  given  sector  are  usually  characterised  by  the 
presence of numerous medium-sized companies investing in research 
and development which thus ensure the strength of the economy in the 
respective sector of activity.
-  The degree of concentration among EU companies is lower than among 
non-EU  companies  in  sectors  such  as  telecommunications  services 
or  health,  but  the  reasons  may  differ  in  each  of  the  two  cases.  In 
telecommunications services, the presence of a major Japanese company 
in the area of research investment is increasing the share a small number 
of top companies account for in the overall R&D investment by all the 
companies declared as active in this sector (out of the companies listed 
in the Scoreboard). In the case of health, the main reason lies in the 
Figure 6.4.
Shares of top 5 companies in total sector R&D investment of companies listed in 
The EU 2004 Industrial R&D Investment Scoreboard registered in EU vs. non-EU 
regions – data for 2003 (%)
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lack of major R&D investors among EU companies operating in this 
sector, which is only the 11th sector in the ranking of sectors of EU-500 
companies by R&D investment.
-  In the EU there is only one sector (engineering & machinery) in which 
the share of the top 5 companies in total R&D investment of companies 
represented in Scoreboard’s top 500 in the respective sector is less 
than 50 %. In the case of non-EU companies there are three sectors 
(engineering & machinery, IT hardware and pharmaceuticals) in which 
this is so. This means that the overall degree of concentration is not 
only high at the global economy level, but also in the case of each 
sector  taken  separately,  among  the  top  groups  of  500  companies 
investing in R&D.  The 2004 EU Industrial R&D Investment Scoreboard  57 
The Sector Mix for
Top Companies Investing in R&D
Section 4 discussed how companies whose registered ofﬁces are located 
in each of the three major economies analysed have different R&D-related 
strengths according to the sectors of activity and that the different sector 
mixes are in general responsible for a substantial part of the overall R&D 
intensity differences between economies and their representative companies. 
The purpose of this section is to examine the effect of the sector mix on the 
R&D/Sales ratio in much more detail. This is particularly important since 
there is much discussion at present of differences in R&D intensity between 
countries and regional economies and it is relevant to understand how much 
of the overall R&D intensity difference in each case is caused by the sector 
mix and how much by differences in R&D intensity between similar sectors 
or by differences between companies in terms of their R&D/Sales ratio. 
Consequently, a ﬁrst step in the analysis is to focus on the breakdown of 
companies by their declared main sector of activity, particularly those sectors 
in which R&D investment is concentrated around the group of top world 
companies included in the 2004 Industrial R&D Investment Scoreboard. The 
top 10 sectors are ordered by their weight in the total R&D investment of 
top EU and non-EU Scoreboard companies.
The procedure for ordering the sectors considers the weight of each sector 
in the total R&D expenditure by a number of 685 companies. This number 
of companies is the sum of top 500 companies in non-EU countries and 
top 185 companies in EU countries, which are shown in the two groups of 
companies on the Scoreboard to have reported R&D investment in 2003 
higher than the threshold of € 51.38 million26.
The starting point for this discussion of R&D /Sales ratio is Table 7.1 which 
shows  the  above  mentioned  shares  of  the  economic  sectors  with  most 
weight in Scoreboard’s worldwide R&D investment, the current value of 
those investments by sector of declared main activity in 2003, the number 
of companies investing in R&D which are present in the Top 685 by sector 
and the average R&D investment per company by sector. The main ﬁndings 
from this sectoral view are:
n  Three sectors alone account (with almost similar weights) for 56.5 % 
of the global R&D investment by the top 685 companies investing in 
research (listed in the Scoreboard), in 2003: IT hardware, automobiles & 
parts and pharmaceuticals & biotechnology.
n  The average R&D investment per company varies widely from sector 
to sector (however, this ﬁnding refers only to the top R&D-investing 
companies). Average R&D investment per company in the automobiles 
& parts sector among the companies listed on the Scoreboard (more 
7.a. The Top Ten Sectors Worldwide
by Weight of their Business R&D Expenditures
26  For comparability reasons, worldwide, we have chosen the threshold of €51.38 million 
as the smallest available for non-EU companies listed in our 2004 Scoreboard database. 
Presumably, the 685 companies selected are the full sample of companies that were 
spending in R&D, worldwide, more than €51.38 million equivalent in 2003 (ﬁnancial year) 
and fulﬁl the criteria of Scoreboard’s selection process.
Section 7
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than € 1 billion per year investment in R&D per company) is six and a 
half times that in the engineering & machinery sector (€ 156 million).
Table 7.1.
The Largest 10 Sectors in Aggregate R&D Investment of top 685 companies listed 

















1 IT hardware 56893 19.6 122 466.3
2 Automobiles & parts 54483 18.8 51 1068.3
3 Pharmaceuticals & biotechnology 52404 18.1 84 623.9
4 Electronics & electrical equipment 31237 10.8 50 624.7
5 Software & computer services 17276 6.0 56 308.5
6 Chemicals 15033 5.2 62 242.5
7 Aerospace & defence 10862 3.7 19 571.7
8 Engineering & machinery 8601 3.0 55 156.4
9 Telecommunication services 6677 2.3 16 417.3
10 Health 5880 2.0 27 217.8
  Total 10 Sectors 259347 89.5 542 478.5
  TOTAL 685 companies 289654 100,0 685 421.6
Note: The worldwide R&D investment (in millions of euros) in each sector is the R&D 
investment by the top 685 companies (disaggregated by sectors). 685 companies were 
considered, with more than 51.38 million euro equivalent R&D investment, of which 542 
were in the main 10 sectors in terms of their weight in the total R&D investment of the top 
companies. The sector’s share is the share the R&D investment of the companies acting in 
the respective sector has in total R&D investment of the 685 companies. The number of 
companies represents how many companies out of the 685 are reporting their main activity 
in the respective sector. R&D Investment/Company is the average R&D investment per 
company for all companies that state their main business to be in the sector in question.
Table 7.2 shows a comparison between the EU-500 companies and the 
non-EU 500 companies on the 2004 Scoreboard, from the point of view of 
the sector’s shares in total R&D investment of the top 500 companies and 
of the R&D/Sales ratio. The big differences between the EU-500 group of 
companies and the non-EU 500 are as follows:
n  The  non-EU  500  group  of  Scoreboard  companies  has  much  larger 
proportions of IT hardware (almost twice as much) and of software 
& computer services (three times as much) than the EU-500 group of 
companies
n  The  EU-500  group  of  companies  has  larger  a  larger  share  of  R&D 
investment in the automobiles & parts sector (50 % more, of aerospace 
& defence (three times as much) and of engineering & machinery and 
chemicals (75 % more) than the non EU-500 group of companies.
The non-EU 500 group of companies is, of course, mainly a combination 
of companies with registered ofﬁces in the US and Japan so it conceals 
big differences between these two economies, for example in software & 
computer services where the US companies have almost 50 times as much 
R&D investment as Japanese companies. However, what is clear from the 
The non-EU 500 group of 
Scoreboard companies 
has much larger shares 
of IT hardware (nearly 
double) and of software & 
computer services (three 
times as much) than the 
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summary of key differences above is that the companies included in the 
R&D Scoreboard’s EU-500 are likely to have a lower aggregate R&D/Sales 
ratio than the non-EU 500 group of companies, since they show relative 
strengths in medium R&D-intensive sectors such as automobiles & parts 
and engineering & machinery and relative weakness in highly R&D-intensive 
sectors such as IT hardware and software & computer services.
*  Not in the EU-500 top 10 sectors but are in the non-EU 500 top 10; in brackets their 
ranking in the EU-500.
†  The numbers in brackets are the order of sector size for the non-EU 500
Table 7.2.
The Largest Sectors among Companies listed in the EU-500 and Non-EU 500 
groups on the Scoreboard (data for 2003)


















Automobiles & parts 23.8 4.6 (3) † 15.7 4.1
Pharmaceuticals & biotechnology 17.0 15.2 (2) 18.5 15.1
IT Hardware 12.4 15.6 (1) 22.9 8.6
Electronic & Electrical equipment 10.3 6.5 (4) 10.9 5.7
Chemicals 7.2 4.2 (6) 4.2 3.8
Aerospace & Defence 6.8 8.0 (10) 2.1 2.7
Engineering & machinery 4.6 2.5 (7) 2.5 2.8
Telecommunication services 2.8 1.0 (11) 2.0 2.5
Software & Computer services 2.6 12.8 (5) 7.8 10.0
Oil & Gas 1.9 0.3 (14) 1.2 0.5
Health (11) 1.7* 5.1 (9) 2.2 8.4
Diversiﬁed industrials (13) 1.1* 3.3 (8) 2.4 2.3
This analysis is taken further by combining sectors into ﬁve groups, each 
group containing a set of sectors with similar R&D/Sales ratios. These are:
n  Group 1  - Pharmaceuticals  &  biotechnology  and  health,  which  are 
closely related and also two of the ﬁve highest R&D intensive 
sectors in Table 7.2.
n  Group 2  - Electronics  &  IT  (electronics  &  electrical  equipment,  IT 
hardware, software & computer services) which are related 
sectors and the other three top 5 R&D-intensive sectors in 
Table 7.2.
n  Group 3  - Engineering  &  chemicals  (automobiles  &  parts,  aerospace 
& defence, engineering & machinery, chemicals and related 
sectors with medium R&D/Sales ratio of companies above 
2.5 % but below 5 %)
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n  Group 4 - Lower intensity sectors with an R&D/Sales ratio of 1 % to 
2.5 % (examples being food producers, construction, steel 
& metals).
n  Group 5 - Very  low  intensity  sectors  with  an  R&D/Sales  ratios 
generally below 1 % (examples are electricity, oil & gas, 
food retailers).
The sectors have been assigned to groups by range of R&D/Sales ratio 
on the basis of global R&D/Sales ratios. These ﬁve groups are then used 
to analyse the companies registered in the three major economies using 
the EU-185, US-288 and Japan-153 sets of companies which have the 
same R&D investment size range. The aim of the analysis is to identify 
the proportions of R&D investment in each of the three groups and the 
individual group R&D/Sales ratio and hence to explain the reasons for 
the  difference  in  overall  R&D/Sales  ratio  between  speciﬁc  groups  of 
companies from different regions of the world (major economies).
Using the 2004 Scoreboard data, the proportions of R&D investment of 
the EU-185, Japan-153 and US-288 groups of companies in each of the ﬁve 
sector groups are shown in Table 7.3 together with the R&D/Sales ratio for 
each group (group’s R&D as percentage of group’s net sales). There are 
a series of substantial differences between the sectoral structures of R&D 
investment for companies with registered ofﬁces in the main three world 
economies as follows:
7.b. Sector Group Analysis for the EU, Japan,
and the US
† The R&D/Sales ratio for each group are shown in brackets
Table 7.3.
Proportions of total R&D Investment and R&D/Sales Ratios  † in the ﬁve Sector 
Groups of Scoreboard Companies registered in the EU, Japan and the US (in 2003)


























































n  The US companies included in the 2004 R&D Scoreboard have over 
two-thirds (68.1 %) of their R&D investment allocated to the highly 
R&D-intensive groups 1 and 2. There is a very small proportion of US 
companies in low R&D/Sales ratio groups 4 and 5 (under 4 %) and 
28 % in the medium R&D/Sales ratio group 3 – substantially less than 
the equivalent proportion of EU and Japanese companies. It is thus the   The 2004 EU Industrial R&D Investment Scoreboard  61 
high proportions in groups 1 and 2 that give the top US companies 
(listed in the R&D Scoreboard) the high overall R&D/Sales ratio of 
4.9 %, aided by the very low proportions in groups 4 and 5.
n  Japanese companies concentrate over half (51.4 %) of their overall 
R&D investment in groups 1 and 2 with nearly 11 % in groups 
4 and 5 and 38 % in the medium intensity group 3. They have a 
substantially  higher  R&D/Sales  ratio  than  the  US  companies  in 
sector-group 3 (4.2  % vs. 3.1 %) but this is more than offset by 
the much lower share than the US companies in group 2 (5.8 % 
vs. 10.1 %). The reason for Japan’s low group 2 R&D/Sales ratio 
is its large proportion of electronics & electrical equipment R&D 
investment in sector-group 2 compared to the US companies’ large 
presence in IT hardware and software & computer services, which 
both  have  higher  R&D/Sales  ratios.  The  overall  effect  is  to  give 
Japanese companies an R&D/Sales ratio mid-way between those of 
EU and US companies.
n  The EU-185 group of top companies investing in research has the 
lowest proportion of R&D investment in groups 1 and 2 (44.1 %) 
but the highest proportion† in group 3 (47 %, well above Japan with 
38 % and the US with 28 %). The EU also has a similar proportion of 
R&D investment in sector-groups 4 and 5 to Japan. One reason for 
the EU companies’ low overall R&D/Sales ratio is its small proportion 
of R&D investment in groups 1 and 2 (particularly group 2), which is 
not compensated for by its higher proportion (and R&D/Sales ratio) 
in group 327. Another more subtle factor is the signiﬁcant proportion 
of R&D investment for EU companies that stated their main activity 
to be in sector-group 5. This is due to the large oil & gas sales which 
also help depress the overall R&D/Sales ratio.
The above discussion concentrates on the relative strengths of the three 
economies. The relative weaknesses are also apparent from Table 7.3.
These are principally:
n  The lower than average R&D/Sales ratio for the US companies in 
group 3 (all engineering & machinery and chemicals).
n  The very low proportion of R&D investment in group 1 for Japanese 
companies (one third of the ﬁgure for US companies) together with 
the low proportion of their group 2 in the higher intensity sectors of 
software & computer services and IT hardware.
n  The  low  proportion  of  R&D  investment  in  group  2  for  the  EU-
registered companies (less than 60 % of that for the US or Japanese 
companies).
Another way of illustrating the effects of the ﬁve groups on the overall R&D/
Sales ratio is to calculate these shares using only some of the groups and 
comparing these between subsets of companies registered in one economy 
or another. This is done in Table 7.4 where the notation used is as follows:
27  It is signiﬁcant that capital expenditure intensity of the EU-185 group of companies is higher 
than that for the non-EU 500 group of companies for most of the group 3 sectors (i.e. 
automobiles & parts, aerospace & defence, chemicals and engineering & machinery).
The EU-185 group of top 
companies investing in 
research has the lowest 
proportion – when 
compared to top Japanese 
and US companies 
- of R&D investment 
in pharmaceuticals, 
biotechnology & health 
sector and in the electronics 
& electrical and IT hardware 
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proportion in the engineering 
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I12  =  R&D/Sales ratio calculated for groups 1 & 2 only.
I123  =  R&D/Sales ratio calculated for groups 1, 2 & 3 only.
IT  =  R&D/Sales ratio calculated using all 5 groups.
It can be seen from Table 7.4 that Japanese companies on the Scoreboard 
have a low I12 (because they have a large electronic & electrical equipment 
sector compared to software & computer services and IT hardware and a 
weakly represented sector-group 1) compared to the US- and EU companies. 
When the R&D/Sales ratios I123 are compared, the Japanese companies’ 
ﬁgure moves much closer to the values calculated for the US and the EU. The 
ﬁnal step to IT leaves the US companies with the highest R&D effort since 
groups 4 and 5 are relatively much smaller. The EU companies drop below 
Japanese ones because of their larger presence in groups 4 and 5, where 
they have lower aggregate R&D/Sales ratios.
Table 7.4.
R&D/Sales Ratio for Clusters of Groups of Companies registered in the Major 
Economies, in 2003
Iijk = R&D/Sales Ratio for Groups i & j & k Only
Economy I12 I123 IT
EU-185 11.1 % 6.2 % 3.6 %
Japan-153 6.4 % 5.2 % 4.2 %
US-288 11.2 % 6.4 % 4.9 %
From this analysis, it can be seen that in R&D/Sales ratio terms, the US-
registered companies in the 2004 R&D Scoreboard beneﬁt in two ways from 
their dominant position in groups 1 and 2. These two groups ﬁrstly have very 
high R&D/Sales ratios of themselves but, secondly, their large combined size 
in the US group of companies reduces the ‘diluting’ effects of groups 4 and 
5 on the overall R&D effort. Groups 4 and 5 contain sectors where capital 
expenditure tends to be larger and more important than R&D investment, so 
it is not surprising that they have low R&D/Sales ratios. The US companies 
enjoy other potential advantages in that the skills needed for R&D activity in 
groups 1 and 2 are most likely to be important for the new, cross-disciplinary 
sectors and sub-sectors that are expected to emerge in the future.
An important implication of this analysis is that the overall R&D/Sales ratio 
for a group of companies registered in a particular country or region appears 
to be a simple single-ﬁgure measure but is, in fact, related to the sector mix 
and sector R&D/Sales ratio in a complex way. The sector group analysis 
of this section helps explain the way in which ﬁve very different groups of 
sectors contribute to the overall intensity.
It is important to focus on the total volume of R&D investment in each sector 
group as well as on companies’ aggregate R&D/Sales ratios and to be aware 
of the balance between the different sector groups. Policy-makers can use 
this analysis to identify priority areas in which the local business environment 
could be improved. However, it is company R&D investment that leads to 
new products, processes and services and this of course does not apply only 
7.c. Implications of the Analysis
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to those companies listed in this Scoreboard. The future competitiveness of 
an economy will also depend on how many smaller companies can grow 
successfully to become leading global competitors in their sub-sectors and 
niches. This is inﬂuenced by the quality of the business environment in the 
countries concerned. A review of global R&D scoreboards28 over the last 
15 years shows just how much change can occur in one or two decades 
with some apparently well established companies disappearing and others 
growing to dominate newer sectors and take their place amongst the top 30 
or so companies.
28  As can be demonstrated using the UK DTI R&D Scoreboards.
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Comparison of Top EU
and US R&D-Investing Companies
The  top  500  R&D-active  companies  on  the  2004  EU  Industrial  R&D 
Investment Scoreboard includes only 185 companies in the same size range 
as the 288 US companies in the non-EU 500. Therefore, to carry out a more 
detailed  comparison  of  a  much  broader  range  of  companies  in  the  two 
economies, the EU-500 group on the Scoreboard has been compared to 
the US-1000 Scoreboard29. However, the US 1000 contains US companies 
with R&D investment down to $1m and sales above $100m. A comparison 
is therefore made between the 725 companies in the US-1000 Scoreboard 
with R&D above € 8.5m ($10.7m at the 2003 exchange rate used for this 
analysis) and the 432 companies within the EU-500 Scoreboard with sales 
above € 79m ($100m). This provides two comparable sets of companies in 
terms of the magnitude of both R&D investment and net sales. It would not 
be meaningful to make a comparison without this correction since R&D-
active companies with very different ranges of R&D investment and sales 
tend to have very different average R&D/Sales ratio30.
Given  that  the  group  of  companies  in  the  EU-500  Scoreboard  contains 
some very large companies and that (see Section 2) the top 25 companies 
account for over 60 % of the overall R&D investment, a comparison of R&D 
investment totals or of the R&D/Sales ratio would always be dominated by 
the largest companies. An alternative approach is therefore used to highlight 
the differences between companies across the full sample of EU and US 
companies. This involves two steps:
n  A comparison of R&D/Sales ratio distributions to see if there are 
differences between the proportions of companies in bands of low, 
medium and high R&D effort
n  An examination of the sectors which are responsible for any large 
differences between the two groups.
A detailed analysis of these two aspects is outlined in the next two sub-
sections.
The  groups  of  EU  and  US  companies  meeting  the  same  criteria  (R&D 
investment over € 8.5m, sales over € 79m), are divided into six R&D/
Sales ratio bands31 ranging from 0-2 % to over 20 %. Table 8.1 shows 
the percentages of companies in each group that fall into each of the six 
intensity  bands.  There  are  big  differences  between  the  two  groups  of 
companies. In the lowest intensity band the EU companies had almost twice 
the proportion of companies as the US (35 % EU vs. US 18 %) in 2003 but 
29  U.S. Industrial R&D Scoreboard 2003, Industrial Research Institute, December 2003.
30  On the other hand, the initial exclusion of companies with less than $100 million net sales 
from the US Scoreboard introduces a distortion in the statistical characteristics of the US 
sample of companies from the very beginning. By selecting similar-sized companies, we 
are improving the quality of comparison of speciﬁc groups of companies, but we lose 
accuracy in the comparisons with a similar number of companies in the two different 
available sets of companies, in addition to reducing the amount of information.
31  An R&D/Sales ratio band between 10% and 20% means that the R&D/Sales ratio of the 
companies will be in the range of 10% to 20%.
8.a. Distributions of R&D/Sales ratios
of EU and US Companies
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the US companies had more than twice the proportion of companies in the 
top two intensity bands for the same year (43 % with R&D/Sales ratios over 
10 % compared to 17 % for the EU). The differences in the middle three 
bands are much smaller and the number of EU companies with R&D/Sales 
ratios within those ranges accounted for 48 % of total compared to 39 % 
for the US companies.
Table 8.1.
The  breakdown  by  R&D/Sales  ratio  band  in  2004  of  R&D-active  companies 
registered in the EU and the US
Note: The percentages are rounded so they sum to 100 %.
 % of companies in each R&D/Sales ratio band
0-2 % 2-4 % 4-6 % 6-10 % 10-20 % >20 %
EU-500 Subset 35 % 19 % 14 % 15 % 13 % 4 %
US-1000 Subset 18 % 14 % 12 % 13 % 26 % 17 %
The breakdown by R&D/Sales ratio band for the top 40 companies registered 
in both the EU and US are shown in Table 8.2. If this is compared with Table 
8.1, it can be seen that the differences between companies located in the EU 
vs. the US are much smaller in Table 8.2. Indeed the distributions in Table 8.2 
would be almost exactly the same if a group of 15 EU-registered companies 
were moved from the 6-10 % band to the two highest bands. This conﬁrms 
that the big differences seen in Table 8.1 are primarily related to companies 
ranked below the top 40 within the 2004 R&D Scoreboard. In the next 
sub-section, the sectorial split of the companies with high R&D/Sales ratio 
is identiﬁed.
Table 8.2.
The  breakdown  by  R&D/Sales  ratio  band  for  top  40  EU  and  US  R&D-active 
companies registered in the EU and the US
 % of companies in each R&D/Sales ratio band
0-2 % 2-4 % 4-6 % 6-10 % 10-20 % >20 %
EU Top 40 5 12 20 25 35 3
US Top 40 5 17 18 7 45 8
The difference between the EU and US companies in Table 8.1 is large. The 
proportion of companies having a R&D/Sales ratio over 10 % is 17 % in 
the EU group and 43 % of the US group. In Table 8.3, all the companies 
with an R&D/Sales ratio over 10 % are assigned to one of four groups. The 
ﬁrst three are groups of related highly intensive R&D sectors – IT hardware 
with electronics & electrical equipment, software & computer services and 
ﬁnally pharmaceuticals & biotechnology with health. The fourth group is an 
‘others’ category which contains all other sectors.
The message from Table 8.3 is clear – the major difference between the EU 
and US groups of companies is in IT hardware and electronics & electrical 
equipment, where the proportion of companies registered in US is over twice 
8.b. Sector Mix of EU and US High
R&D/Sales Ratio Companies
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as large as the proportion of EU companies and in software & computer 
services where the proportion of companies registered in US is almost four 
times as large. These three FTSE sectors alone account for almost three-
quarters of the overall difference between the companies registered in the 
EU vs. those in the US (from the Scoreboard) for the two highest intensity 
bands in Table 8.1.
The conclusion is that the companies registered in the US show ‘strength 
in  depth’  in  the  sectors  showing  large  percentages  in  Table  8.3  with  a 
wide range of companies of different sizes all contributing to the 43 % of 
companies with R&D/Sales ratio above 10 %.
Companies registered in 11 EU countries make up the group with R&D/Sales 
ratio over 10 %. The UK, French and German-registered companies together 
contribute over 72 % of these R&D intensive companies with nearly 40 % 
of the total companies that are registered in the UK. It is important for EU 
policy-makers to ensure that the business environment for developing and 
growing companies in R&D intensive sectors such as those of Table 8.3 is at 
least as good as that in competitor economies.
Table 8.3.








1000 Subset with 
R&D/Sales Ratio 
above 10 %
IT Hardware and Electronics & 
Electrical Equipment 7 % 15 %
Software & Computer Services 4 % 15 %
Pharmaceuticals & Biotechnology 
and Health 4 % 5 %
Other Sectors 2 % 8 %
Totals 17 % 43 %
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R&D Investment and
Business Performance
There have been many studies of companies that have shown sustained 
success over many years and each study identiﬁes several factors contributing 
to success. These success factors usually include innovation (leading to the 
development of new products and services) and a range of other ingredients 
such as strategy and leadership, culture and people, efﬁciency and customer 
care. For R&D-active companies, these factors can be grouped under the 
three headings of strategy; operations; and investment in the future. R&D 
for new products and services is a key aspect of the third category but a 
successful company also needs to excel in the ﬁrst two categories. The three 
categories can be summarised32 as follows:
n  Good strategic choices. This means that a company carefully selects 
the sub-sector(s) it will lead in and the growth route (organic growth, 
acquisitions or a mix of organic growth and smaller acquisitions).
n  Operational excellence. This involves lean production, efﬁcient business 
processes  and  good  customer  care  (quality,  on-time  delivery  and 
service).
n  Wise and balanced investment in the future such as in R&D investment, 
capital expenditure, brands and the development of markets, skills and 
people.
This implies that a company can have excellent R&D which develops new 
products, processes and services of high potential but may still not enjoy 
business success. This could be because of limitations in strategy (such as 
poorly chosen acquisitions), in operations or in market development or the 
launch of new products. However, the converse is also true – a company that 
under-invests in R&D relative to its best competitors will ﬁnd that its range 
of products and services become less competitive and it is then difﬁcult 
for it to maintain business performance. Examples may be found in more 
mature  sectors  where  one  company’s  product  range  may  become  more 
biased towards the commodity rather than value added part of the sector 
market than that of its major competitors. In R&D-intensive sectors such as 
pharmaceuticals, if a company’s successful drugs come off patent faster than 
they are replaced by new patented medicines, then its business performance 
is  likely  to  fall  behind  that  of  its  competitors  since  products  previously 
protected by patents will be competing against generic medicines.
Previous work in both Europe and the US on the links between R&D investment 
(and similar investments) and company performance has identiﬁed several 
statistically signiﬁcant links such as:
n  Higher R&D/Sales ratio is linked to higher sales growth33 
9.a. Links between R&D and Company Performance
32 DTI 2004 Value Added Scoreboard, UK Department of Trade & Industry, April 2004. 
Copies can be obtained by email from publications@dti.gsi.gov.uk. See also the website 
www.innovation.gov.uk/ﬁnance
33  See, for example, G.K.Morbey – Journal of Prod. Innov. Management 5, p191-200, 1988.
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n  Labour productivity (sales or value added per employee) is linked to 
investment (R&D Investment and capital expenditure) per employee 
across a range of sectors34.
n  In the particular case of companies listed in this 2004 Industrial R&D 
Investment Scoreboard35, for sectors where R&D investment and capital 
expenditure  are  signiﬁcant,  three-quarters  of  companies  with  above 
average wealth creation efﬁciency36 also have above average investment 
intensity (R&D/Sales ratio or total ﬁxed asset intensity or both).
As well as these links, there are differences in the valuation that the ﬁnancial 
markets  put  on  sectors  and  the  companies  within  each  sector.  These 
differences and particularly those linked to investment in the future are 
discussed in the next sub-section.
The market capitalisation of a listed company represents the valuation put 
on it by ﬁnancial markets. The ratio of market capitalisation to value added 
(MC/VA) rises with wealth creation efﬁciency and proves to be a useful 
measure to distinguish between sectors and between companies within a 
sector. However, as value added data are only available for EU companies37, 
the ratio of market capitalisation to net sales (MC/S) is used instead in 
the  analysis  of  this  Scoreboard38.  The  MC/S  ratio  for  several  sectors  is 
summarised in Table 9.1 for a range of R&D-active sectors for EU versus 
non-EU companies listed on the Scoreboard.
9.b.  Market Capitalisation to Sales Ratio
34  DTI 2003 Value Added Scoreboard, UK Department of Trade & Industry, April 2003. 
Copies can be obtained by email from publications@dti.gsi.gov.uk. See also the website 
www.innovation.gov.uk/ﬁnance
35  DTI 2004 Value Added Scoreboard, UK Department of Trade & Industry, April 2004. 
Copies can be obtained by email from publications@dti.gsi.gov.uk. See also the website 
www.innovation.gov.uk/ﬁnance
36  Wealth creation efﬁciency is value added divided by the sum of employee costs and 
depreciation.
37  US and Japanese companies follow US GAAP which does not require companies to disclose 
enough information to allow VA to be calculated
38  This may introduce a bias (only at aggregate level, not by sector, consequence of the 
given different sector mixes) against the Scoreboard companies registered in EU due to 
the already proved fact that top EU-registered companies investing in R&D have relatively 
higher aggregate net sales as compared to their R&D-active competitors (consequently, 
their share of R&D investment in net sales is smaller).
Table 9.1.
Market  Capitalisation  to  Net  Sales  Ratios  (MC/S)  for  R&D–Intensive  Sectors 
(companies listed in the Scoreboard, data for the 2003 ﬁnancial year).







Engineering† Sectors & Chemicals 0.3 – 0.7 0.5 – 0.9
IT Hardware 1.6 1.8
Personal Care 2.1 2.8
Software & computer services 3.7 3.8
Health 1.2 4.2
Pharmaceuticals & biotechnology 3.0 4.2
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The message of Table 9.1 is that a substantial group of companies whose 
main  activity  is  in  engineering-related  sectors  (aerospace  &  defence, 
automobiles  &  parts,  chemicals,  electronics  &  electrical  equipment, 
engineering & machinery) all have MC/S ratios below 1.0 (whether they 
are EU or non-EU companies) and a group of companies with declared main 
activity in ﬁve other sectors have higher MC/S values. This latter 5-sector 
group consists of the R&D intensive sectors such as health, IT hardware, 
pharmaceuticals & biotechnology and software & computer services. It 
also includes personal-care products, a sector in which non-EU companies 
from the Scoreboard show an R&D/Sales ratio of 3.3 % and EU companies 
(belonging to the subset of 185 companies with a similar size and R&D 
investment volume as the non-EU 500) have a share of 2.7 %. The EU 
companies belonging to the top 185 group which are active in the health 
sector form a sample that is almost too small to be included since three of 
the larger companies are not listed on an ofﬁcial stock exchange (so they 
do not have a market capitalisation) leaving only four listed companies 
with R&D investment over € 100m.
Table 9.1 also suggests that the top 185 EU companies whose stated main 
business is in software & computer services and IT hardware have similar 
MC/S ratios to the top 500 non-EU companies, but that there is an apparent 
gap in the case of companies in pharmaceuticals & biotechnology and in 
personal care products sectors. Sector averages, however, can be deceptive 
since one or two companies can dominate the aggregate market capitalisation 
of a sector on the Scoreboard (see Table 9.2). The most extreme case is SAP, 
which is registered in Germany, and which accounts for over 70 % of the 
Scoreboard’s EU-185 software & computer services sector aggregate market 
capitalisation (and 63 % of the equivalent aggregate for Scoreboard’s EU-
500 companies whose stated main business is in the software & computer 
services sector).
Table 9.2.
Concentration of Market Capitalisation
†- only companies included in the EU 2004 Industrial R&D Investment Scoreboard
Share of Sector Market Capitalisation
for Largest Company†
Sector EU-185 Non-EU 500
IT Hardware 35 % (Nokia) 14 % (Intel)
Personal care products 55 % (L’Oreal) 50 % (Procter & Gamble)
Software & computer services 71 % (SAP) 43 % (Microsoft)
Pharmaceuticals & biotechnology 32 % (GlaxoSmithKline) 19 % (Pﬁzer)
The pharmaceuticals sector is one in which there are several substantial 
companies in both the EU top 185 group and the non-EU top 500 group 
and Table 9.3 shows the MC/S ratio and the company net sales for the top 
10 R&D-active companies in each case. The MC/S range for the non-EU 
registered companies is 3.0 to 5.4 except for a low of 2.1 and a high of 8.6. 
For the top 185 companies with their registered ofﬁces in EU, the range is 
1.8 to 3.9 except for a low of 0.3 and a high of 4.8. It is interesting that 
the company with the highest MC/S ratio – Amgen at 8.6 – is also on the 
list of the top 10 non-EU companies by R&D/Sales ratio. Equally, the two 
EU companies with the lowest MC/S ratios – Merck and UCB – have the 
lowest R&D/Sales ratios. However, Merck (which has its registered ofﬁce 
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in Germany) also has non-pharmaceutical activities (e.g. liquid crystals), 
underscoring the point that some differences within a sector can also be 
caused by differences in companies’ specialisations in particular sub-sectors. 
Within the pharmaceuticals & biotechnology sector, a generic drug division 
will, for example, make a big difference.
Table 9.3.
MC/S and Net Sales for Top 10 Pharmaceuticals Companies (included in 2004 
Industrial R&D Investment Scoreboard), in 2003
EU-185 Non-EU 500
Company MC/S Sales € bn Company MC/S Sales € bn
GlaxoSmithKline  3.1 30.4 Pﬁzer 5.4 35.8
Aventis 2.8 17.8 Johnson & Johnson 3.9 33.2
AstraZeneca 3.9 14.9 Roche 3.5 20.0
Sanoﬁ-Synthelabo 4.8 8.0 Novartis 5.0 19.7
Schering 1.8 4.8 Merck 4.5 17.8
Merck 0.3 7.2 Eli Lilly 5.7 10.0
Novo Nordisk 3.3 3.6 Bristol-Myers Squibb 2.1 16.6
Altana 2.2 2.7 Wyeth 3.0 12.6
Lundbeck 2.8 1.3 Amgen 8.6 6.6
UCB 1.8 3.0 Schering-Plough 3.4 6.6
In previous sections it has been pointed out that EU companies are relatively 
strong in the pharmaceuticals & biotechnology sector. If Table 9.3 were recast 
as Europe vs. the US, Roche and Novartis would move from the non-EU 500 
column to the “Europe” column in positions 2 & 3, which will add further 
“strength” to the new category of companies registered in Europe. However, 
the point of Table 9.3 is not a non-EU vs. EU companies comparison but a 
demonstration of the wide variation in MC/S among companies declaring 
their main activity within a sector.
The overall message of this section is that the ﬁnancial markets give very 
different values to the sales of different sectors and of different companies 
within each sector. Those sectors which have substantial R&D intensities and 
where R&D investment can give a lasting competitive beneﬁt to companies 
acting  on  those  markets  have  the  highest  MC/S  values.  Examples  are 
pharmaceuticals  &  biotechnology  (patented  medicines)  and  software  & 
computer services (both copyright and customers’ existing investment in 
the company’s software). The reasons for MC/S variations within a sector 
include, taking pharmaceuticals as an example, sub-sector differences such 
as between generic and patented medicines and differing success rates of 
R&D investment in producing new patented medicines.
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This pilot 2004 EU Industrial R&D Investment Scoreboard has explored 
the research investments of the top 500 R&D-investing companies with 
registered ofﬁces located in the EU, and the top 500 companies registered 
outside the EU.
The  main  ﬁndings  and  outcomes  are  discussed  under  the  following 
headings:
n  Levels and growth of R&D.
n  Business performance and R&D.
n  How R&D is distributed.
n  R&D specialisations and strengths.
n  Intensity (R&D/Sales ratios).
n  R&D Reporting.
NOTE:
- In  this  report  “R&D  Investment”  refers  to  investments  in  R&D 
undertaken by companies on their own behalf and funded by the 
companies themselves. It excludes R&D performed under contract for 
customers such as governments or other companies. It also excludes 
the companies’ share of any associated company or joint-venture R&D 
investment. Where part or all of R&D costs have been capitalised, the 
additions to the appropriate intangible assets are included to calculate 
the cash investment net of amortisation.
- The deﬁnition of “R&D” is that used by companies, following accepted 
international accounting standards (IAS 38), in accordance with the 
deﬁnitions used in ofﬁcial statistics (as deﬁned in the OECD’s ‘Frascati 
Manual’).
-  The  terms  “EU-company,  non-EU  company  or  German-  company, 
Finnish-company, US- company, Japanese- company, etc. ” are used 
throughout this report to refer to a company whose ultimate parent 
has chosen to locate its registered ofﬁce in that country or region.
- The term “R&D/Sales ratio” is used in this report to mean the ratio of 
a company’s R&D investment to its net sales.
- The “sectors” in which groups of companies are classiﬁed in this report 
are those sectors of economic activity as deﬁned by the FTSE (Financial 
Times Stock Exchange index) sectorial classiﬁcations, and corresponds 
to the sector which individual companies declare their main activity 
to lie in.
- When a year is mentioned in the analysis of company data, it refers to the 
company’s published accounts for the given ﬁnancial year. Companies 
in most countries have discretion in the choice of accounting period 
end and as a result the current year set can include accounts ending on 
a range of dates from the middle of one year to early next year.
Synopsis of Main Findings
Main Findings from the Analysis
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Levels and growth of R&D
In the 2004 Scoreboard, the R&D investment of the EU top 500 companies 
totalled € 100.8 billion. The overall R&D investment of the non-EU top 500 
companies listed in the Scoreboard was equivalent to € 195.6 billion.39 
R&D investment by the EU-500 companies fell in 2003. Growth rates of R&D 
investment of the two sets of companies in 2003 were -2.0 % for the EU-500 
companies and 3.9 % for the non-EU group. The compound annual growth 
rates, over the period 2000-2003, were 1.2 % and 3.8 % respectively, the 
difference between the EU and non-EU companies being mainly caused by 
the reduction in R&D spending in 2003 by the EU companies.
Using comparable sets of EU and non-EU companies from the Scoreboard, 
the proportion of EU companies in the global top R&D-active companies 
was 32.5 % in 2003, showing a decrease from 34.2 % in 2001 (computed 
at 2003 exchange rate equivalents).
Figure 10.1.
The R&D investment share of top 68540 Scoreboard companies worldwide, by 
region of ofﬁce registration, in 2003
There has been an overall decrease in R&D/Sales ratio in 2003, as compared 
to 2002, for both EU and non-EU companies (from 3.31 % to 3.21 % in the 
case of the Scoreboard’s top 500 EU-based companies (referred to here as 
the EU-500) and from 4.66 % to 4.51 % in the case of Scoreboard’s top 
500 non-EU companies). In 2003, the top 40 non-EU companies included 
20 companies with R&D investment increases of more than 5 % over the 
previous year and 10 companies for which R&D investment had decreased; 
the EU top 40 comprised 11 companies whose R&D investment increased 
over the previous year, but 16 companies whose R&D investment decreased. 
39  In order to convert the non-euro currencies the end-of-year exchange rate was used, as 
reported at 31 December 2003. This applies also to the historical comparative data. The 
principal rates used are: Sweden: 9.08 (Swedish Kronor); Japan: 135.18 (Yen); Switzerland: 
1.56 (Swiss Franc); UK: 0.70 (£ Sterling); US: 1.26 (US$).
40  These are the top 685 EU and non-EU Scoreboard companies worldwide – (see beginning 
of Section 2) 
R&D investment by the 
EU-500 companies fell 
in 2003. Growth rates of 
R&D investment of the two 
sets of companies in 2003 
were -2.0 % for the EU-500 
companies and 3.9 % for 
the non-EU group.
In 2003, the top 40 non-
EU companies included 
20 companies with R&D 
investment increases of 
more than 5 % over the 
previous year and 10 
companies for which R&D 
investment had decreased.  The 2004 EU Industrial R&D Investment Scoreboard  75 
Over the last 4 year period, however, the top 40 companies in both regions 
show approximately the same growth behaviour in R&D investment.
Business performance and R&D
In 2003, both EU and non-EU ﬁrms were recovering from the recession 
of 2001-2002, but were in different phases of the cycle. Among non-EU 
companies, sales, proﬁtability and R&D expenditure all rose between 2001 
and 2002. EU companies experienced increasing proﬁtability, but sales and 
R&D investment continued to decline. However, averaged over the past four 
years, growth shows positive or constant ﬁgures for both EU and non EU 
companies in terms of R&D investment.
How R&D is distributed
The level of concentration of R&D investment among the companies included 
on the Scoreboard is high. The top companies are responsible for a large 
proportion of overall R&D investment, regardless the region where they are 
registered, though the degree of concentration is more marked in the case of 
EU companies than non-EU companies. In 2003, the top 20 EU companies 
for instance (4 % of the sample of companies) accounted for more than 55 
% of the total R&D investment by the EU-500 group of companies from the 
Scoreboard. For the non-EU region, the same proportion was almost 37 %.
These differences in concentration mean that the non-EU world has a larger 
proportion  of  medium-sized  R&D  performing  companies.  Nevertheless, 
from 2000-2003 there is a declining trend in R&D share of the top 20 EU 
companies, from 57.5 % in 2000 to 55.3 % in 2003, which means that 
EU companies from the bottom end of the EU-500 increased their R&D 
investment faster than the very large EU R&D-investing companies.
There  is  also  a  signiﬁcant  concentration  of  R&D  investment  among  the 
Scoreboard companies inside each of the ten main FTSE sectors. Within 
each sector the top R&D-investing company invested a proportion ranging 
between 15-35 % of the aggregate R&D investment of all the Scoreboard 
companies active in the respective sector, regardless of location (EU or non-
EU), with few exceptions (although non-EU companies active in IT Hardware 
show less concentration, as do EU companies in health).
Just  as  R&D  investment  is  concentrated  among  companies  it  is  also 
concentrated among sectors. For the world’s companies in this Scoreboard 
the four largest FTSE sectors in aggregate R&D investment are IT hardware, 
pharmaceuticals & biotechnology, automobiles & parts, and electronics & 
electrical equipment.
When companies of similar size are compared in the 2004 EU Industrial 
R&D Investment Scoreboard the four largest sectors for the non-EU world 
are IT hardware (19.6 % of all RTD), pharmaceuticals & biotechnology (18.8 
%), automobiles & parts (18.1 %) and electronics & electrical equipment 
(10.8 %). The order differs signiﬁcantly for the EU top 500 companies - 
automobiles & parts (23.8 %), pharmaceuticals & biotechnology (17 %), IT 
hardware (12.4 %) and electronics & electrical equipment (10.3 %).
R&D investment is highly concentrated geographically in three major EU 
Member  States:  Germany,  France  and  United  Kingdom,  which  in  2003 
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accounted for 73.5 % of the aggregate R&D investment of the Scoreboard’s 
top 500 EU-based companies.
Figure 10.2.
Share of R&D investment among EU Top 500 Scoreboard companies in 2003, by 
















R&D specialisations and strengths
With one important exception, namely French companies, EU companies, 
when  grouped  by  Member  State,  tend  to  show  at  least  one  strong 
specialisation in terms of R&D investment when compared to the average 
for the EU-500. In this case, by ‘specialisation’ we mean that the share of a 
particular sector’s R&D investment in the total R&D investment of Scoreboard 
companies, registered in a given EU country, is more than twice the similar 
share for the EU-500 as a whole.
German top R&D-investing companies are particularly strong in automobiles 
& parts, which is one of the Europe’s most important sectors in terms of 
its investment in research. Finnish companies concentrate more than 80 % 
of their R&D investment in IT hardware. Swedish companies show R&D 
strength and specialisation in IT hardware and its traditional engineering 
&  machinery  sector.  Dutch  companies  make  an  interesting  case  with 
three clear sector specialisations: aerospace, chemicals and electronics & 
electrical equipment (although aerospace clearly reﬂects the fact that EADS 
is registered in the Netherlands). United Kingdom companies specialise in 
the pharmaceuticals & biotechnology sector, but are also well above the 
EU average in aerospace & defence.
Specialisation can also be found across the so-called “Triad” of Europe, 
Japan and the US, and is linked to concentration among companies. In fact, 
to understand the relative strengths of the EU and non-EU world is it almost 
sufﬁcient to look at the top 10 companies in the EU, the US and Japan: 
i.e. the concentration of R&D investment in these 10 companies reﬂect the 
sectoral strengths of these three economies. For example, the EU and the 
US have three pharmaceutical companies each in their top 10 but Japan has 
none. Japan, which is strong in electronics & electrical equipment and IT 
At the level of individual 
sectors, EU companies 
in the Scoreboard can be 
strong compared to the 
rest of the world, while the 
overall R&D/Sales ratio is 
lower in the EU because 
the very high R&D/Sales 
sectors are relatively 
smaller, not because 
individual company 
performance is weaker.  The 2004 EU Industrial R&D Investment Scoreboard  77 
Hardware, has six such companies in its top 10 compared to ﬁve in the US 
and four in the EU. The remaining top 10 companies in each case are active 
in the automobiles & parts sector, where EU companies show more strength 
than their non-EU competitors.
Intensity (R&D/Sales ratios)
EU companies have higher R&D/Sales ratios than non-EU companies across 
all  sectors  except  for  engineering  &  machinery,  telecommunications,  oil 
and gas, and health. EU companies have higher R&D/Sales ratios in each 
of the top 5 R&D performing sectors in the EU, and in each of the top 
5 R&D performing sectors in the non-EU. However, looking at the overall 
R&D/Sales ratio across all sectors for comparable-size companies, the overall 
R&D/Sales ratio for EU companies is 3.6 %, signiﬁcantly less than that of 
Japanese companies at 4.2 % and US companies at 4.9 %.
The analysis of the Scoreboard data shows that the reason for this is the 
EU’s sector mix (that is, the composition of main activities declared by the 
companies listed on the Scoreboard).
The ﬁndings of the 2004 EU Industrial R&D Investment Scoreboard conﬁrm 
that the structure of European industry differs from that of the non EU 
world – with the EU having a much larger proportion of output ﬂowing 
from  relatively  low  R&D/Sales  sectors,  and  a  smaller  proportion  of  its 
output ﬂowing from such high R&D/Sales industries such as IT hardware, 
pharmaceuticals, and software & computer services. In fact, at the level of 
individual sectors, EU-500 companies can be strong compared to the rest of 
the world, while the overall R&D/Sales ratio is lower in the EU because the 
very high R&D/Sales sectors are relatively smaller, not because individual 
company performance is weaker.
A comparison of US and EU companies in the same size range shows very 
different distributions of companies by R&D/Sales ratio, with the EU having 
twice the US’ proportion of companies with low R&D/Sales ratio (between 
0 and 2 %) and the US having more than twice the EU’s proportion (43 % 
vs. 17 %) of companies with a high R&D/Sales ratio of over 10 %. The main 
reason for this difference is that there are many more large and medium-
sized US companies in the IT hardware sectors and a large proportion of 
these show high R&D/Sales ratio.
Improving R&D Reporting
There are a number of ways in which our understanding of corporate R&D 
could be improved by better data gathering.
First, the Scoreboard does not list companies with R&D investment below € 
8.54 m, so that there is no information on the vigour of smaller size companies 
by sector. To obtain this in a reasonably complete form, it is necessary to 
have the annual reports and accounts for smaller companies. To achieve this, 
clearer requirements for disclosing R&D investment and statistics on other 
form of intellectual capital in companies are needed, particularly for private 
companies not listed on a recognised stock exchange.
Second, the EU-500 companies included in the Scoreboard are drawn from 
just 16 of the 25 EU Member States. Regular publication of the Scoreboard 
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- with a larger number of companies in it - would provide more complete 
information and could also contribute to encouraging the disclosure of data 
in companies registered in all Member States.
Finally, while R&D-active foreign-owned companies are not included in the 
Scoreboard’s EU-500 group of top R&D-investing companies, it should not 
be forgotten that they do contribute in a signiﬁcant way to the EU economy 
and are an asset to the EU countries in which their R&D activity is based. 
Comprehensive data is available for such foreign-owned companies in the 
UK but is much more difﬁcult to obtain in many other EU countries. It will be 
important in the future to collect such data on an EU-wide basis.  The 2004 EU Industrial R&D Investment Scoreboard  79 
R&D Indicators for
EU companies, by Member State
Figures A.1 to A.6 show the progress over the period 2000-2003 of three 
important indicators for the aggregate of companies investing in R&D in 
each of the six Member States analysed in this section (Germany, France, 
UK, the Netherlands, Sweden and Finland). These indicators are: the annual 
growth rates for R&D investment; their net sales; the overall employment. 
Correlations may be assumed to exist between these indicators according 
to the existing literature on R&D. The following comments arise out of the 
analysis of data in the 2004 Scoreboard on which these graphs are based:
-  Net  sales  and  employment  were  synchronised  in  all  years  and  for 
companies registered in all the countries looked at, except for the United 
Kingdom41, which means that – generally and on aggregate level – EU 
companies investing in research were trying to maintain or increase their 
productivity regardless of the overall economic outlook (by adjusting 
their employment decisions to the growth of net sales). Therefore, it 
would make sense to look only at the relationship between net sales and 
R&D investment when analysing companies’ performances, as there is 
empirical evidence for a correlation between net sales and employment 
in the EU companies included in the Scoreboard.
-  German  companies  seem  to  have  a  one  year  lag  in  adjusting  R&D 
investment  decisions  to  variations  in  net  sales.  Anyway,  given  the 
longer-term nature of the decisions companies make about investment 
in research and innovation, net sales are only one factor among others 
which need to be considered. The structure of the economy and especially 
the R&D investment structure by sector of the top companies investing 
in R&D that are registered in a given country may also be an important 
factor. There is a considerable difference in the way decisions are made 
within a company depending on the R&D/Sales ratio already achieved 
and on the speed of product obsolescence within a given sector.
-  For most of the companies registered in EU Member States, 2003 was 
not a good year for R&D investments, particularly in Germany, France 
and the Netherlands. In the case of French and Dutch companies it 
followed another year of negative growth. The appreciation of the euro 
against other currencies may explain some of the recession in R&D 
activities, particularly during 2003.
-  The differing business cycles between EU Member States and the various 
economic policy mixes leading to differences in business environment 
may  be  one  explanation  for  the  overall  lower  performance  of  EU 
companies in R&D as compared to US companies. Despite their degree 
of internationalisation, EU companies still consider (with good reason) 
other EU Member States to be different from their national territory and 
business environment, and this may build barriers to the development 
of research and innovation activity (such as extramural research or scale 
economy development of R&D).
41  In the case of the 149 UK companies’ aggregate ﬁgures from the EU 2004 R&D Scoreboard, 
the net sales show positive growth rates for all years, while employment presents negative 
rates,  which  may  lead  to  the  conclusion  that  UK  companies  were  affected  by  other 
economic factors in assuming employment-related decisions during the latest years.
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Figures
Annual growth rates of R&D Investment, Net Sales and Employment for EU top 
500 companies investing in research, by country of registered ofﬁce, 2000-2003
Figure A.1
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Dutch Companies in Scoreboard
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Finnish Companies in Scoreboard
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The 2004 EU Industrial R&D
Investment Scoreboard lists of
EU-500 and non-EU 500 companies
METHODOLOGICAL NOTE:
The header of the Top 500 listing of ultimate parent companies 
contains the following notations:
FTSE Sector is the sector of economic activity – according to the 
FTSE  classiﬁcation  –  which  the  company  itself  has  declared  as 
main activity in its ﬁnancial accounts and/or reports or when listed 
on  a  recognised  stock  exchange.  The  code  number  of  the  FTSE 
classiﬁcation for the respective sector is given in brackets.
Country  is  the  country  where  the  ultimate  parent  company  has 
chosen to site its registered ofﬁce.
R&D Investment is companies’ cash investment in R&D conducted 
on their own behalf and funded by the companies themselves. It 
excludes  R&D  undertaken  under  contract  for  customers  such  as 
governments or other companies. It also excludes the companies’ 
share of any associated company or joint venture R&D investment. 
Where all or part of a company’s R&D costs have been capitalised, 
the additions to the appropriate intangible assets are included to 
calculate  the  cash  investment  and  any  amortisation  eliminated. 
The deﬁnitions of “R&D” used by companies, following accepted 
international accounting standards, accord with deﬁnitions used in 
ofﬁcial statistics (as deﬁned in the OECD’s ‘Frascati Manual’).
Number of companies for calculation is the number of companies for 
which ﬁgures were available in the 2004 Scoreboard for the given 
R&D-related indicator in the given year. If a computed indicator 
which needs data from two or more years in order to be calculated 
is used, the number in italics is the number of companies used in the 
aggregate calculations. This number is arrived at by subtracting all 
the companies for which data for at least one year is missing from 
the Scoreboard (i.e. the data were not available).
The Methodological Notes at the end of Volume II provide more 
detailed  information  on  all  the  variables  and  indicators  that  are 
referred to with each company listed in the 2004 EU Industrial R&D 
Investment Scoreboard.
Annex 2  84  The 2004 EU Industrial R&D Investment Scoreboard
 Top 500 companies 100 790 -2.0 3 139 330 3.2 7.1 8.4 89.0
number of companies for calculation 500 493 497 497 499 497 431
1 DaimlerChrysler Automobiles & parts (31) Germany 5 571 -8 136 437 4 1 15 26
2 Siemens Electronic & electrical (25) Germany 5 511 -5 74 233 7 4 13 67
3 Volkswagen Automobiles & parts (31) Germany 4 140 -5 88 414 5 3 13 14
4 Nokia IT hardware (93) Finland 3 978 15 29 455 14 17 77 144
5 GlaxoSmithKline Pharma & biotech (48) UK 3 961 -5 30 429 13 30 38 308
6 Ericsson IT hardware (93) Sweden 3 229 -0 12 973 25 -9 57 262
7 Aventis Pharma & biotech (48) France 2 924 -15 17 815 16 14 39 280
8 AstraZeneca Pharma & biotech (48) UK 2 736 12 14 944 18 22 45 391
9 Robert Bosch Automobiles & parts (31) Germany 2 650 7 36 357 7 5 12 ..
10 Philips Electronics Electronic & electrical (25) The Netherlands 2 617 -14 29 037 9 3 18 87
11 BMW Automobiles & parts (31) Germany 2 559 10 41 525 6 8 25 56
12 Bayer Chemicals (11) Germany 2 414 -5 28 567 9 -7 20 54
13 EADS Aerospace & defence (21) The Netherlands 2 193 5 30 133 7 1 20 58
14 Peugeot (PSA) Automobiles & parts (31) France 2 098 13 54 238 4 4 11 21
15 Istituto Finanziario Industriale Automobiles & parts (31) Italy 1 763 0 53 509 3 -4 9 1
16 Renault Automobiles & parts (31) France 1 737 -2 37 525 5 8 13 47
17 Alcatel IT hardware (93) France 1 593 -33 12 513 13 -13 26 102
18 BAE Systems Aerospace & defence (21) UK 1 560 22 11 903 13 5 23 82
19 Sanoﬁ-Synthelabo (now Sanoﬁ-Aventis) Pharma & biotech (48) France 1 316 8 8 048 16 37 40 480
20 Finmeccanica Aerospace & defence (21) Italy 1 227 24 7 497 16 6 27 63
21 Boehringer Ingelheim Pharma & biotech (48) Germany 1 176 -10 7 382 16 12 35 ..
22 BASF Chemicals (11) Germany 1 105 -3 33 361 3 7 13 72
23 Inﬁneon Technologies IT hardware (93) Germany 1 083 12 6 152 18 -5 34 104
24 Unilever Food producers (43) UK 1 065 -9 42 693 3 12 4 111
25 SAP Software & computer services (97) Germany 996 10 7 025 14 24 34 573
26 Schering Pharma & biotech (48) Germany 947 -2 4 828 20 15 36 181
27 STMicroelectronics IT hardware (93) France 921 23 5 735 16 4 20 230
28 Deutsche Telekom Telecommunication services (67) Germany 900 0 55 838 2 8 4 103
29 AKZO Nobel Chemicals (11) The Netherlands 892 -2 13 051 7 8 13 57
30 Volvo Engineering & machinery (26) Sweden 865 4 20 195 4 2 12 62
31 Michelin Automobiles & parts (31) France 711 1 15 370 5 5 6 41
32 Total Oil & gas (07) France 667 1 104 652 1 13 6 95
33 Snecma Aerospace & defence (21) France 624 0 6 431 10 6 16 66
34 Merck Pharma & biotech (48) Germany 605 2 7 202 8 7 18 32
35 Valeo Automobiles & parts (31) France 564 -2 9 234 6 3 8 29
36 Novo Nordisk Pharma & biotech (48) Denmark 563 1 3 564 16 24 31 335
37 ZF Automobiles & parts (31) Germany 524 -3 8 928 6 -0 10 ..
38 Continental Automobiles & parts (31) Germany 498 1 11 534 4 7 8 47
39 Schneider Electronic & electrical (25) France 494 5 8 780 6 7 7 133
40 L’Oreal Personal care & household (47) France 480 3 14 029 3 16 10 272
41 France Telecom Telecommunication services (67) France 478 -17 46 121 1 24 2 103
42 BT Telecommunication services (67) UK 474 -12 26 282 2 15 5 87
43 ALSTOM Electronic & electrical (25) France 473 -24 16 688 3 -5 6 3
44 Shell Oil & gas (07) UK 463 24 159 931 0 11 4 70
45 RWE Utilities - other (73. 78) Germany 436 0 42 771 1 7 3 50
46 Solvay Chemicals (11) Belgium 420 2 7 557 6 9 14 74
47 Altana Pharma & biotech (48) Germany 412 12 2 735 15 21 41 222
48 MAN Engineering & machinery (26) Germany 407 -4 15 021 3 3 6 29
49 Rolls-Royce Aerospace & defence (21) UK 399 -5 8 011 5 4 11 70
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50 Electricite de France Electricity (72) France 381 -12 44 919 1 5 2 ..
51 Thales Aerospace & defence (21) France 381 -12 10 569 4 2 7 45
52 Heidelberger Druckmaschinen Engineering & machinery (26) Germany 365 -7 3 661 10 -9 16 58
53 Degussa Chemicals (11) Germany 355 .. 11 427 3 3 8 48
54 Groupe Lagardere Diversiﬁed industrials (24) France 330 4 12 454 3 4 8 54
55 Saint-Gobain Construction & building (13) France 306 -2 29 590 1 8 2 45
56 Thomson Electronic & electrical (25) France 295 -21 8 459 4 2 5 49
57 ASML IT hardware (93) The Netherlands 287 -4 1 543 19 -14 54 354
58 AREVA Electricity (72) France 285 -14 8 255 4 3 6 4
59 TeliaSonera Telecommunication services (67) Sweden 280 118 9 082 3 17 11 179
60 Marconi IT hardware (93) UK 280 -40 2 211 13 -16 19 80
61 BP Oil & gas (07) UK 277 -6 184 383 0 7 3 87
62 DSM Chemicals (11) The Netherlands 268 -1 6 050 4 2 13 66
63 Amersham (now part of General Electric. US) Health (44) UK 258 -1 2 228 12 13 25 ..
64 Henkel Personal care & household (47) Germany 257 -1 9 436 3 6 5 85
65 Lundbeck Pharma & biotech (48) Denmark 246 25 1 335 18 21 47 276
66 Reuters Media & entertainment (54) UK 243 -15 4 537 5 3 14 146
67 Vodafone Telecommunication services (67) UK 243 4 47 627 1 -13 4 237
68 Autoliv Automobiles & parts (31) Sweden 242 33 4 203 6 8 8 75
69 ENI Oil & gas (07) Italy 238 36 51 487 1 18 3 126
70 Scania Engineering & machinery (26) Sweden 237 4 5 613 4 10 9 94
71 Invensys Electronic & electrical (25) UK 234 -26 5 522 4 -6 5 23
72 Agfa-Gevaert Health (44) Belgium 233 -6 4 215 6 8 13 58
73 ICI Chemicals (11) UK 221 5 8 301 3 2 6 46
74 UCB Pharma & biotech (48) Belgium 216 1 2 966 7 16 18 182
75 Dassault Systemes Software & computer services (97) France 216 -3 755 29 28 53 532
76 Oce IT hardware (93) The Netherlands 208 -2 2 769 8 5 9 38
77 Pirelli Diversiﬁed industrials (24) Italy 204 -7 6 671 3 3 6 41
78 Rhodia Chemicals (11) France 203 1 5 453 4 -16 9 12
79 Elan Pharma & biotech (48) Ireland 202 -20 604 33 -140 75 1 041
80 Carl-Zeiss Health (44) Germany 190 2 2 029 9 2 13 ..
81 Rheinmetall Engineering & machinery (26) Germany 189 -9 4 248 4 4 8 26
82 Sandvik Engineering & machinery (26) Sweden 185 11 5 378 3 10 5 134
83 Smiths Aerospace & defence (21) UK 184 11 4 337 4 12 6 134
84 Behr Automobiles & parts (31) Germany 184 5 3 005 6 3 11 ..
85 Electrolux Household goods & textiles (34) Sweden 184 -8 13 671 1 6 2 31
86 Thyssen Krupp Engineering & machinery (26) Germany 183 -4 36 137 1 3 1 20
87 Shire Pharmaceuticals Pharma & biotech (48) UK 182 8 1 080 17 -40 96 306
88 Linde Chemicals (11) Germany 179 4 8 992 2 5 4 63
89 Vivendi Universal Media & entertainment (54) France 170 45 25 482 1 1 3 83
90 Hella Automobiles & parts (31) Germany 168 12 3 028 6 0 8 ..
91 Diehl Stiftung Diversiﬁed industrials (24) Germany 161 -10 1 433 11 5 16 ..
92 Deutsche Post Support services (58) Germany 156 -36 40 017 0 6 0 22
93 Wacker-Chemie Chemicals (11) Germany 152 -4 2 468 6 -2 9 ..
94 Celltech (now part of UCB. Belgium) Pharma & biotech (48) UK 151 11 501 30 -20 78 ..
95 UBI Soft Entertainment Software & computer services (97) France 147 119 449 33 6 74 66
96 Amadeus Global Travel Leisure & hotels (53) Spain 145 16 1 929 8 16 28 156
97 Schwarz Pharma Pharma & biotech (48) Germany 144 16 1 496 10 18 37 82
98 Freudenberg Diversiﬁed industrials (24) Germany 140 40 3 867 4 6 5 ..
99 Telecom Italia Telecommunication services (67) Italy 139 .. 30 850 1 19 2 111
100 Ipsen Pharma & biotech (48) Luxembourg 136 4 737 19 21 36 ..
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101 JM Voith Diversiﬁed industrials (24) Germany 135 -3 3 109 4 5 6 ..
102 Repsol YPF Oil & gas (07) Spain 134 2 36 069 0 10 4 59
103 BioMerieux Health (44) France 131 11 915 14 11 24 122
104 Danone Food producers (43) France 130 -2 13 131 1 12 2 133
105 Phoenix Venture Automobiles & parts (31) UK 128 99 2 470 5 -5 20 ..
106 Atlas Copco Engineering & machinery (26) Sweden 128 -4 4 916 3 12 5 118
107 Metso Engineering & machinery (26) Finland 126 -14 4 250 3 -6 5 33
108 Misys Software & computer services (97) UK 126 -2 1 277 10 3 20 108
109 Fresenius Health (44) Germany 121 -12 7 064 2 11 2 104
110 Knorr-Bremse Engineering & machinery (26) Germany 120 1 2 206 5 8 11 ..
111 SNPE Chemicals (11) France 115 8 784 15 -7 22 ..
112 GKN Automobiles & parts (31) UK 115 -1 4 732 2 5 3 51
113 Merial Pharma & biotech (48) UK 106 2 1 368 8 13 17 ..
114 B Braun Melsungen Health (44) Germany 105 3 2 647 4 6 4 ..
115 Essilor International Health (44) France 104 20 2 116 5 15 5 238
116 BAT Tobacco (49) UK 104 18 15 001 1 18 2 171
117 Novozymes Chemicals (11) Denmark 101 5 779 13 17 26 ..
118 Beiersdorf Personal care & household (47) Germany 100 8 4 673 2 10 6 164
119 Dragerwerk Health (44) Germany 97 25 1 413 7 4 9 19
120 Smith & Nephew Health (44) UK 95 6 1 673 6 17 13 440
121 Amdocs Software & computer services (97) UK 95 -4 1 176 8 14 9 316
122 L’Air Liquide Chemicals (11) France 94 2 8 394 1 14 3 167
123 Spirent IT hardware (93) UK 94 -15 662 14 5 21 113
124 MG Technologies Engineering & machinery (26) Germany 94 3 8 157 1 -2 3 24
125 GUS General retailers (52) UK 92 -4 10 712 1 9 1 116
126 HVB Banks (81) Germany 91 -38 7 183 1 -37 1 131
127 SAAB Aerospace & defence (21) Sweden 89 -1 1 901 5 7 7 75
128 Stora Enso Forestry & paper (15) Finland 89 -23 12 172 1 4 2 76
129 Trumpf Diversiﬁed industrials (24) Germany 89 77 1 193 7 8 16 ..
130 Kone Engineering & machinery (26) Finland 88 40 5 344 2 6 3 47
131 Kerry Food producers (43) Ireland 88 13 3 693 2 7 5 82
132 Corus Steel & other metals (18) UK 88 -5 11 287 1 -3 2 25
133 Adidas-Salomon Household goods & textiles (34) Germany 86 1 6 267 1 8 6 75
134 Orion Health (44) Finland 86 -22 2 262 4 4 15 61
135 Bouygues Construction & building (13) France 85 -73 21 822 0 5 1 41
136 British Nuclear Fuels Electricity (72) UK 84 -12 3 295 3 -12 4 ..
137 Tomkins Engineering & machinery (26) UK 83 14 4 471 2 7 2 62
138 SKF Engineering & machinery (26) Sweden 83 -2 4 559 2 8 2 75
139 Sage Software & computer services (97) UK 82 0 795 10 28 14 395
140 Avecia Chemicals (11) UK 82 -2 689 12 -16 26 ..
141 LogicaCMG Software & computer services (97) UK 82 -10 2 422 3 -1 4 72
142 Reckitt Benckiser Personal care & household (47) UK 81 6 5 269 2 18 4 300
143 ASM International IT hardware (93) The Netherlands 79 -11 582 14 2 11 113
144 Celanese Chemicals (11) Germany 79 7 4 075 2 4 8 57
145 Suez Utilities - other (73. 78) France 79 -37 39 622 0 7 1 39
146 Danfoss Engineering & machinery (26) Denmark 78 20 2 073 4 5 4 ..
147 Johnson Matthey Chemicals (11) UK 77 13 6 376 1 4 10 45
148 Business Objects Software & computer services (97) France 76 27 445 17 8 19 342
149 Cadbury Schweppes Food producers (43) UK 75 66 9 141 1 11 1 145
150 Stork Engineering & machinery (26) The Netherlands 74 131 1 946 4 5 5 29
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151 Telefonica Telecommunication services (67) Spain 73 -22 28 400 0 11 1 199
152 Gemplus International Electronic & electrical (25) Luxembourg 72 -31 749 10 -19 14 129
153 Gambro Health (44) Sweden 71 20 2 879 2 6 3 99
154 Wartsila Engineering & machinery (26) Finland 70 -20 2 358 3 -2 6 46
155 Barco Electronic & electrical (25) Belgium 70 -37 629 11 9 17 134
156 EPCOS Electronic & electrical (25) Germany 69 -26 1 272 6 1 5 79
157 Svenska Cellulosa Forestry & paper (15) Sweden 69 -29 9 403 1 9 2 73
158 Infogrames Entertainment Software & computer services (97) France 69 -38 661 11 -6 38 24
159 E ON Utilities - other (73. 78) Germany 69 -82 42 541 0 9 1 93
160 ARM IT hardware (93) UK 68 -4 182 38 14 94 840
161 Danisco Food producers (43) Denmark 68 -2 2 202 3 11 8 93
162 Chr Hansen Pharma & biotech (48) Denmark 67 17 582 12 5 19 78
163 Claas Engineering & machinery (26) Germany 67 7 1 496 5 3 9 ..
164 Cognis Deutschland Chemicals (11) Germany 65 -15 2 950 2 1 8 ..
165 Cambridge Antibody Pharma & biotech (48) UK 64 44 12 532 -542 216 2 400
166 Belgacom Telecommunication services (67) Belgium 63 43 5 377 1 9 4 177
167 Grundfos Engineering & machinery (26) Denmark 62 2 1 498 4 10 5 ..
168 Wavecom IT hardware (93) France 62 -3 276 23 -11 90 16
169 Eberspaecher Automobiles & parts (31) Germany 61 -5 1 336 5 0 12 ..
170 Bull IT hardware (93) France 60 -18 1 265 5 4 8 20
171 IWKA Engineering & machinery (26) Germany 60 -1 2 287 3 3 5 21
172 Software Software & computer services (97) Germany 58 -9 422 14 -1 21 169
173 VA Technologie Engineering & machinery (26) Austria 58 -8 3 923 2 2 3 31
174 Koenig & Bauer Engineering & machinery (26) Germany 58 17 1 232 5 -4 8 17
175 Salzgitter Steel & other metals (18) Germany 58 22 4 842 1 1 3 13
176 Cobham Aerospace & defence (21) UK 57 28 1 182 5 15 6 184
177 BOC Chemicals (11) UK 57 -15 5 277 1 11 1 127
178 Lafarge Construction & building (13) France 56 2 13 658 0 12 1 85
179 NEG Micon  
(now part of Vestas Wind Systems) Engineering & machinery (26) Denmark 55 39 707 8 -7 21 ..
180 Deutz Automobiles & parts (31) Germany 55 17 1 173 5 3 10 24
181 Deutsche Borse Speciality & other ﬁnance (87) Germany 55 -38 1 650 3 27 17 258
182 Intracom IT hardware (93) Greece 54 -17 641 8 8 .. 67
183 Trelleborg Automobiles & parts (31) Sweden 53 3 1 979 3 7 3 53
184 Vattenfall Electricity (72) Sweden 53 -2 12 333 0 14 2 40
185 Voest-Alpine Steel & other metals (18) Austria 52 12 4 646 1 5 2 32
186 Zeltia Pharma & biotech (48) Spain 51 15 74 69 -32 87 1 373
187 Arla Foods Food producers (43) Denmark 51 .. 5 459 1 3 3 ..
188 Bookham Technology IT hardware (93) UK 51 -10 127 40 -98 28 190
189 Intentia International Software & computer services (97) Sweden 51 -15 323 16 -8 16 43
190 SNIA Health (44) Italy 50 11 881 6 -2 9 5
191 Eircom Telecommunication services (67) Ireland 50 -68 1 628 3 7 6 62
192 Assa Abloy Engineering & machinery (26) Sweden 49 4 2 653 2 5 2 123
193 Spectris Electronic & electrical (25) UK 48 15 806 6 8 9 90
194 UPM-Kymmene Forestry & paper (15) Finland 48 4 9 948 1 6 1 80
195 Outokumpu Steel & other metals (18) Finland 48 2 5 921 1 1 3 38
196 Bang & Olufsen Electronic & electrical (25) Denmark 48 7 534 9 8 17 99
197 Kemira Chemicals (11) Finland 48 4 2 738 2 5 5 46
198 Nexans Electronic & electrical (25) France 47 -2 4 046 1 1 3 15
199 Symbian Software & computer services (97) UK 47 4 42 112 -136 72 ..
200 Genmab Pharma & biotech (48) Denmark 47 -13 9 516 -522 234 3 611
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201 Eidos Software & computer services (97) UK 46 -16 215 22 9 86 90
202 Cookson Engineering & machinery (26) UK 46 -2 2 328 2 0 3 41
203 Vernalis Pharma & biotech (48) UK 44 33 18 247 -389 210 861
204 Heraeus Steel & other metals (18) Germany 44 .. 7 412 1 2 5 ..
205 Draka Electronic & electrical (25) The Netherlands 44 -3 1 420 3 3 6 26
206 Phoenix Automobiles & parts (31) Germany 44 -10 1 153 4 3 5 23
207 Borealis Chemicals (11) Denmark 43 5 3 673 1 2 9 ..
208 HeidelbergCement Construction & building (13) Germany 43 -2 6 372 1 7 1 54
209 Telekom Austria Telecommunication services (67) Austria 43 41 3 970 1 10 3 155
210 Novar Construction & building (13) UK 42 15 2 030 2 -2 3 44
211 Enel Electricity (72) Italy 42 -58 28 937 0 14 1 132
212 Umicore Steel & other metals (18) Belgium 42 4 784 4 677 1 2 4 28
213 Gildemeister Engineering & machinery (26) Germany 42 -13 978 4 4 8 27
214 Pilkington Construction & building (13) UK 41 -3 3 463 1 8 2 50
215 Burelle Automobiles & parts (31) France 41 9 1 951 2 4 5 ..
216 Christian Dior Household goods & textiles (34) France 41 -13 12 466 0 13 1 70
217 Gamesa Engineering & machinery (26) Spain 41 22 1 572 3 15 7 172
218 Groupe SEB Household goods & textiles (34) France 41 9 2 348 2 8 3 64
219 Alfa Laval Engineering & machinery (26) Sweden 41 4 1 533 3 8 4 93
220 Filtronic IT hardware (93) UK 40 -12 342 12 3 14 54
221 CSM Food producers (43) The Netherlands 40 14 3 517 1 7 3 42
222 GN Store Nord IT hardware (93) Denmark 40 -50 637 6 2 9 228
223 IMI Engineering & machinery (26) UK 40 0 2 232 2 8 2 81
224 William Demant Health (44) Denmark 40 8 520 8 22 9 370
225 Sidel Engineering & machinery (26) France 40 5 981 4 5 9 ..
226 Industria de Turbo Propulsores Aerospace & defence (21) Spain 39 3 405 10 7 18 ..
227 Pace Micro Technology Household goods & textiles (34) UK 38 -27 236 16 -30 50 81
228 e Biscom Telecommunication services (67) Italy 38 -32 529 7 -69 26 ..
229 Aegis Media & entertainment (54) UK 37 5 921 4 8 4 144
230 Leoni Electronic & electrical (25) Germany 37 12 1 080 3 5 2 38
231 Gedeon Richter Pharma & biotech (48) Hungary 36 16 555 7 22 .. 263
232 Bekaert Engineering & machinery (26) Belgium 36 -14 1 797 2 8 3 59
233 Metsaliitto Forestry & paper (15) Finland 36 13 8 318 0 1 1 ..
234 SkyePharma Pharma & biotech (48) UK 36 66 75 47 -75 75 659
235 Fortum Oil & gas (07) Finland 35 -8 11 392 0 12 3 82
236 GPC Biotech Pharma & biotech (48) Germany 35 -10 21 166 -129 193 1 314
237 Ingenico Electronic & electrical (25) France 34 -20 356 10 -7 19 128
238 Barilla Food producers (43) Italy 34 .. 3 436 1 3 3 ..
239 Technip-Coﬂexip (now Technip) Engineering & machinery (26) France 33 -11 4 711 1 2 2 58
240 Jungheinrich Engineering & machinery (26) Germany 33 11 1 471 2 5 4 19
241 Duerr Engineering & machinery (26) Germany 33 -6 2 265 2 1 3 11
242 Ahlstrom Chemicals (11) Finland 33 19 1 556 2 3 5 ..
243 Micronic Laser Systems IT hardware (93) Sweden 33 -5 47 70 -45 105 468
244 Neopost Electronic & electrical (25) France 33 -2 751 4 20 7 186
245 Recordati Pharma & biotech (48) Italy 33 -7 488 7 9 15 162
246 Haldex Automobiles & parts (31) Sweden 33 2 665 5 3 8 38
247 Zambon Pharma & biotech (48) Italy 32 2 459 7 10 13 ..
248 TTP Communications IT hardware (93) UK 32 5 70 46 -7 65 257
249 IBS Software & computer services (97) Sweden 32 -8 265 12 1 16 29
250 BHP Billiton Mining UK 32 0 12 374 0 21 1 142
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251 AP Moller-Maersk Transport (59) Denmark 32 59 21 100 0 16 1 113
252 Jenoptik Engineering & machinery (26) Germany 31 6 1 982 2 -1 3 18
253 Active Biotech Pharma & biotech (48) Sweden 31 1 .. .. .. 175 ..
254 lastminute com General retailers (52) UK 31 82 267 12 -26 26 235
255 Krka Pharma & biotech (48) Slovenia 31 13 408 8 15 7 251
256 Anglo American Mining UK 31 35 14 776 0 14 0 211
257 AMER Household goods & textiles (34) Finland 31 29 1 104 3 9 8 92
258 Dialog Semiconductor IT hardware (93) UK 31 -2 93 33 -31 112 136
259 Boots General retailers (52) UK 30 -17 7 557 0 10 0 97
260 De La Rue Support services (58) UK 30 -17 969 3 3 4 87
261 Societe BIC Household goods & textiles (34) France 30 -18 1 360 2 13 4 134
262 PUMA Household goods & textiles (34) Germany 30 24 1 274 2 21 11 245
263 BBC Media & entertainment (54) UK 30 23 5 259 1 -10 1 ..
264 Industrial & Financial Systems Support services (58) Sweden 30 18 257 12 -1 10 30
265 Beru Automobiles & parts (31) Germany 30 69 354 8 15 11 151
266 Sud-Chemie Chemicals (11) Germany 29 3 763 4 6 6 43
267 Sopra Software & computer services (97) France 29 11 521 6 7 5 72
268 Getinge Health (44) Sweden 28 4 1 009 3 14 5 171
269 Meggitt Aerospace & defence (21) UK 28 -13 571 5 16 8 161
270 Acambis Pharma & biotech (48) UK 28 22 240 12 22 91 214
271 Vestas Wind Systems Electronic & electrical (25) Denmark 28 38 1 653 2 5 4 107
272 Coloplast Health (44) Denmark 28 .. 761 4 16 5 223
273 Tessenderlo Chemicals (11) Belgium 27 5 1 972 1 5 3 38
274 NKT Electronic & electrical (25) Denmark 27 -15 782 4 2 6 56
275 BTG Support services (58) UK 27 23 69 39 -57 167 320
276 Nolato Chemicals (11) Sweden 27 4 294 9 2 12 42
277 M-real Media & entertainment (54) Finland 27 4 6 044 0 1 1 17
278 Compagnie Generale de Geophysique Oil & gas (07) France 27 -1 612 4 1 8 80
279 Campina Food producers (43) The Netherlands 27 11 3 655 1 1 4 ..
280 Kidde Engineering & machinery (26) UK 27 2 1 331 2 12 3 107
281 Kontron IT hardware (93) Germany 26 1 229 12 -11 17 119
282 Sudzucker Food producers (43) Germany 26 2 4 575 1 10 1 60
283 Henlys Engineering & machinery (26) UK 26 13 445 6 -8 9 ..
284 Andritz Engineering & machinery (26) Austria 26 -16 1 225 2 4 6 41
285 Innogenetics Pharma & biotech (48) Belgium 25 17 65 39 -26 43 528
286 Merant (now part of Serena Software. US) Software & computer services (97) UK 25 -25 112 23 -18 42 ..
287 Dunlop Standard Aerospace Aerospace & defence (21) UK 25 20 648 4 13 6 ..
288 JCB Service Engineering & machinery (26) UK 24 -11 1 159 2 2 6 ..
289 Tate & Lyle Food producers (43) UK 24 -6 4 079 1 9 4 55
290 Nutreco Food producers (43) The Netherlands 24 12 3 674 1 -3 2 22
291 KSB Engineering & machinery (26) Germany 24 3 1 178 2 3 2 21
292 Guerbet Pharma & biotech (48) France 24 33 225 11 10 21 72
293 Elisa Communications Telecommunication services (67) Finland 24 -33 1 538 2 -2 3 91
294 Qiagen Pharma & biotech (48) The Netherlands 23 8 279 8 20 15 409
295 Telelogic Software & computer services (97) Sweden 23 -17 103 23 1 34 291
296 KPN Telecommunication services (67) The Netherlands 23 -28 11 870 0 27 1 122
297 Auriga Industries Chemicals (11) Denmark 23 -9 600 4 6 8 26
298 Imagination Technologies IT hardware (93) UK 23 25 44 52 -14 84 377
299 Galen (now Warner Chilcott) Pharma & biotech (48) UK 23 15 343 7 29 22 470
300 OMV Oil & gas (07) Austria 23 -0 7 644 0 9 4 62
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301 Rexam Support services (58) UK 23 -20 4 417 1 7 1 79
302 Fuchs Petrolub Chemicals (11) Germany 23 -4 1 041 2 7 5 43
303 Seco Tools Engineering & machinery (26) Sweden 23 14 432 5 17 6 136
304 Radiometer Health (44) Denmark 22 -9 241 9 17 13 201
305 Morgan Crucible Engineering & machinery (26) UK 22 -22 1 206 2 -4 2 45
306 Unit 4 Agresso Software & computer services (97) The Netherlands 22 -3 219 10 9 15 120
307 IONA Technologies Software & computer services (97) Ireland 22 -31 59 37 -59 61 131
308 Euronext Speciality & other ﬁnance (87) The Netherlands 21 21 975 2 19 8 258
309 Xenova Pharma & biotech (48) UK 21 -15 11 195 -218 204 518
310 Rockwool International Construction & building (13) Denmark 21 8 1 103 2 6 3 70
311 Diageo Beverages (41) UK 21 -46 13 397 0 24 1 221
312 Karstadt Quelle General retailers (52) Germany 21 28 15 270 0 2 0 13
313 Vaisala Electronic & electrical (25) Finland 21 -5 189 11 13 19 134
314 Raisio Food producers (43) Finland 21 4 861 3 -2 8 33
315 Aviagen Food producers (43) UK 21 -13 225 9 17 14 ..
316 SGL Carbon Electronic & electrical (25) Germany 21 -18 1 046 2 1 3 46
317 TUI Leisure & hotels (53) Germany 21 -22 19 215 0 2 0 15
318 NSB Software & computer services (97) UK 21 -15 91 23 -44 22 139
319 Elekta Health (44) Sweden 21 31 306 7 12 21 181
320 Stada Arzneimittel Pharma & biotech (48) Germany 21 29 745 3 11 8 113
321 MGI Coutier Automobiles & parts (31) France 21 -6 489 4 2 7 15
322 ELMOS Semiconductor IT hardware (93) Germany 20 -9 121 17 17 23 182
323 LGP ALLGON 
(now part of Powerwave Technologies. US) IT hardware (93) Sweden 20 116 233 9 -5 16 112
324 Medigene Pharma & biotech (48) Germany 20 -37 2 1 013 -1 600 163 4 250
325 Renishaw Electronic & electrical (25) UK 20 2 157 13 14 13 358
326 Charter Engineering & machinery (26) UK 20 4 1 236 2 3 2 27
327 Clarins Personal care & household (47) France 20 20 889 2 11 4 169
328 Crucell Pharma & biotech (48) The Netherlands 20 -9 5 401 -580 110 4 360
329 Abengoa Diversiﬁed industrials (24) Spain 20 103 1 635 1 5 2 38
330 International Power Electricity (72) UK 20 .. 1 209 2 -14 8 191
331 British Energy Electricity (72) UK 20 -7 2 152 1 24 4 9
332 Anoto IT hardware (93) Sweden 19 -32 21 91 -181 105 724
333 iXOS Software Software & computer services (97) Germany 19 21 127 15 -3 22 143
334 Urenco Support services (58) UK 19 22 632 3 27 11 ..
335 Egis Pharmaceuticals Pharma & biotech (48) Hungary 19 30 307 6 8 4 85
336 Enodis Engineering & machinery (26) UK 19 -2 964 2 5 3 54
337 Antisoma Pharma & biotech (48) UK 19 10 17 109 -47 411 312
338 Union Electrica Fenosa Electricity (72) Spain 19 -81 5 509 0 10 1 97
339 IMERYS Construction & building (13) France 18 -26 2 729 1 11 1 115
340 Biotest Pharma & biotech (48) Germany 18 -2 222 8 3 17 25
341 Recticel Chemicals (11) Belgium 18 19 1 238 2 1 2 14
342 Ion Beam Applications Health (44) Belgium 18 48 234 8 -44 11 61
343 Axis-Shield Pharma & biotech (48) UK 18 30 71 26 -20 40 172
344 Rio Tinto Mining UK 18 -8 7 316 0 24 1 438
345 ISOFT Software & computer services (97) UK 18 61 212 9 14 14 558
346 Compagnie Industriali Riunite Diversiﬁed industrials (24) Italy 18 11 2 839 1 8 2 40
347 GW Pharmaceuticals Pharma & biotech (48) UK 18 18 7 257 -214 153 2 671
348 Ultra Electronics Aerospace & defence (21) UK 18 19 404 5 11 7 145
349 Oxford Instruments Electronic & electrical (25) UK 18 -4 266 7 3 11 49
350 Psion IT hardware (93) UK 18 0 183 10 -17 19 197
Rank     Company FTSE Sector Country









03/02 2003 2003 2003 2003 2003
€m % €m %
% of
Net sales €k
% of Net 
Sales
Table A2.1 (cont.)
Listing of the EU-500 group of companies on the 2004 Scoreboard ranked by their R&D investment in ﬁnancial year 2003  The 2004 EU Industrial R&D Investment Scoreboard  91 
351 London Bridge Software 
(now part of Fair Isaac. US) Software & computer services (97) UK 18 -7 83 22 1 24 ..
352 Transgene Pharma & biotech (48) France 18 2 3 592 -733 107 2 267
353 Spector Photo Media & entertainment (54) Belgium 18 -3 377 5 5 11 16
354 ARC International IT hardware (93) UK 18 -5 15 118 -267 89 340
355 Oberthur Card Systems Electronic & electrical (25) France 18 -12 430 4 7 6 99
356 Hunter Douglas Household goods & textiles (34) The Netherlands 17 -19 1 655 1 11 1 92
357 Rautaruukki Steel & other metals (18) Finland 17 0 2 953 1 4 1 33
358 Q-Med Pharma & biotech (48) Sweden 17 3 67 25 -3 40 157
359 Delft Instruments Engineering & machinery (26) The Netherlands 17 -2 237 7 8 15 ..
360 Dyson Technology Household goods & textiles (34) UK 17 48 333 5 8 10 ..
361 RM Software & computer services (97) UK 17 -15 306 5 2 11 50
362 Singulus Technologies Engineering & machinery (26) Germany 16 1 363 5 17 27 134
363 SSL International Health (44) UK 16 -12 855 2 6 3 94
364 Alizyme Pharma & biotech (48) UK 16 18 2 809 -800 1 079 16 100
365 Flamel Technologies Pharma & biotech (48) France 16 65 20 80 -20 92 1 600
366 Yule Catto Chemicals (11) UK 16 -8 766 2 11 5 76
367 Aliaxis Construction & building (13) Belgium 16 -28 1 612 1 9 1 ..
368 Sanitec Construction & building (13) Finland 16 -19 951 2 -5 2 ..
369 Uponor Engineering & machinery (26) Finland 16 0 1 021 2 2 3 98
370 Halma Engineering & machinery (26) UK 16 17 415 4 16 6 188
371 Exact Software & computer services (97) The Netherlands 16 -16 206 8 20 8 241
372 FKI Engineering & machinery (26) UK 16 44 1 909 1 3 1 52
373 Wagon Automobiles & parts (31) UK 16 -23 691 2 3 3 24
374 Systems Union Software & computer services (97) UK 16 4 111 14 6 18 118
375 ML Laboratories Pharma & biotech (48) UK 16 1 9 172 -133 100 611
376 Evotec OAI Pharma & biotech (48) Germany 16 -33 77 20 -20 24 130
377 Hexagon Engineering & machinery (26) Sweden 15 26 783 2 6 3 60
378 Bohler-Uddeholm Steel & other metals (18) Austria 15 -9 1 500 1 8 2 47
379 Oxford Biomedica Pharma & biotech (48) UK 15 -1 1 1 529 -1 900 212 8 500
380 Lenzing Chemicals (11) Austria 15 13 622 3 12 5 ..
381 NicOx Pharma & biotech (48) France 15 7 1 1 522 -2 000 254 6 800
382 Hoganas Mining Sweden 15 3 413 4 15 9 150
383 FLS Industries Engineering & machinery (26) Denmark 15 -26 2 003 1 -21 2 29
384 Dynaction Chemicals (11) France 15 -10 257 6 2 8 19
385 Provimi Food producers (43) France 15 40 1 545 1 6 2 24
386 Saipem Oil & gas (07) Italy 15 7 4 105 0 11 1 81
387 Ilog Software & computer services (97) France 15 23 73 21 3 25 201
388 Cardo Engineering & machinery (26) Sweden 15 -43 847 2 6 2 71
389 Microscience Pharma & biotech (48) UK 15 -5 .. .. .. 204 ..
390 Anite Software & computer services (97) UK 15 65 307 5 -44 7 81
391 Lectra Software & computer services (97) France 14 5 185 8 5 11 129
392 Intec Telecom Systems Software & computer services (97) UK 14 26 72 20 -4 27 253
393 Aixtron IT hardware (93) Germany 14 18 91 16 -32 35 299
394 Balfour Beatty Construction & building (13) UK 14 -17 4 486 0 4 1 42
395 mmO2 Telecommunication services (67) UK 14 11 8 081 0 3 1 136
396 National Grid Transco Utilities - other (73. 78) UK 14 -45 12 820 0 23 1 149
397 Interbrew Beverages (41) Belgium 14 -7 7 044 0 12 0 147
398 Huhtamaki Support services (58) Finland 14 17 2 108 1 5 1 51
399 PPL Therapeutics Pharma & biotech (48) UK 14 -13 .. .. .. 68 ..
400 WEB DE Software & computer services (97) Germany 14 17 33 42 -9 42 809
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401 Axis IT hardware (93) Sweden 14 5 69 20 0 39 145
402 Empire Interactive Software & computer services (97) UK 14 -11 43 32 2 87 21
403 Biacore International Health (44) Sweden 14 18 57 24 7 41 191
404 AMS Aerospace & defence (21) UK 13 -7 698 2 7 3 ..
405 BBA Transport (59) UK 13 -8 1 888 1 6 1 95
406 Intercell Pharma & biotech (48) Austria 13 35 1 1 333 -1 600 111 ..
407 BE Semiconductor Industries IT hardware (93) The Netherlands 13 6 86 15 -23 19 159
408 K+S Chemicals (11) Germany 13 -1 2 288 1 5 1 54
409 Cambridge Silicon Radio (now CSR) Electronic & electrical (25) UK 13 32 54 24 -4 71 1 078
410 Gardena Household goods & textiles (34) Germany 13 -6 398 3 1 4 ..
411 Edison Utilities - other (73. 78) Italy 13 -74 5 426 0 8 3 102
412 Augusta Technologie IT hardware (93) Germany 13 -14 236 5 -1 12 4
413 SAES Getters Electronic & electrical (25) Italy 13 -6 126 10 -4 12 69
414 Lucite International Chemicals (11) UK 13 -10 985 1 10 6 ..
415 AGBAR Utilities - other (73. 78) Spain 13 -39 2 677 1 6 1 78
416 Simcorp Software & computer services (97) Denmark 13 -16 67 19 9 24 236
417 Villeroy & Boch Household goods & textiles (34) Germany 13 -5 949 1 5 1 13
418 LION Bioscience Software & computer services (97) Germany 13 -64 20 63 -115 71 45
419 Radiall IT hardware (93) France 13 3 145 9 -2 8 89
420 Vitec Engineering & machinery (26) UK 13 11 274 5 6 8 69
421 Telemetrix (now Zetex) IT hardware (93) UK 12 17 130 10 -11 12 169
422 ADVA Software & computer services (97) Germany 12 7 90 14 4 31 189
423 Pharmexa Pharma & biotech (48) Denmark 12 -29 3 411 -533 116 1 200
424 TT Electronics Electronic & electrical (25) UK 12 6 758 2 1 2 47
425 Bacou-Dalloz Household goods & textiles (34) France 12 -4 796 2 8 2 44
426 Funkwerk Support services (58) Germany 12 41 179 7 10 13 150
427 Domino Printing Sciences Electronic & electrical (25) UK 12 3 233 5 12 7 141
428 Danieli Engineering & machinery (26) Italy 12 -25 987 1 3 4 23
429 Plasmon IT hardware (93) UK 12 -17 71 17 -7 29 238
430 Melexis IT hardware (93) Belgium 12 20 134 9 19 22 283
431 Cerep Pharma & biotech (48) France 12 8 34 35 -3 35 324
432 Dyckerhoff (now part of Buzzi Unicem. Italy) Construction & building (13) Germany 12 -27 1 320 1 7 1 73
433 Autonomy Software & computer services (97) UK 12 35 47 25 2 55 555
434 XRT Software & computer services (97) France 12 13 39 29 0 31 54
435 Brembo Automobiles & parts (31) Italy 11 25 634 2 9 3 60
436 Roxboro Electronic & electrical (25) UK 11 -15 194 6 5 7 70
437 Genus Support services (58) UK 11 -7 245 5 5 8 43
438 Beta Systems Software Software & computer services (97) Germany 11 29 56 20 9 31 113
439 LISI Aerospace & defence (21) France 11 -17 506 2 8 2 78
440 Muhlbauer Engineering & machinery (26) Germany 11 6 95 12 8 9 185
441 Rational Engineering & machinery (26) Germany 11 12 187 6 23 17 293
442 First Technology Electronic & electrical (25) UK 11 -3 181 6 9 7 177
443 BG Oil & gas (07) UK 11 -27 5 091 0 34 3 338
444 Pharmagene Pharma & biotech (48) UK 11 -8 7 160 -157 141 500
445 Holmen Forestry & paper (15) Sweden 11 10 1 743 1 15 2 112
446 Eniro Media & entertainment (54) Sweden 11 2 540 2 13 2 190
447 Swedish Match Tobacco (49) Sweden 11 1 1 436 1 17 1 190
448 Sygen International Food producers (43) UK 11 12 188 6 6 9 70
449 Tarkett Sommer (now Tarkett) Household goods & textiles (34) Germany 11 -4 1 349 1 7 2 34
450 Photo-Me Media & entertainment (54) UK 11 55 312 4 10 6 189
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451 Northgate Information Solutions Software & computer services (97) UK 11 11 194 6 -6 6 203
452 Head Household goods & textiles (34) The Netherlands 11 24 342 3 0 .. 28
453 ESI Software & computer services (97) France 11 11 43 25 -2 29 140
454 Skanditek Electronic & electrical (25) Sweden 11 17 57 19 -4 31 240
455 Energie Baden Electricity (72) Germany 11 .. 10 609 0 -5 0 24
456 Channel Four Television Media & entertainment (54) UK 11 6 1 092 1 6 13 ..
457 Staffware (now part of Tibco Software. US) Software & computer services (97) UK 11 6 61 17 7 30 ..
458 Biotie Therapies Pharma & biotech (48) Finland 11 -51 2 528 -700 160 ..
459 SUSS MicroTec IT hardware (93) Germany 11 -16 96 11 -18 14 90
460 Thrane & Thrane Electronic & electrical (25) Denmark 10 63 86 12 14 26 176
461 Miba Automobiles & parts (31) Austria 10 -4 294 4 8 4 12
462 Mayﬂower Automobiles & parts (31) UK 10 181 884 1 3 2 ..
463 DICOM Software & computer services (97) UK 10 -2 222 5 5 13 103
464 Phytopharm Pharma & biotech (48) UK 10 20 3 342 -267 302 3 033
465 Medisys Health (44) UK 10 -52 56 18 -13 32 86
466 Biotage Pharma & biotech (48) Sweden 10 -30 19 53 -153 61 284
467 Vectura Pharma & biotech (48) UK 10 163 5 200 -200 102 1 760
468 Hellenic Telecommunications Telecommunication services (67) Greece 10 93 4 270 0 16 1 111
469 Ubizen Software & computer services (97) Belgium 10 5 72 14 -53 29 114
470 BWT Engineering & machinery (26) Austria 10 -21 416 2 3 4 79
471 Elektrobit Support services (58) Finland 10 1 149 7 11 9 194
472 Boliden Mining Sweden 10 -6 1 052 1 4 3 36
473 Kyro Engineering & machinery (26) Finland 10 49 227 4 9 10 125
474 Coop Norden Food & drug retailers (63) Sweden 10 -14 8 736 0 0 0 ..
475 AVEVA Software & computer services (97) UK 10 16 54 18 17 30 306
476 Sydsvenska Kemi Chemicals (11) Sweden 10 24 633 2 6 4 ..
477 Royalblue Software & computer services (97) UK 10 13 80 12 14 20 258
478 Croda International Chemicals (11) UK 10 11 431 2 14 6 130
479 AEA Technology Support services (58) UK 10 -52 357 3 2 3 55
480 Memscap IT hardware (93) France 10 70 6 158 -483 37 467
481 Epigenomics Pharma & biotech (48) Germany 10 1 11 86 -64 66 ..
482 Schouw Diversiﬁed industrials (24) Denmark 10 13 414 2 1 4 52
483 Games Workshop Household goods & textiles (34) UK 9 6 215 4 13 3 141
484 Tecnomen Software & computer services (97) Finland 9 -16 45 21 -16 21 158
485 Innovation Software & computer services (97) UK 9 -19 83 11 -42 9 181
486 Baxi General retailers (52) UK 9 -5 933 1 8 2 ..
487 Gyrus Health (44) UK 9 -18 111 8 4 14 217
488 NXT Electronic & electrical (25) UK 9 3 11 82 -136 52 636
489 Bespak Health (44) UK 9 15 125 7 2 11 147
490 Karo Bio Pharma & biotech (48) Sweden 9 3 654 9 100 -267 77 267
491 Morphosys Pharma & biotech (48) Germany 9 -54 15 60 -20 95 787
492 Vacon Electronic & electrical (25) Finland 9 14 112 8 11 21 146
493 Baltimore Technologies Speciality & other ﬁnance (87) UK 9 -43 26 35 -96 40 65
494 PSI Software & computer services (97) Germany 9 -22 138 7 0 7 24
495 Pfeiffer Vacuum Technology Engineering & machinery (26) Germany 9 -14 144 6 13 12 188
496 F-Secure Software & computer services (97) Finland 9 -10 39 22 8 30 577
497 Alvis Aerospace & defence (21) UK 9 11 495 2 5 3 101
498 Hackman Household goods & textiles (34) Finland 9 5 346 3 6 3 ..
499 Glunz & Jensen IT hardware (93) Denmark 9 30 92 9 -9 22 11
500 Bavarian Nordic Pharma & biotech (48) Denmark 9 5 68 13 43 104 499
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 Top 500 companies 195 637 3.9 4 342 382 4.5 9.1 12.1 138
number of companies for calculation 500 496 500 500 500 477 492
1 Ford Motor Automobiles & parts (31) US 5 946 -3 130 865 5 6 18 16
2 Pﬁzer Pharma & biotech (48) US 5 654 38 35 825 16 7 46 544
3 Toyota Motor Automobiles & parts (31) Japan 4 945 13 114 672 4 8 19 99
4 General Motors Automobiles & parts (31) US 4 519 -2 147 084 3 7 14 13
5 Matsushita Electric Electronic & electrical (25) Japan 4 285 5 55 331 8 3 15 47
6 IBM Software & computer services (97) US 4 011 7 70 663 6 11 13 165
7 Johnson & Johnson Pharma & biotech (48) US 3 714 18 33 188 11 25 34 392
8 Microsoft Software & computer services (97) US 3 694 8 25 518 15 40 67 957
9 Intel IT hardware (93) US 3 457 8 23 896 15 24 43 536
10 Sony Electronic & electrical (25) Japan 3 278 2 55 286 6 2 20 46
11 Honda Motor Automobiles & parts (31) Japan 3 232 11 58 969 6 8 26 64
12 Roche Pharma & biotech (48) Switzerland 3 055 12 20 012 15 18 47 351
13 Motorola IT hardware (93) US 2 990 1 21 452 14 4 34 141
14 Novartis Pharma & biotech (48) Switzerland 2 978 7 19 712 15 23 38 502
15 NTT Telecommunication services (67) Japan 2 929 1 80 803 4 13 14 129
16 Hewlett-Packard IT hardware (93) US 2 895 10 57 923 5 4 20 85
17 Hitachi IT hardware (93) Japan 2 751 -1 63 858 4 2 8 26
18 Merck Pharma & biotech (48) US 2 520 19 17 827 14 42 40 449
19 Toshiba IT hardware (93) Japan 2 491 2 41 274 6 3 16 23
20 Cisco Systems IT hardware (93) US 2 485 -9 14 967 17 23 73 761
21 Samsung Electronic Electronic & electrical (25) South Korea 2 382 18 43 127 6 10 .. 104
22 Nissan Motor Automobiles & parts (31) Japan 2 222 15 50 514 4 10 17 75
23 Fujitsu IT hardware (93) Japan 2 114 -18 34 158 6 -3 14 29
24 General Electric Diversiﬁed industrials (24) US 2 106 20 105 356 2 21 7 256
25 Canon Electronic & electrical (25) Japan 1 917 11 23 658 8 15 19 145
26 NEC IT hardware (93) Japan 1 899 -13 36 298 5 3 13 26
27 Eli Lilly Pharma & biotech (48) US 1 863 9 9 975 19 26 40 570
28 Bristol-Myers Squibb Pharma & biotech (48) US 1 807 3 16 565 11 23 41 213
29 Nortel Networks IT hardware (93) Canada 1 768 -31 8 372 21 -37 34 146
30 Wyeth Pharma & biotech (48) US 1 660 1 12 566 13 11 32 298
31 Delphi Automobiles & parts (31) US 1 586 18 22 275 7 2 8 19
32 Sun Microsystems IT hardware (93) US 1 456 0 9 065 16 -24 40 116
33 Texas Instruments IT hardware (93) US 1 386 8 7 796 18 9 41 373
34 Abbott Laboratories Health (44) US 1 374 11 15 603 9 20 20 312
35 Denso Automobiles & parts (31) Japan 1 353 -2 17 256 8 10 15 99
36 Procter & Gamble Personal care & household (47) US 1 320 4 34 389 4 18 14 316
37 Amgen Pharma & biotech (48) US 1 312 48 6 625 20 37 102 863
38 Boeing Aerospace & defence (21) US 1 309 1 40 025 3 2 8 84
39 Mitsubishi Electric IT hardware (93) Japan 1 196 -21 26 920 4 0 11 29
40 Lucent Technologies IT hardware (93) US 1 180 -36 6 715 18 -9 34 154
41 Fuji Photo Film Media & entertainment (54) Japan 1 177 8 18 536 6 5 16 66
42 Schering-Plough Pharma & biotech (48) US 1 165 3 6 607 18 -1 38 341
43 Sharp Electronic & electrical (25) Japan 1 126 21 14 819 8 3 24 86
44 EI du Pont de Nemours Chemicals (11) US 1 070 7 21 403 5 2 13 159
45 Oracle Software & computer services (97) US 936 10 7 512 13 35 23 582
46 Takeda Chemical Pharma & biotech (48) Japan 919 24 7 738 12 37 63 429
47 Sanyo Electric Electronic & electrical (25) Japan 894 13 16 821 5 -3 11 33
48 Agilent Technologies Electronic & electrical (25) US 833 -10 4 801 17 -16 29 189
49 United Technologies Diversiﬁed industrials (24) US 814 -14 24 604 3 12 4 154
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50 Mitsubishi Heavy Engineering & machinery (26) Japan 810 -8 19 188 4 4 13 36
51 Dow Chemical Chemicals (11) US 778 -8 25 871 3 7 17 114
52 Nestle Food producers (43) Switzerland 772 -0 56 396 1 11 3 145
53 Applied Materials IT hardware (93) US 730 -13 3 550 21 -7 61 646
54 Lockheed Martin Aerospace & defence (21) US 716 9 25 230 3 6 6 75
55 Visteon Automobiles & parts (31) US 716 0 14 001 5 -6 10 8
56 Xerox IT hardware (93) US 688 -5 12 448 6 3 11 71
57 Ricoh Electronic & electrical (25) Japan 684 11 13 169 5 6 9 87
58 Advanced Micro Devices IT hardware (93) US 676 4 2 434 28 -7 47 143
59 Mitsubishi Chemical Chemicals (11) Japan 674 8 13 963 5 4 18 30
60 EMC IT hardware (93) US 660 -8 4 945 13 6 33 425
61 Mazda Motor Automobiles & parts (31) Japan 650 -8 17 491 4 2 18 19
62 Sankyo Pharma & biotech (48) Japan 641 6 4 216 15 13 56 70
63 Hyundai Motor Automobiles & parts (31) South Korea 638 55 30 998 2 6 .. 24
64 Eastman Kodak Media & entertainment (54) US 619 3 10 558 6 1 10 57
65 Allergan Pharma & biotech (48) US 604 227 1 392 43 -1 123 578
66 Altria Tobacco (49) US 604 11 64 877 1 19 4 120
67 Honeywell Aerospace & defence (21) US 595 -1 18 316 3 8 6 140
68 Medtronic Health (44) US 594 16 6 077 10 31 22 784
69 3M Diversiﬁed industrials (24) US 594 2 14 454 4 20 9 354
70 Aisin Seiki Automobiles & parts (31) Japan 592 18 10 416 6 8 13 49
71 Syngenta Chemicals (11) Switzerland 576 4 5 215 11 8 27 141
72 Computer Associates Software & computer services (97) US 560 0 2 597 22 0 37 443
73 Sumitomo Chemical Chemicals (11) Japan 539 9 8 220 7 6 30 67
74 LG Electronics Electronic & electrical (25) South Korea 532 -13 13 425 4 5 19 37
75 Tyco International Diversiﬁed industrials (24) Bermuda 532 6 23 330 2 10 2 211
76 Caterpillar Engineering & machinery (26) US 530 2 18 047 3 8 8 110
77 Bridgestone Automobiles & parts (31) Japan 525 4 17 043 3 8 5 72
78 Micron Technology IT hardware (93) US 520 17 2 451 21 -37 31 264
79 Broadcom IT hardware (93) US 518 -9 1 276 41 -59 190 556
80 Yamanouchi Pharmaceutical Pharma & biotech (48) Japan 495 3 3 748 13 19 53 264
81 Exxon Mobil Oil & gas (07) US 490 -2 169 025 0 15 5 142
82 Asea Brown Boveri Electronic & electrical (25) Switzerland 486 12 14 901 3 -1 4 59
83 BMC Software Software & computer services (97) US 465 20 1 125 41 -2 72 242
84 Fujisawa Pharmaceutical Pharma & biotech (48) Japan 462 9 2 826 16 11 .. 225
85 Deere Engineering & machinery (26) US 458 9 10 583 4 6 11 117
86 Suzuki Motor Automobiles & parts (31) Japan 447 34 14 908 3 3 .. 50
87 Fuji Heavy Industries Automobiles & parts (31) Japan 445 10 10 152 4 4 16 33
88 Eisai Pharma & biotech (48) Japan 442 9 3 452 13 15 59 196
89 Schlumberger Oil & gas (07) US 441 -14 11 014 4 5 6 273
90 Baxter International Health (44) US 438 10 7 069 6 14 8 207
91 Qualcomm IT hardware (93) US 415 16 3 148 13 30 56 1 481
92 Yamaha Motor Automobiles & parts (31) Japan 414 15 7 495 6 6 13 44
93 Guidant Health (44) US 411 19 2 932 14 10 34 469
94 Emerson Electric Electronic & electrical (25) US 408 -3 11 066 4 12 4 184
95 Electronic Arts Software & computer services (97) US 405 27 2 344 17 26 84 502
96 ADP Support services (58) US 396 5 5 666 7 21 10 345
97 Daiichi Pharmaceutical Pharma & biotech (48) Japan 395 10 2 382 17 11 .. 172
98 Matsushita Electric Works Construction & building (13) Japan 391 -4 9 122 4 4 8 53
99 Millennium Pharmaceuticals Pharma & biotech (48) US 387 45 344 113 -112 253 799
100 Serono Pharma & biotech (48) Switzerland 387 36 1 473 26 22 84 385
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101 Raytheon Aerospace & defence (21) US 386 -17 14 357 3 6 5 78
102 Johnson Controls Automobiles & parts (31) US 384 10 17 954 2 5 3 47
103 Pioneer Electronic & electrical (25) Japan 381 13 5 185 7 7 11 60
104 Apple Computer IT hardware (93) US 373 6 4 921 8 0 34 193
105 Tokyo Electron IT hardware (93) Japan 371 -7 3 407 11 -4 37 202
106 Agere Systems IT hardware (93) US 370 -33 1 458 25 -15 54 110
107 Asahi Kasei Chemicals (11) Japan 365 -1 8 830 4 -7 14 58
108 Sumitomo Electric Electronic & electrical (25) Japan 360 0 11 014 3 -1 5 50
109 Boston Scientiﬁc Health (44) US 358 32 2 756 13 20 24 917
110 Mitsubishi Pharma Pharma & biotech (48) Japan 357 41 2 077 17 3 41 201
111 Analog Devices IT hardware (93) US 357 6 1 623 22 18 43 729
112 Telstra Telecommunication services (67) Australia 356 7 12 242 3 27 10 139
113 Kyocera IT hardware (93) Japan 350 17 7 914 4 6 .. 146
114 National Semiconductor IT hardware (93) US 345 -1 1 326 26 -2 35 368
115 Peoplesoft Software & computer services (97) US 343 27 1 797 19 5 28 284
116 LSI Logic IT hardware (93) US 343 -5 1 342 26 -16 73 115
117 Japan Tobacco (49) Tobacco (49) Japan 329 -16 33 231 1 4 9 14
118 Northrop Grumman Aerospace & defence (21) US 317 -2 20 776 2 6 3 72
119 Komatsu Engineering & machinery (26) Japan 315 9 8 850 4 3 10 52
120 Chiron Pharma & biotech (48) US 310 20 1 400 22 17 58 490
121 Tokyo Electric Power Electricity (72) Japan 298 -16 36 389 1 10 6 67
122 Omron Electronic & electrical (25) Japan 298 -3 3 958 8 1 13 108
123 Taiwan Semiconductor IT hardware (93) Taiwan 297 8 4 840 6 26 19 483
124 Avaya IT hardware (93) US 288 -21 3 439 8 2 17 150
125 Kao Personal care & household (47) Japan 285 2 6 677 4 13 15 168
126 Maxtor IT hardware (93) US 281 -12 3 240 9 3 21 28
127 Alps Electric Electronic & electrical (25) Japan 280 28 4 584 6 7 9 41
128 Goodyear Automobiles & parts (31) US 278 -8 11 986 2 -2 3 13
129 Mitsui Chemicals Chemicals (11) Japan 275 -5 7 791 4 4 22 36
130 Corning IT hardware (93) US 273 -29 2 450 11 -14 13 549
131 Cadence Design Systems Software & computer services (97) US 270 4 888 30 -3 56 319
132 Asahi Glass Construction & building (13) Japan 270 18 12 260 2 7 5 69
133 Genzyme Pharma & biotech (48) US 266 14 1 359 20 -2 47 674
134 Toray Industries Chemicals (11) Japan 264 -4 7 641 4 4 8 69
135 Dell IT hardware (93) US 262 3 32 857 1 9 6 216
136 Whirlpool Household goods & textiles (34) US 258 15 9 653 3 6 4 35
137 Olympus Optical Electronic & electrical (25) Japan 257 14 4 175 6 9 11 94
138 Applera Pharma & biotech (48) US 256 -15 1 409 18 3 47 270
139 JFE Steel & other metals (18) Japan 245 .. 17 953 1 3 5 62
140 Siebel Systems Software & computer services (97) US 245 -16 1 074 23 -3 49 291
141 Veritas Software Software & computer services (97) US 241 11 1 385 17 22 37 470
142 NCR IT hardware (93) US 240 2 4 438 5 1 8 79
143 TDK Electronic & electrical (25) Japan 236 -18 4 504 5 3 7 158
144 Rohm IT hardware (93) Japan 235 48 2 591 9 27 14 385
145 Murata Manufacturing IT hardware (93) Japan 233 -1 2 922 8 14 9 315
146 Shionogi Pharma & biotech (48) Japan 231 2 2 118 11 4 38 227
147 PetroChina Oil & gas (07) China 231 34 29 039 1 33 1 239
148 PPG Industries Chemicals (11) US 230 6 6 942 3 11 7 116
149 Kyowa Hakko Kogyo Pharma & biotech (48) Japan 229 6 2 658 9 4 34 89
150 Synopsys Software & computer services (97) US 229 27 933 25 18 52 279
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151 Tellabs IT hardware (93) US 227 -15 777 29 -28 65 378
152 Ono Pharmaceutical Pharma & biotech (48) Japan 225 7 999 23 35 .. 457
153 Konica (now Konica Minolta) Media & entertainment (54) Japan 224 4 4 135 5 6 13 131
154 General Dynamics Aerospace & defence (21) US 224 12 13 174 2 8 3 118
155 Kimberly-Clark Personal care & household (47) US 223 -3 11 375 2 16 4 227
156 Unisys Software & computer services (97) US 222 3 4 686 5 8 6 59
157 Teijin Chemicals (11) Japan 221 -6 6 587 3 -1 10 39
158 Toyota Industries Automobiles & parts (31) Japan 220 -1 7 909 3 3 9 75
159 AT&T Telecommunication services (67) US 220 9 27 375 1 15 4 35
160 Adobe Systems Software & computer services (97) US 220 13 1 026 21 29 63 781
161 Taisho Pharmaceutical Pharma & biotech (48) Japan 218 -8 2 027 11 20 45 271
162 Maxim Integrated Products IT hardware (93) US 216 -1 914 24 39 35 1 369
163 Nvidia IT hardware (93) US 214 20 1 445 15 5 117 140
164 Kla-Tencor IT hardware (93) US 213 -7 1 049 20 11 43 612
165 Lexmark IT hardware (93) US 211 7 3 770 6 13 18 242
166 Sega Software & computer services (97) Japan 205 19 1 459 14 2 59 128
167 Amazon com General retailers (52) US 204 2 4 173 5 3 26 301
168 Nikon IT hardware (93) Japan 204 1 3 469 6 -3 15 80
169 Intuit Software & computer services (97) US 203 14 1 309 16 22 30 442
170 Textron Diversiﬁed industrials (24) US 202 23 7 816 3 5 5 86
171 Teradyne IT hardware (93) US 202 -13 1 073 19 -13 33 245
172 Kansai Electric Power Electricity (72) Japan 202 -11 19 345 1 9 6 73
173 Symantec Software & computer services (97) US 200 28 1 483 14 28 38 774
174 Dana Automobiles & parts (31) US 200 -12 6 314 3 6 3 36
175 Cypress Semiconductor IT hardware (93) US 199 -13 663 30 -1 49 167
176 Accenture Support services (58) Bermuda 199 7 10 621 2 12 3 103
177 Fuji Electric Electronic & electrical (25) Japan 198 -5 6 158 3 2 8 23
178 Clariant Chemicals (11) Switzerland 197 -13 5 459 4 4 7 45
179 Korea Electric Power Electricity (72) South Korea 197 -14 14 528 1 23 6 58
180 Atmel IT hardware (93) US 196 -2 1 055 19 -6 25 153
181 Xilinx IT hardware (93) US 196 12 1 108 18 23 71 731
182 Ajinomoto Food producers (43) Japan 196 -2 7 307 3 7 8 82
183 Forest Laboratories Pharma & biotech (48) US 195 20 2 101 9 35 39 671
184 Shin-Etsu Chemical Chemicals (11) Japan 195 -4 6 161 3 15 11 185
185 Kirin Brewery Beverages (41) Japan 192 13 8 624 2 8 8 89
186 Navistar International Engineering & machinery (26) US 192 11 5 819 3 3 14 34
187 St Jude Medical Health (44) US 191 20 1 532 13 24 26 621
188 KT Telecommunication services (67) South Korea 190 4 7 701 3 8 5 90
189 Comverse Technology IT hardware (93) US 190 -3 607 31 -3 41 436
190 Rohm & Haas Chemicals (11) US 189 -9 5 091 4 8 11 137
191 ChevronTexaco Oil & gas (07) US 189 8 80 966 0 14 4 100
192 Halliburton Oil & gas (07) US 189 -3 12 900 2 -3 2 86
193 Yokogawa Electric Electronic & electrical (25) Japan 187 31 2 432 8 -5 10 95
194 Becton Dickinson Health (44) US 186 -22 3 590 5 17 8 264
195 Biogen Idec Pharma & biotech (48) US 185 157 538 34 -133 50 2 854
196 Furukawa Electric Electronic & electrical (25) Japan 184 8 5 257 4 -20 .. 41
197 McKesson Food & drug retailers (63) US 183 -31 55 105 0 1 7 14
198 Tanabe Seiyaku Pharma & biotech (48) Japan 182 5 1 284 14 16 .. 137
199 Novellus Systems IT hardware (93) US 180 2 733 25 -10 62 432
200 Ciba Specialty Chemicals Chemicals (11) Switzerland 180 -4 4 260 4 8 10 91
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201 Minolta (now part of Konica Minolta) Electronic & electrical (25) Japan 180 -16 3 907 5 4 9 ..
202 Dai Nippon Printing Media & entertainment (54) Japan 178 3 9 683 2 3 5 88
203 Goodrich Aerospace & defence (21) US 177 28 3 475 5 7 9 87
204 Daikin Industries Electronic & electrical (25) Japan 177 2 4 237 4 7 11 117
205 Eaton Electronic & electrical (25) US 177 10 6 391 3 9 4 121
206 Advantest IT hardware (93) Japan 175 -12 723 24 -19 50 644
207 Sepracor Pharma & biotech (48) US 175 -10 273 64 -30 178 1 125
208 Sekisui Chemical Construction & building (13) Japan 173 4 5 916 3 2 8 53
209 Kubota Engineering & machinery (26) Japan 172 -12 6 881 3 3 8 71
210 Marvell Technology IT hardware (93) Bermuda 172 44 650 26 7 103 754
211 Rockwell Collins Aerospace & defence (21) US 171 -15 2 015 9 15 12 239
212 POSCO Steel & other metals (18) South Korea 170 27 11 836 1 17 .. 80
213 Teva Pharmaceutical Industries Pharma & biotech (48) Israel 169 29 2 598 7 27 15 557
214 ATI Technologies IT hardware (93) Canada 169 29 1 098 15 4 77 278
215 Yamaha Household goods & textiles (34) Japan 167 0 3 991 4 10 9 61
216 Autodesk Software & computer services (97) US 166 21 754 22 11 48 471
217 Calsonic Kansei Automobiles & parts (31) Japan 166 8 4 032 4 3 11 31
218 SunGard Data Systems Software & computer services (97) US 165 19 2 276 7 22 17 239
219 Yahoo! Software & computer services (97) US 164 34 1 288 13 21 30 2 522
220 Danaher Engineering & machinery (26) US 164 19 4 197 4 16 6 295
221 IHI Engineering & machinery (26) Japan 163 -12 7 538 2 -1 7 20
222 Colgate-Palmolive Personal care & household (47) US 162 4 7 851 2 22 4 287
223 Storage Technology IT hardware (93) US 162 -5 1 730 9 9 23 129
224 Ingersoll-Rand Engineering & machinery (26) US 162 2 7 830 2 9 4 121
225 Gillette Personal care & household (47) US 160 9 7 335 2 22 5 422
226 Petroleo Brasiliero Oil & gas (07) Brazil 159 37 24 416 1 31 3 97
227 Cummins Engineering & machinery (26) US 159 3 4 992 3 3 7 47
228 Ciena IT hardware (93) US 158 -22 224 71 -131 87 567
229 Brother Industries Electronic & electrical (25) Japan 156 16 3 023 5 8 10 61
230 Beckman Coulter Health (44) US 154 6 1 738 9 15 16 155
231 AlCoA Steel & other metals (18) US 154 -9 17 048 1 9 1 130
232 Japan Radio Electronic & electrical (25) Japan 150 -11 1 919 8 2 .. 23
233 Toppan Printing Media & entertainment (54) Japan 150 6 9 259 2 5 5 61
234 SK Telecom Telecommunication services (67) South Korea 149 15 6 334 2 32 36 142
235 Eastman Chemical Chemicals (11) US 149 6 4 598 3 -4 10 60
236 Mentor Graphics Software & computer services (97) US 147 13 536 27 2 41 119
237 Networks Associates Software & computer services (97) US 146 24 742 20 7 40 317
238 Novell Software & computer services (97) US 146 9 876 17 -7 25 255
239 DST Systems Software & computer services (97) US 146 25 1 916 8 14 13 161
240 Human Genome Sciences Pharma & biotech (48) US 145 -9 6 2 422 -3 000 132 16 767
241 China Petroleum & Chemical Oil & gas (07) China 145 17 31 339 1 9 0 184
242 Stryker Health (44) US 143 27 2 874 5 19 10 526
243 Cerner Software & computer services (97) US 143 20 666 21 9 28 195
244 Altera IT hardware (93) US 142 -2 656 22 24 71 942
245 Juniper Networks IT hardware (93) US 140 9 556 25 9 90 1 735
246 Givaudan Personal care & household (47) Switzerland 139 5 1 740 8 13 23 216
247 Compuware Software & computer services (97) US 139 13 1 003 14 4 16 154
248 Baker Hughes Oil & gas (07) US 137 5 4 196 3 7 5 253
249 Winbond Electronic IT hardware (93) Taiwan 137 -25 778 18 -14 36 175
250 EMBRAER Aerospace & defence (21) Brazil 137 9 1 699 8 12 11 219
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251 United Microelectronics IT hardware (93) Taiwan 137 -21 2 235 6 8 15 399
252 Chubu Electric Power Electricity (72) Japan 136 -8 16 097 1 13 8 77
253 Lear Automobiles & parts (31) US 136 -3 12 484 1 5 1 24
254 Silicon Graphics IT hardware (93) US 136 -6 762 18 -14 37 42
255 Cephalon Pharma & biotech (48) US 135 33 567 24 22 82 395
256 Mattel Household goods & textiles (34) US 133 5 3 932 3 16 5 149
257 ArvinMeritor Automobiles & parts (31) US 132 27 6 174 2 4 4 18
258 Harley-Davidson Automobiles & parts (31) US 132 9 3 888 3 24 14 360
259 Kobe Steel Steel & other metals (18) Japan 132 -19 8 912 2 4 5 37
260 Meiji Seika Kaisha Food producers (43) Japan 131 -6 2 615 5 2 .. 50
261 Koito Manufacturing Automobiles & parts (31) Japan 131 -8 2 302 6 5 10 45
262 Gilead Sciences Pharma & biotech (48) US 131 22 688 19 -18 92 1 566
263 Shiseido Personal care & household (47) Japan 130 2 4 618 3 8 5 91
264 Lam Research IT hardware (93) US 127 -10 599 21 -1 61 420
265 UTStarcom IT hardware (93) US 126 85 1 557 8 14 23 106
266 Conexant Systems IT hardware (93) US 126 -51 476 27 -125 87 123
267 eBay General retailers (52) US 126 33 1 716 7 29 22 1 917
268 International Flavors & Fragrances Personal care & household (47) US 126 11 1 508 8 15 23 185
269 Dover Diversiﬁed industrials (24) US 126 -6 3 499 4 10 5 183
270 Showa Denko Chemicals (11) Japan 126 10 5 100 3 5 12 39
271 Scientiﬁc-Atlanta Media & entertainment (54) US 124 2 1 150 11 9 18 325
272 MedImmune Pharma & biotech (48) US 124 8 836 15 23 75 536
273 GlobespanVirata  
(now part of Conexant Systems) IT hardware (93) US 124 13 181 68 -290 177 ..
274 Dow Corning Chemicals (11) US 123 -11 2 069 6 6 15 ..
275 JDS Uniphase IT hardware (93) US 122 -40 536 23 -3 22 767
276 Skyworks Solutions IT hardware (93) US 120 14 490 25 -69 32 203
277 Statoil Oil & gas (07) Norway 120 36 29 616 0 17 6 73
278 OKI Electric Electronic & electrical (25) Japan 119 6 4 840 3 2 6 36
279 Bausch & Lomb Health (44) US 119 17 1 601 7 13 10 161
280 General Mills Food producers (43) US 118 14 8 329 1 17 4 163
281 Pitney Bowes Electronic & electrical (25) US 117 4 3 629 3 19 5 214
282 Thermo Electron Engineering & machinery (26) US 116 -6 1 663 7 9 11 203
283 Bombardier Aerospace & defence (21) Canada 115 -34 13 080 1 3 2 27
284 Brocade Communications IT hardware (93) US 115 10 416 28 -27 94 241
285 Sybase Software & computer services (97) US 115 -4 617 19 14 31 178
286 Kawasaki Heavy Industries Engineering & machinery (26) Japan 115 -6 9 170 1 2 4 19
287 Hasbro Household goods & textiles (34) US 114 -7 2 488 5 10 17 102
288 Harman International Industries Electronic & electrical (25) US 114 30 1 767 6 8 11 254
289 East Japan Railway Transport (59) Japan 113 13 18 979 1 14 1 94
290 Dainippon Pharmaceutical Pharma & biotech (48) Japan 113 16 1 274 9 6 45 84
291 BEA Systems Software & computer services (97) US 112 6 803 14 18 36 258
292 JSR Chemicals (11) Japan 112 8 2 035 6 11 26 169
293 Alcan Steel & other metals (18) Canada 111 22 10 814 1 5 2 107
294 Vertex Pharmaceuticals Pharma & biotech (48) US 111 24 55 201 -382 154 1 013
295 Time Warner Media & entertainment (54) US 110 2 31 367 0 15 1 185
296 Bandai Household goods & textiles (34) Japan 110 4 1 812 6 10 42 105
297 Nintendo Software & computer services (97) Japan 108 -14 3 726 3 20 .. 331
298 ConocoPhillips Petroleum Oil & gas (07) US 108 25 71 684 0 10 3 60
299 Western Digital IT hardware (93) US 107 12 2 155 5 7 9 53
300 Swatch Household goods & textiles (34) Switzerland 105 16 2 553 4 15 5 243
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301 Parametric Technology Software & computer services (97) US 105 -3 533 20 -13 30 175
302 Ebara Engineering & machinery (26) Japan 104 -18 3 832 3 -7 7 26
303 Casio Computer IT hardware (93) Japan 104 0 3 259 3 3 9 88
304 Kaneka Chemicals (11) Japan 103 1 2 754 4 7 15 94
305 Rockwell Automation Electronic & electrical (25) US 103 -1 3 254 3 9 5 168
306 Nitto Denko Chemicals (11) Japan 103 6 2 801 4 9 10 213
307 RF Micro Devices Electronic & electrical (25) US 102 26 516 20 6 54 170
308 Osaka Gas Utilities - other (73. 78) Japan 102 -9 7 013 1 6 7 73
309 Applied Micro Circuits IT hardware (93) US 102 -37 104 98 -114 140 856
310 American Standard Companies Engineering & machinery (26) US 102 -27 6 792 2 8 2 95
311 Norsk Hydro Diversiﬁed industrials (24) Norway 101 4 20 470 1 14 2 65
312 Exelixis Pharma & biotech (48) US 101 14 41 247 -185 177 1 063
313 NGK Spark Plug Automobiles & parts (31) Japan 101 2 1 693 6 1 11 107
314 Kellogg Food producers (43) US 101 19 6 986 1 17 4 194
315 Sumitomo Metal Steel & other metals (18) Japan 100 -27 9 059 1 4 4 45
316 Newell Rubbermaid Household goods & textiles (34) US 99 42 6 144 2 1 3 77
317 Unaxis Diversiﬁed industrials (24) Switzerland 99 -2 1 032 10 0 15 112
318 Anritsu IT hardware (93) Japan 98 -13 581 17 1 26 105
319 Federal-Mogul Automobiles & parts (31) US 98 11 4 397 2 0 2 0
320 SMC Engineering & machinery (26) Japan 97 2 1 530 6 13 9 369
321 Kissei Pharmaceutical Pharma & biotech (48) Japan 97 0 440 22 8 58 207
322 ITT Industries Engineering & machinery (26) US 96 6 4 461 2 9 3 131
323 NGK Insulators Diversiﬁed industrials (24) Japan 96 -16 2 232 4 6 9 100
324 Air Products and Chemicals Chemicals (11) US 96 0 4 993 2 11 5 187
325 Dainippon Ink & Chemicals Chemicals (11) Japan 96 1 7 116 1 3 4 20
326 Intermune Pharma & biotech (48) US 95 -8 122 78 -59 366 243
327 Fanuc Electronic & electrical (25) Japan 95 13 1 585 6 30 .. 677
328 PMC-Sierra IT hardware (93) US 95 -13 198 48 -7 102 840
329 Santen Pharmaceutical Pharma & biotech (48) Japan 94 4 668 14 11 38 180
330 BorgWarner Automobiles & parts (31) US 94 8 2 433 4 10 7 86
331 Brunswick Household goods & textiles (34) US 94 15 3 273 3 6 4 89
332 Dade Behring Pharma & biotech (48) US 93 2 1 139 8 11 35 148
333 Molex Electronic & electrical (25) US 93 5 1 461 6 6 5 278
334 Kuraray Chemicals (11) Japan 93 3 2 386 4 5 13 97
335 Yokohama Rubber Automobiles & parts (31) Japan 93 2 2 962 3 6 7 36
336 Incyte Pharma & biotech (48) US 92 -24 37 249 -338 203 941
337 Openwave Systems Software & computer services (97) US 91 -20 212 43 -80 63 273
338 Ceridian Support services (58) US 91 22 994 9 15 10 213
339 3Com IT hardware (93) US 90 -60 740 12 -32 27 206
340 Network Appliance IT hardware (93) US 90 -3 707 13 10 38 775
341 Schindler Engineering & machinery (26) Switzerland 89 8 4 892 2 5 2 60
342 Hilti Construction & building (13) Liechtenstein 88 2 1 931 5 8 6 ..
343 Palm (now palmOne) IT hardware (93) US 88 -22 691 13 -25 89 208
344 Vitesse Semiconductor IT hardware (93) US 87 -35 124 70 -104 110 389
345 Daicel Chemical Industries Chemicals (11) Japan 87 2 2 007 4 4 16 68
346 Tokyo Gas Utilities - other (73. 78) Japan 87 .. 8 342 1 10 8 96
347 Symbol Technologies Electronic & electrical (25) US 86 49 1 213 7 1 16 201
348 ADC Telecommunications IT hardware (93) US 86 -38 613 14 -12 15 251
349 Ivax Pharma & biotech (48) US 86 43 1 126 8 16 10 327
350 Mitsubishi Materials Steel & other metals (18) Japan 86 -25 7 137 1 -2 4 26
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351 Pliva Pharma & biotech (48) Croatia 86 20 854 10 17 13 ..
352 Mitsubishi Gas Chemical Chemicals (11) Japan 85 -3 2 309 4 0 18 65
353 Celgene Pharma & biotech (48) US 85 40 215 40 -1 121 1 576
354 Maytag Household goods & textiles (34) US 85 -3 3 799 2 6 4 34
355 Illinois Tool Works Engineering & machinery (26) US 85 5 7 956 1 16 2 279
356 Kajima Construction & building (13) Japan 85 -0 13 869 1 2 8 18
357 Terumo Health (44) Japan 84 11 1 484 6 18 10 272
358 Fujikura Electronic & electrical (25) Japan 84 -5 2 344 4 -3 4 63
359 UBE Industries Chemicals (11) Japan 84 -12 3 799 2 5 8 24
360 Zimmer Health (44) US 84 31 1 507 6 27 13 975
361 Toto Construction & building (13) Japan 84 -8 3 253 3 4 5 87
362 Acterna IT hardware (93) US 83 -35 539 15 -49 29 ..
363 Rieter Engineering & machinery (26) Switzerland 83 -0 1 999 4 6 6 46
364 Ballard Power Systems Automobiles & parts (31) Canada 82 -9 95 87 -132 75 699
365 Quantum IT hardware (93) US 82 -8 641 13 -2 45 54
366 Adaptec IT hardware (93) US 82 -13 359 23 6 54 182
367 Kyushu Electric Power Electricity (72) Japan 81 -10 9 992 1 12 4 72
368 Tektronix IT hardware (93) US 80 -17 627 13 -2 19 325
369 Mylan Laboratories Pharma & biotech (48) US 80 16 1 090 7 37 29 289
370 Mitsubishi Rayon Chemicals (11) Japan 80 -0 2 224 4 5 9 75
371 Dainippon Screen Mfg Engineering & machinery (26) Japan 80 7 1 242 6 -3 18 77
372 Black & Decker Household goods & textiles (34) US 80 4 3 554 2 9 4 126
373 Sasol Oil & gas (07) South Africa 80 -35 7 667 1 19 3 114
374 Tohoku Electric Power Electricity (72) Japan 79 -7 11 790 1 12 4 56
375 AU Optronics Electronic & electrical (25) Taiwan 79 52 2 449 3 15 5 177
376 Harris IT hardware (93) US 79 -4 1 659 5 3 8 151
377 Watson Pharmaceuticals Pharma & biotech (48) US 79 22 1 156 7 21 20 184
378 Integrated Device Technology IT hardware (93) US 78 -24 274 29 -2 25 351
379 Activision Software & computer services (97) US 78 72 751 10 12 59 215
380 KDDI Telecommunication services (67) Japan 77 17 20 604 0 5 6 81
381 Tosoh Chemicals (11) Japan 77 6 3 491 2 5 8 45
382 Electronics For Imaging Software & computer services (97) US 77 8 301 26 9 56 282
383 SPX Electronic & electrical (25) US 76 -19 4 029 2 11 3 61
384 Sumitomo Heavy Industries Engineering & machinery (26) Japan 76 .. 3 560 2 2 7 37
385 SIG Support services (58) Switzerland 76 9 1 896 4 0 8 52
386 Sumitomo Bakelite Chemicals (11) Japan 76 5 1 186 6 1 .. 97
387 Medarex Pharma & biotech (48) US 76 16 9 841 -1 144 179 4 189
388 International Game Technology Leisure & hotels (53) US 75 18 1 687 5 32 14 530
389 Tularik Pharma & biotech (48) US 75 52 24 313 -350 185 5 517
390 Convergys Support services (58) US 75 -17 1 815 4 12 1 102
391 Saurer Engineering & machinery (26) Switzerland 75 3 1 746 4 5 7 35
392 Bio-Rad Laboratories Health (44) US 75 14 795 9 15 16 134
393 Lubrizol Chemicals (11) US 74 0 1 625 5 9 15 87
394 Nippon Oil Oil & gas (07) Japan 74 -4 23 320 0 3 5 32
395 Parker Hanniﬁn Engineering & machinery (26) US 74 -15 5 082 2 6 2 107
396 Engelhard Chemicals (11) US 74 6 2 945 3 9 11 98
397 OSI Pharmaceuticals Pharma & biotech (48) US 74 3 26 284 -558 154 7 254
398 Taisei Construction & building (13) Japan 73 0 12 166 1 2 .. 20
399 Linear Technology IT hardware (93) US 73 15 481 15 48 28 2 013
400 Intersil IT hardware (93) US 72 -30 402 18 16 45 508
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401 Macromedia Software & computer services (97) US 72 -7 293 25 13 60 384
402 Barr Laboratories
(now Barr Pharmaceuticals) Pharma & biotech (48) US 72 21 716 10 29 59 397
403 Georg Fischer Engineering & machinery (26) Switzerland 72 -8 2 113 3 -3 5 31
404 Cell Therapeutics Pharma & biotech (48) US 71 52 20 355 -485 191 1 060
405 McData IT hardware (93) US 70 50 332 21 -2 69 143
406 ImClone Systems Pharma & biotech (48) US 70 -29 70 101 -123 121 5 019
407 Regeneron Pharmaceuticals Pharma & biotech (48) US 70 -22 46 153 -172 104 783
408 Reynolds and Reynolds Software & computer services (97) US 70 -0 799 9 19 16 148
409 Campbell Soup Food producers (43) US 70 14 5 294 1 16 3 157
410 Qlogic IT hardware (93) US 70 8 415 17 38 85 431
411 FMC Chemicals (11) US 69 7 1 523 5 5 13 81
412 CR Bard Health (44) US 69 42 1 136 6 16 8 402
413 Lattice Semiconductor IT hardware (93) US 69 2 166 42 -45 66 265
414 Nippon Shokubai Chemicals (11) Japan 68 1 1 214 6 6 23 96
415 ICOS Pharma & biotech (48) US 68 41 60 113 -188 101 1 958
416 Avid Technology IT hardware (93) US 68 4 374 18 9 43 309
417 ON Semiconductor IT hardware (93) US 68 26 848 8 0 7 95
418 Microchip Technology IT hardware (93) US 68 -3 554 12 25 18 857
419 Cell Genesys Pharma & biotech (48) US 68 14 14 483 -529 194 1 629
420 Toyo Tire Automobiles & parts (31) Japan 67 3 1 888 4 4 11 27
421 Hyundai Heavy Industries Engineering & machinery (26) South Korea 67 11 6 358 1 4 .. 19
422 Yue Yuen Industrial Household goods & textiles (34) Hong Kong 67 39 1 990 3 13 0 161
423 SanDisk IT hardware (93) US 67 33 856 8 22 89 363
424 Enterasys Networks IT hardware (93) US 67 -1 329 20 -28 48 85
425 Andrew IT hardware (93) US 67 45 804 8 2 11 167
426 ECI Telecom IT hardware (93) Israel 66 -10 334 20 -17 27 160
427 Nippon Sheet Glass Construction & building (13) Japan 66 9 2 072 3 1 5 63
428 PerkinElmer IT hardware (93) US 66 -4 1 217 5 9 7 146
429 Weatherford International Oil & gas (07) US 66 4 2 054 3 11 4 239
430 Yamatake Electronic & electrical (25) Japan 66 1 1 243 5 8 9 48
431 Abgenix Pharma & biotech (48) US 66 -24 13 505 -1 223 163 5 139
432 Science Applications International Software & computer services (97) US 65 -5 5 328 1 7 2 ..
433 Toyobo Household goods & textiles (34) Japan 65 -3 2 784 2 -4 7 49
434 Hamamatsu Photonics Engineering & machinery (26) Japan 65 11 451 14 7 21 219
435 Delta Electronics Electronic & electrical (25) Taiwan 65 19 1 135 6 9 .. 134
436 Paccar Engineering & machinery (26) US 64 45 6 497 1 12 4 128
437 Akebono Brake Industry Automobiles & parts (31) Japan 64 -9 936 7 4 14 42
438 Denki Kagaku Kogyo Chemicals (11) Japan 64 6 1 804 4 5 .. 69
439 I2 Technologies Software & computer services (97) US 64 -53 392 16 4 26 67
440 National Instruments Software & computer services (97) US 64 26 338 19 10 21 533
441 Neurocrine Biosciences Pharma & biotech (48) US 64 -17 110 58 -42 194 1 186
442 Chugoku Electric Power Electricity (72) Japan 64 -14 7 466 1 13 4 68
443 Amcor Support services (58) Australia 63 51 6 397 1 6 2 52
444 Nippon Kayaku Chemicals (11) Japan 63 -2 913 7 6 17 85
445 Macronix International IT hardware (93) Taiwan 63 -29 406 16 -42 18 292
446 Micronas Semiconductor IT hardware (93) Switzerland 63 13 491 13 17 36 216
447 International Rectiﬁer IT hardware (93) US 63 13 685 9 -15 11 300
448 Citizen Watch Household goods & textiles (34) Japan 62 -21 2 471 3 5 4 99
449 Mettler-Toledo International Engineering & machinery (26) US 62 10 1 034 6 12 7 142
450 NSK Engineering & machinery (26) Japan 62 3 3 868 2 1 3 50
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451 FileNET Software & computer services (97) US 61 7 289 21 3 36 199
452 Hydro-Quebec Electricity (72) Canada 61 -8 7 009 1 69 3 ..
453 Cirrus Logic IT hardware (93) US 60 -20 156 39 13 79 262
454 Clorox Personal care & household (47) US 60 13 3 285 2 19 7 258
455 Zarlink Semiconductor IT hardware (93) Canada 60 -15 157 38 -22 57 225
456 Praxair Chemicals (11) US 60 9 4 450 1 17 2 228
457 Avery Dennison Chemicals (11) US 59 0 3 776 2 8 3 141
458 Fairchild Semiconductor IT hardware (93) US 59 -9 1 107 5 -1 6 125
459 Toyo Ink Manufacturing Chemicals (11) Japan 59 2 1 606 4 4 .. 49
460 Pentax Media & entertainment (54) Japan 59 17 800 7 3 11 64
461 Hyperion Solutions Software & computer services (97) US 59 1 405 14 10 26 314
462 Nippon Shinyaku Pharma & biotech (48) Japan 58 12 392 15 8 32 78
463 Credence Systems IT hardware (93) US 58 -14 145 40 -63 56 471
464 Tekelec IT hardware (93) US 58 23 209 28 4 55 458
465 International Paper Forestry & paper (15) US 58 -5 19 962 0 4 1 83
466 Brooks Automation IT hardware (93) US 58 -3 272 21 -51 30 187
467 Edwards Lifesciences Health (44) US 58 12 682 9 12 12 243
468 Aspen Technology Software & computer services (97) US 58 -12 256 23 -50 33 72
469 Polycom Software & computer services (97) US 58 -5 333 17 5 49 437
470 Tokuyama Chemicals (11) Japan 58 -4 1 668 4 3 13 59
471 Genencor International Pharma & biotech (48) US 58 43 304 19 8 46 243
472 AGCO Engineering & machinery (26) US 57 25 2 771 2 6 5 54
473 NetIQ Software & computer services (97) US 56 17 246 23 -296 41 172
474 Cooper Tire & Rubber Automobiles & parts (31) US 56 -4 2 786 2 6 3 50
475 MeadWestvaco Forestry & paper (15) US 56 -22 5 988 1 0 2 81
476 Nissan Chemical Industries Chemicals (11) Japan 55 12 1 123 5 6 .. 101
477 Shimizu Construction & building (13) Japan 55 -10 11 463 1 3 .. 23
478 Valspar Chemicals (11) US 55 6 1 782 3 10 8 112
479 Taiheiyo Cement Construction & building (13) Japan 55 0 6 865 1 3 3 26
480 CV Therapeutics Pharma & biotech (48) US 55 -19 9 612 989 211 3 689
481 Telenor Telecommunication services (67) Norway 55 -13 6 303 1 17 3 153
482 Asahi Breweries Beverages (41) Japan 55 7 6 321 1 8 4 68
483 Solectron Electronic & electrical (25) US 55 -8 8 732 1 -24 1 48
484 Intergraph Software & computer services (97) US 55 9 418 13 4 15 187
485 Sealed Air Support services (58) US 55 16 2 800 2 15 3 114
486 Trimble Navigation Electronic & electrical (25) US 54 11 429 13 9 25 260
487 American Power Conversion Electronic & electrical (25) US 54 13 1 161 5 16 8 206
488 Fair Isaac Software & computer services (97) US 54 67 499 11 28 23 322
489 Quest Software Software & computer services (97) US 54 14 241 22 8 31 366
490 Zeon Chemicals (11) Japan 53 12 1 560 3 4 18 78
491 Lonza Chemicals (11) Switzerland 53 -20 1 437 4 6 9 123
492 Redback Networks IT hardware (93) US 53 -27 85 62 -91 109 259
493 Advanced Fibre Communications IT hardware (93) US 52 7 264 20 7 68 443
494 LTX IT hardware (93) US 52 -7 95 55 -119 91 414
495 Affymetrix Pharma & biotech (48) US 52 -8 238 22 6 60 547
496 LG Chem Chemicals (11) South Korea 52 .. 4 589 1 10 .. 40
497 Showa Engineering & machinery (26) Japan 52 3 1 455 4 8 8 50
498 Triquint Semiconductor IT hardware (93) US 52 11 248 21 -22 25 176
499 Benq IT hardware (93) Taiwan 51 34 2 576 2 7 17 75
500 Yaskawa Electric Engineering & machinery (26) Japan 51 -10 1 673 3 -0 7 57
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